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resumo 
 
 
A inativação fotodinâmica tem sido usada com sucesso na inativação de 
microorganismos. Diversos aspetos da inativação fotodinâmica foram já 
estudados para diferentes microrganismos, contudo, existe ainda pouca 
informação disponível no que diz respeito à inativação de bacteriófagos por 
processos fotodinâmicos. Este trabalho pretendeu elucidar e avaliar vários 
aspetos da fotoinativação de vírus, em particular de bacteriófagos, incluindo (i) 
o efeito de diversos parâmetros de luz utilizados na fotoinativação de 
bacteriófagos; (ii) a eficiência da inativação fotodinâmica de diferentes tipos de 
bacteriófagos (fagos do tipo DNA e RNA); (iii) o principal mecanismo através 
do qual a inativação fotodinâmica tem lugar; (iv) o efeito da fotoinativação nas 
proteínas do bacteriófago; e (v) o possível desenvolvimento de resistência e 
recuperação da viabilidade após vários tratamentos fotodinâmicos 
consecutivos. Para avaliar o efeito dos diferentes parâmetros de luz, 
suspensões fágicas com 107 UFP mL-1 foram irradiadas com diferentes fontes 
e doses de luz, intensidades luminosas e tempos de irradiação (30,90 e 270 
min) na presença de 0,5; 1,0 e 5,0 µM dos derivados porfirínicos catiónicos Tri-
Py+-Me-PF e Tetra-Py+-Me. A eficiência da fotoinativação de diferentes fagos 
do tipo DNA e RNA, foi avaliada através da irradiação da suspensão fágica 
com luz branca (40 W m-2) durante 270 min na presença de 0,5 e 5,0 µM do 
derivado porfirínico Tri-Py+-Me-PF, respetivamente para os fagos do tipo RNA 
e DNA. O mecanismo através do qual a fotoinativação de fagos de DNA (fago 
do tipo T4) e de RNA (fago Qβ) tem lugar foi avaliado por exposição da 
suspensão fágica à luz branca com uma potência de 40 W m-2, na presença de 
fotossensibilizador (Tri-Py+-Me-PF e Tetra-Py+-Me) e inibidores, quer do 
oxigénio singuleto (azida de sódio e L-histidina) quer de radicais livres (D-
manitol e L-cisteína). Os danos nas proteínas do fago do tipo T4, induzidos 
pelas espécies reativas de oxigénio geradas por 5,0 µM Tri-Py+-Me-PF, foram 
avaliados pelo método convencional de SDS-PAGE e por espectroscopia de 
infravermelho. O possível desenvolvimento de resistência e recuperação da 
viabilidade após a inativação fotodinâmica dos bacteriófagos foi avaliado após 
dez ciclos consecutivos de tratamento fotodinâmico incompletos (120 min sob 
irradiação de luz branca a uma potência de 40 W m-2) na presença de 5,0 µM 
do derivado porfirínico Tri-Py+-Me-PF. Os resultados deste trabalho mostraram 
que (i) quando uma quantidade de energia (dose de luz) determinada foi 
aplicada numa suspensão fágica, a partir de uma mesma fonte irradiação, a 
fotoinactivação do fago foi tanto mais eficiente quanto mais baixa foi a potência 
luminosa aplicada; (ii) os bacteriófagos foram eficientemente inativados até ao 
limite de deteção (redução de 6-7 log); (ii) os fagos do tipo RNA foram 
inativados mais facilmente do que os fagos do tipo DNA (tempos de exposição 
mais curtos e com concentração de fotossensibilizador dez vezes menor do 
que a usada para inativar os fagos do tipo DNA); (iii) o mecanismo do tipo II 
(via produção de oxigénio singuleto) foi o principal mecanismo através do qual 
a fotoinativação dos bacteriófagos teve lugar; (iv) foi possível detectar danos 
no perfil proteico após tratamento fotodinâmico e a espectroscopia de 
infravermelho apresentou-se como uma metodologia promissora de screening 
para avaliação dos danos induzidos pela inativação fotodinâmica em proteínas; 
e (v) após dez ciclos consecutivos de tratamento fotodinâmico, o fago do tipo 
T4 não revelou nenhum tipo de resistência ao tratamento fotodinâmico nem 
recuperou a sua viabilidade. Como conclusão, a inativação fotodinâmica 
microbiana é uma tecnologia bastante eficaz para a fotoinativação de 
bacteriófagos do tipo DNA e RNA sem invólucro, a qual pode ser considerada 
como uma alternativa ao tratamento convencional com agentes antivíricos, 
mesmo com intensidades luminosas baixas, sem o risco associado de 
desenvolvimento de mecanismos de resistência. 
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abstract 
 
Microbial photodynamic inactivation (PDI) has been successfully used to 
inactivate microorganisms. PDI has already been studied under different 
conditions for different microorganisms; however, there is still scarce 
information about bacteriophage inactivation by photodynamic procedures. The 
goal of this study was to elucidate and evaluate several aspects of viral PDI 
which include (i) the effect of different light sources, doses and intensities on 
phage inactivation; (ii) the photoinactivation efficiency on different types of 
bacteriophages (DNA- and RNA-type phages), (iii) the main mechanism by 
which phage photosensitization takes place, (iv) the effect of PDI on phage 
proteins; and (v) the possibility of resistance development and viability recovery 
after consecutive phototreatments. To evaluate the efficiency of 
photoinactivation, T4-like phage suspensions of 107 PFU mL-1 were exposed to 
different light sources(fluorescent PAR lamps, solar light and halogen lamp), 
and fluence rates (40 W m-2, 600 W m-2 and 1690 W m-2) during 30, 90 and 270 
min in the presence of 0.5, 1.0 and 5.0 µM of the cationic porphyrin derivatives 
Tri-Py+-Me-PF and Tetra-Py+-Me. DNA- and RNA-type phages were exposed 
to white light (40 W m-2) during 270 min in the presence of Tri-Py+-Me-PF at the 
concentrations of 0.5 and 5.0 µM, respectively for RNA- and DNA-type phages. 
The mechanism of phage inactivation was evaluated for DNA- (T4-like) and 
RNA-type (Qβ) phages, in the presence of photosensitizer (Tri-Py+-Me-PF and 
Tetra-Py+-Me) and singlet oxygen quenchers (sodium azide and L-histidine) 
and free radicals scavengers (D-mannitol and L-cysteine). The damages on T4-
like phage proteins, induced by the ROS generated by Tri-Py+-Me-PF, were 
assessed by the conventional SDS-PAGE analysis and by IR spectroscopy. 
Ten consecutive and incomplete (120 min of irradiation at 40 W m-2) cycles of 
T4-like phage photosensitization by 5.0 µM Tri-Py+-Me-PF were also performed 
in order to determine the possible development of resistance and viability 
recovery after phage PDI. From this study it can be concluded that (i) 
considering the same light source and a fixed light dose, applied at different 
fluence rates, phage photoinactivation was significantly higher when low 
fluence rates were used at long irradiation times; (ii) the phages were efficiently 
inactivated to the detection limit (reductions of 6-7 log); (ii) RNA-type phages 
were much more easily inactivated than the DNA-type ones (sooner and with 
ten times less porphyrin concentration than that used for DNA-type phages); 
(iii) type II mechanism (production of singlet oxygen) was the main mechanism 
by which phage photosensitization took place; (iv) IR spectroscopy represents 
a promising and fast-screening methodology when the damages induced by 
photosensitization on phage proteins are to be studied; and (v) after ten 
consecutive photodynamic cycles, T4-like phage did not exhibit any resistance 
to PDI nor recovered its viability. In conclusion, viral PDI is a very efficient 
technology for the inactivation of non-enveloped DNA- and RNA-type phages, 
which may be used as an alternative to the conventional antiviral treatments, 
even at low light fluence rates, without the problem of viral resistance. 
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THESIS OUTLINE 
 
 
The present work is focused on the potential use of a photodynamic inactivation (PDI) procedure 
to inactivate viruses, which are known to pose a threat to public health. As the traditional viral culture 
methods are time-consuming, labour-intensive processes, some viruses are not cultivated in cell lines and 
molecular methods do not allow determining viral viability, bacteriophages were used as surrogates of 
mammalian viruses to evaluate the efficiency of viral PDI. In this work, only non-enveloped model 
bacteriophages were used but, as enveloped viruses are significantly more sensitive to photodynamic 
inactivation than non-enveloped ones, a PDI protocol that is effective to inactivate non-enveloped phages 
will also be effective against non-enveloped and enveloped mammalian viruses. 
In order to get a clear insight of the process of viral photoinactivation, several goals were 
established: 
• Evaluation of the effect of light parameters (light sources, doses and intensities) on the 
photodynamic inactivation of bacteriophages. 
• Evaluation of the different susceptibilities to photosensitization of DNA- and RNA-type 
bacteriophages; 
• Evaluation of the main mechanism by which phage photosensitization takes place; 
• Evaluation of the damages induced by photosensitization on phage proteins and; 
• Evaluation of resistance development and viral viability recovery after consecutive 
episodes of photosensitization. 
 
A careful bibliographic revision of the state of the art of viral photodynamic inactivation was done 
(Chapter 1), experimental studies were performed (Chapters 2-6) and a final discussion of all the results 
was undertaken (Chapter 7) in order to achieve the main goals of this study.  
The phage photoinactivation procedures were performed in the presence of the 5-
(pentafluorophenyl)-10,15,20-tris(1-methylpyridinium-4-yl)porphyrin tri-iodide (Tri-Py+-Me-PF), a 
promising and efficient photosensitizer synthesized at the Department of Chemistry of the University of 
Aveiro, which was generally compared with the well-known photosensitizer 5,10,15,20-tetrakis(1-
methylpyridinium-4-yl)porphyrin tetra-iodide (Tetra-Py+-Me) (Figure 1). 
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Figure 1. Structure of the PS used for bacteriophages photodynamic inactivation. 
 
In Chapter 1, an introduction to PDI was done and it was also summarized the main 
approaches developed until now for the photodynamic inactivation of bacteriophages and 
mammalian viruses. Since bacteriophages are frequently used as surrogates of mammalian viruses it 
is important to discuss and compare the past and present state of the art of mammalian viruses PDI 
with phage photoinactivation. This chapter intends to give a special focus to the inactivation of 
different nucleic acid-type bacteriophages and also to the most relevant mechanisms of 
photosensitization, viral molecular targets, development of viral resistance and other factors 
affecting the viral inactivation process. 
 
Since the photosensitizer used to inactivate the viruses need a light source in order to be 
activated to exert their toxic effect, the factors associated with the light conditions required for an 
efficient PDI need to be assessed. However, the effect of different light sources, fluence rates and 
light doses in PDI efficiency was not yet well evaluated for viral inactivation. This chapter includes 
a study about the effect of different light sources, doses and intensities in the rate of a DNA-type 
phage photoinactivation (Chapter 2). 
 
The next step of this work was to make a comparative study of the different susceptibilities 
of several DNA- and RNA-type phages to photosensitization. For this purpose, different non-
enveloped DNA- and RNA-type phages were submitted to the same PDI protocol and the efficiency 
of their photoinactivation was subsequently evaluated (Chapter 3). 
 
After assessing the efficacy of DNA- and RNA-type phages it is important to study the main 
mechanism involved on DNA- and RNA-type bacteriophages photosensitization. In the presence of 
molecular oxygen and excited photosensitizers, free radical species (type I mechanism) and singlet 
oxygen (type II mechanism) are generated, which are known to cause damages to important 
biomolecules. By the use of different singlet oxygen quenchers and free radicals scavengers, the 
main mechanism of DNA- and RNA-type bacteriophages photosensitization was evaluated (Chapter 
4). 
 
Reactive oxygen species (ROS) like singlet oxygen and free radicals are extremely toxic and 
can damage important viral structures, such as the envelope lipids and proteins (in the particular case 
of enveloped viruses), capsid and core proteins and the nucleic acids. From all these viral targets, the 
outer structures (proteins) are told to be the most important ones due to their significant destruction 
after PDI, which is associated with viral inactivation. For this reason, the damages on T4-like phage 
proteins after photosensitization with Tri-Py+-Me-PF and white light irradiation were evaluated by 
IR spectroscopy, in comparison with the conventional SDS-PAGE analysis (Chapter 5). 
 
Due to the worldwide increased use of antiviral agents, the risk of viral resistance is gaining 
a new importance. In this way, viral PDI may represent a good alternative for the purpose of viral 
inactivation in a less expensive and in an environmental-friendly way. However, the possible 
development of viral resistance after consecutive episodes of viral photosensitization was not yet 
evaluated for viruses. The possible development of photoresistance to PDI was evaluated for the 
DNA phage T4-like after ten cycles of sub-lethal treatments. The possibility of the viruses to recover 
their viability after repeated phototreatments was also evaluated (Chapter 6). 
 
In the final chapter of this thesis all the experimental results were discussed together and 
some conclusions about the photoinactivation of viruses were taken (Chapter 7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 CHAPTER 1 
 
INTRODUCTION 
 
Photodynamic inactivation of mammalian viruses and bacteriophages 
 
Abstract 
Photodynamic inactivation (PDI) has been used to inactivate microorganisms through the use of 
photosensitizers. The inactivation of mammalian viruses and bacteriophages by photosensitization 
has been applied with success since the first decades of the last century. Due to the fact that 
mammalian viruses are known to pose a threat to public health and that bacteriophages are 
frequently used as models of mammalian viruses, it is important to know and understand the 
mechanisms and photodynamic procedures involved in their photoinactivation. The aim of this 
review is to (i) summarize the main approaches developed until now for the photodynamic 
inactivation of bacteriophages and mammalian viruses and, (ii) discuss and compare the present 
state of the art of mammalian viruses PDI with phage photoinactivation, with special focus on the 
most relevant mechanisms, molecular targets and factors affecting the viral inactivation process. 
 
Keywords: bacteriophages; mammalian viruses; photodynamic therapy; photosensitizer; viral 
photoinactivation process. 
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1. Introduction 
Humans are exposed to pathogenic viruses through various routes and the development of viral-
induced diseases is a common occurrence. 
Although the transmission of viral diseases has been reduced by the development of good water 
supplies and hygienic-based procedures for a whole range of human activities (Jori and Brown, 2004), 
pathogenic viruses are still the causative agents of many diseases in humans and other species. The most 
usual human diseases caused by viruses include the common cold (coronaviruses), influenza (influenza 
viruses), chickenpox (varicella zoster virus), cold sores (herpes simplex virus), gastroenteritis and 
diarrhoea (caliciviruses, rotaviruses and adenoviruses) (van der Poel et al, 2000; Blerkom, 2009). 
Pathogenic viruses are also implicated in serious diseases, such as Ebola (Ebola virus), AIDS 
(immunodeficiency viruses), avian influenza and sudden acute respiratory syndrome (SARS) (SARS-
coronavirus), and they are also an established cause of cancer (papillomavirus, hepatitis B and C viruses, 
Epstein-Barr virus, Kaposi’s sarcoma-associated herpes virus, human T-lymphotropic virus, and Merkel 
cell polyomavirus) (Pulitzer et al, 2009).  
The enhanced implication of viruses in severe infectious diseases and the increasing knowledge 
about the complex mechanisms of viral pathogenesis have greatly contributed to the rapid development of 
antiviral drugs. Consequently, the use of antivirals has largely increased in the last years and resistance to 
antiviral drugs is now well documented for several pathogenic viruses (Sullivan et al, 1993; Smee et al, 
1995; Kimberlin and Whitley, 1996; Jabs et al, 1998; Pillay and Zambon, 1998; Smee et al, 2002). 
Moreover, as viruses are genetically flexible, they may mutate quickly and mutations come as no 
surprises, leading to the development of resistance to conventional antiviral drugs. Consequently, the 
emergence of antiviral drug resistance can become a great problem, such the resistance observed for 
bacteria relative to antibiotics. So, alternative methods unlikely to cause resistance are required. 
Photodynamic inactivation (PDI) of viruses represents a promising and inexpensive potential alternative to 
meet that need. 
The sensitivity of viruses to photodynamic procedures was reported in the 1930s (Schultz and 
Krueger, 1928; Perdrau and Todd, 1933) but only within the last 30 years, with the development of new 
active molecules, namely photosensitizers (PS), and an increment of light technologies (lasers, LED, 
portability, etc.), have photodynamic techniques for the inactivation of viruses received growing attention 
(Käsermann and Kempf, 1998). Most of the clinical applications of PDI for treatment of infections have 
so far been directed to viral lesions (Hamblin and Hasan, 2004). Clinical PDI was first applied to the 
treatment of herpes infection in the early 1970s (Felber et al, 1973), particularly for herpes genitalis. 
Since then, a great variety of viruses has been effectively inactivated by photodynamic treatment using in 
vitro conditions (Almeida et al, 2011) but, considering the clinical use of viral PDI, the procedures are 
limited to the treatment of papillomatosis, caused by human papillomatosis virus (HPV), like laryngeal 
papillomatosis (Mullooly et al, 1990) and epidermodysplasia verruciformis (Karrer et al, 1999) and, in a 
small scale, to the treatment of viral complications in AIDS patients (Lavie et al, 1995; Smetana et al, 
1997). However, considerable progress has been made in the viral photodynamic disinfection of blood 
products. The major threat of viral contamination in blood and blood products comes from the 
immunodeficiency viruses (HIV) (Sloand et al, 1995), hepatitis viruses (Mannucci, 1992; Klein, 1994; 
Sloand et al, 1995), cytomegalovirus (Klein, 1994), human parvovirus B19 (Azzi et al, 1993) and human 
T-cell lymphotropic virus type I and type II (Klein, 1994). HIV has been inactivated in vitro following a 
photodynamic procedure (Asanaka et al, 1989; Dixon et al, 1990; Lambrecht et al, 1991; Levere et al, 
1991; Matthews et al, 1992; Lenard et al, 1993; Neurath et al, 1993; Debnath et al, 1994; North et al, 
1994; Bachmann et al, 1995; Song et al, 1997; Vzorov et al, 2002; Vanyur et al, 2003; Dairou et al, 2004; 
Marchesan et al, 2005). The photoinactivation of hepatitis viruses in blood products has also been 
successfully tested against the hepatitis C virus (HCV) (North et al, 1992; Müller-Breitkreutz and Mohr, 
1998; Vanyur et al, 2003; Cheng et al, 2010), hepatitis B virus (HBV) (Lin and Hu, 2008) and hepatitis A 
virus (HAV) (Casteel et al, 2004). Inactivation of cytomegalovirus (O’Brien et al, 1992), human 
parvovirus B19 (Mohr et al, 1997) and human T-cell lymphotropic virus (Sieber et al, 1987) in blood 
products was also efficiently achieved after photodynamic treatment. 
The availability of a simple and quantitative assay to follow the viral photoinactivation process is 
important. Traditional viral quantification techniques, such as in vitro viral cultures, are time-consuming 
and labor-intensive processes. Molecular quantitative methods such as nucleic acid amplification 
procedures, including real time PCR, are rapid and sensitive but detect only viral nucleic acid and do not 
determine infectivity. When the virucidal properties of different photosensitizing compounds are initially 
evaluated, bacteriophages can be useful as surrogates of mammalian viruses. The reasons for their use 
are: (i) the detection methods are much simpler, faster and cheaper than those of mammalian viruses, 
avoiding the advanced facilities and equipment needed for propagating human pathogens; (ii) they are 
non-pathogenic to humans; (iii) they can be grown to higher titers than most mammalian viruses and, 
therefore, enhancing the sensitivity of the assay; (iv) the results of bacteriophages assays are available 
within several hours post-inoculation, instead of the days or weeks required by mammalian viruses 
infectivity-based assays; (v) they are at least as resistant as the mammalian viruses to environmental 
factors and to water treatment (Leclerc et al, 2000). 
It has been shown that enveloped viruses are significantly more sensitive to photodynamic 
destruction than non-enveloped viruses (Rywkin et al, 1994; Käsermann and Kempf, 1997). As most of 
the bacteriophages are non-enveloped, they are more difficult to suffer photoinactivation than the 
enveloped viruses. In general, this property makes them good indicators to evaluate the efficiency of viral 
PDI. A PDI protocol that is effective to inactivate a non-enveloped phage will most likely be effective 
against enveloped mammalian viruses. 
Several bacteriophages were used in photoinactivation studies as surrogates for mammalian 
viruses, e.g., MS2 (Casteel et al, 2004), M13 (DiMascio et al, 1989; Abe et al, 1997), PM2 (Specht, 
1994), Qβ (Schneider et al, 1993; Jockush et al, 1996; Lee et al, 1997), PRD1 (Hotze et al, 2009), λ 
(Kastury and Platz et al, 1992; Martin et al, 2005), φ6 (Wagner et al, 1998), R17 (Wagner et al, 1998), 
Serratia phage kappa (Brendel, 1970), T5 (Yamamoto, 1957), T3 (Witmer and Fraser, 1971), T7 (Gábor 
et al, 2001; Egyeki et al, 2003; Hotze et al, 2009) and T4-like (Kadish et al, 1964; Costa et al, 2008; Costa 
et al, 2010; Costa et al, 2011), and the results show that they are effectively photoinactivated. 
 
2. Antimicrobial PDI 
PDI is a simple and controllable method for the inactivation of microorganisms based on the 
production of reactive oxygen species (ROS) (free radicals and singlet oxygen). This technology requires 
the combined action of oxygen, light and a photosensitizer (PS), which absorbs and uses the energy from 
light to produce those ROS (DeRosa and Crutchley, 2002). Therefore, the photodynamic effects depend 
on multiple variables including: the structural features of the PS, the concentrations of PS and molecular 
oxygen, and the properties of the light used (e.g., wavelength, type, dose and fluence rate) (DeRosa and 
Crutchley, 2002; Capella and Capella, 2003; Castano et al, 2004; Costa et al, 2008; Prates et al, 2009; 
Costa et al, 2010). Changes in any of these parameters will affect the rate of microbial photoinactivation 
(Welsh and Adams, 1954; Huang et al, 2004; Costa et al, 2008; Costa et al, 2010). 
The majority of the PS used in PDI is derived from tetrapyrrolic macrocycles known as 
porphyrins. These chromophores and their analogs, such as chlorins and bacteriochlorins, are involved in 
very important biological functions, such as respiration (heme group) and photosynthesis (chlorophyll 
and bacteriochlorophyll (Figure 1). Based on these macrocycles, the scientific community was able to 
develop a number of synthetic analogs, such as meso-tetraarylporphyrins, phthalocyanines, texaphyrins, 
porphycenes and saphyrins, which proved to have very promising features for being used as PS (Figure 2) 
(Almeida et al, 2011). Also, non-tetrapyrrolic derivatives, such as the naturally occurring hypericin, or 
synthetic dyes like toluidine blue O (TBO), rose bengal, eosin, methylene blue (MB) and fullerenes, were 
considered in many PDI studies (Figure 3) (Castano et al, 2004). 
In order to be efficient, photosensitizing agents used for viral PDI must bind specifically to vital viral 
components, such as lipid envelope (when present), the protein coat or to the nucleic acids (Jockush et al, 
1996). 
 
 
Figure 1. Structure of some tetrapyrrolic macrocycles with natural occurrence. 
 
 
Figure 2. Skeletons of some synthetic pyrrolic macrocycles used as photosensitizers. 
 
 Figure 3. Structure of some non-tetrapyrrolic photosensitizers. 
 
The efficiency of mammalian viruses and bacteriophages PDI has been described for 
porphyrin derivatives, chlorin derivatives, chlorophyll derivatives, phthalocyanine derivatives, 
hypericin, methylene blue, rose bengal, merocyanine 540, proflavine, and fullerene derivatives 
(Table 1). 
 
Table 1. Some PS used for mammalian viruses and bacteriophages PDI 
Photosensitizer Microorganism PDI Reference 
Mammalian viruses  
Hematoporphyrin derivative  HSV-1 7 log Schnipper et al, 
1980 
 HSV-1 < 0.8 log Vzorov et al, 
2002 
    
Uroporphyrin  Adenovirus 7 log Schagen et al, 
1999 
    
Natural metalloporphyrin derivatives HIV-1 < 0.8 log Vzorov et al, 
2002 
    
Chlorophyll derivatives VSV ∼ 6 log Lim et al, 2002 
    
7-despropionate-7- 
hydroxypropylmesopyropheophorbide 
a 
BVDV 
EMCV 
∼ 5 log 
∼ 0.2 log 
Sagristá et al, 
2009 
    
Benzoporphyrin derivative monoacid 
ring A 
HIV-1 > 4 log North et al, 
1994 
    
Glycoconjugated meso-
tetraarylporphyrin derivatives 
HSV-1 
HSV-2 
6 log 
6 log 
Tomé et al, 
2005 
    
Metallo tetrasulfonated meso-
tetraarylporphyrin derivatives 
HIV-1 ≤ 2 log 
 
Vzorov et al, 
2002 
    
Tetrasulfonated meso-
tetraarylporphyrin derivatives 
HIV-1 ≤ 2 log 
 
Vzorov et al, 
2002 
 HAV ∼ 4 log Casteel et al, 
2004 
    
meso-Tetrakis(1-methylpyridinium-4-
yl)porphyrin 
HAV ∼ 4 log 
 
Casteel et al, 
2004 
    
meso-Tetrakis(1-butylpyridinium-4-
yl)porphyrin 
HAV > 3.8 log Casteel et al, 
2004 
    
meso-Tetrakis(1-octylpyridinium-4-
yl)porphyrin 
HAV > 3.9 log Casteel et al, 
2004 
    
Cationic β-vinyl substituted meso-
tetraphenylporphyrin derivatives 
HSV-1 < 3 log Silva et al, 2005 
    
Aluminum 
dibenzodisulfophthalocyanine  
HIV-1 3.7 log Rywkin et al, 
1994 
    
Aluminum phthalocyanine 
tetrasulfonate 
HIV-1 > 5 log Rywkin et al, 
1994 
 VSV 4.2 log Moor et al, 1997 
 Adenovirus 4 log Schagen et al, 
1999 
    
Silicon phthalocyanine derivative 
 
VSV 4 log Moor et al, 1997 
    
Cationic phthalocyanines HIV-1 > 5 log Rywkin et al, 
1994 
 HSV-1 ≥ 5 log Smetana et al, 
1998 
    
Hypericin HIV-1 
VSV 
Influenza virus 
Sendai virus 
NQ 
4-5 log 
NQ 
NQ 
Lenard et al, 
1993 
    
Methylene blue VSV 4.7 log Abe and 
Wagner, 1995 
 HSV-1 5 log Müller-
Breitkreutz et al, 
1995 
 SHV-1 2.5 log Müller-
Breitkreutz et al, 
1995 
 HCV < 2 log Müller-
Breitkreutz and 
Mohr, 1998 
 HIV-1 < 2 log Müller-
Breitkreutz and 
Mohr, 1998 
 Adenovirus  7 log Schagen et al, 
1999 
 Dengue virus 5-6.4 log Huang et al, 
2004 
 Enterovirus 71 ∼ 8 log Wong et al, 
2010 
 Vaccinia virus 5 log Turner and 
Kaplan, 1968 
    
Phenothiazine derivatives VSV > 4.4 log Wagner et al, 
1998 
    
Rose bengal Vaccinia virus 5 log Turner and 
Kaplan, 1968 
 HIV-1 NQ Lenard et al, 
VSV 
Influenza virus 
Sendai virus 
4-5 log 
NQ 
NQ 
1993 
 Adenovirus 7 log Schagen et al, 
1999 
    
Buckminsterfullerene SFV 
VSV 
7 log 
7 log 
Käsermann and 
Kempf, 1997 
 
    
Merocyanine 540 HSV-1 5-6 log O’Brien et al, 
1992 
    
Bacteriophages    
Glycoconjugated meso-
tetraarylporphyrins 
T7 phage < 3 log Gábor et al, 
2001 
 T7 phage < 3.5 log Egyeki et al, 
2003 
    
Tetrasulfonated meso-
tetraarylporphyrin derivatives 
MS2 phage > 3.8 log Casteel et al, 
2004 
    
meso-Tetrakis(1-methylpyridinium-4-
yl)porphyrin 
λ phage < 7 log Kastury and 
Platz, 1992 
 MS2 phage > 4.1 log Casteel et al, 
2004 
 T4 phage 7 log Costa et al, 
2008; Costa et 
al, 2010 
 T7 phage < 4 log Zupán et al, 
2008 
    
5-(pentafluorophenyl)-10,15,20-tris(1-
methylpyridinium-4-yl)porphyrin 
T4 phage 7 log Costa et al, 
2008; Costa et 
al, 2010; Costa 
et al, 2011 
    
5-(4-methoxicarbonylphenyl)-
10,15,20-tris(1-methylpyridinium-4-
yl)porphyrin 
T4 phage 7 log Costa et al, 
2008 
    
5-(4-carboxyphenyl)- 
10,15,20-tris(1-methylpyridinium-4- 
yl)porphyrin 
T4 phage 3.9 log Costa et al, 
2008 
    
5,10-bis(4-carboxyphenyl)-15,20-
bis(1-methylpyridinium-4-
yl)porphyrin 
T4 phage 1.4 log Costa et al, 
2008 
    
5,15-bis(4-carboxyphenyl)-10,20-
bis(1-methylpyridinium-4-
yl)porphyrin 
T4 phage 1.2 log Costa et al, 
2008 
    
5,10,15-tris(1-methylpyridinium-4-yl)-
20-phenylporphyrin 
T7 phage 1.7 log Zupán et al, 
2008 
    
Methylene blue Serratia phage kappa > 4 log Brendel, 1970 
 M13 phage 2.2 log Abe and 
Wagner, 1995; 
Abe et al, 1997 
 f2 phage  5 log Lee et al, 1997 
 Qβ phage 7-8 log Lee et al, 1997 
 Qβ phage 7-8 log Schneider et al, 
1998 
    
Phenothiazine derivatives R17 phage 
φ6 
4-7 log 
4-6.5 log 
Wagner et al, 
1998 
    
Rose bengal PRD1 phage 
T7 phage 
∼ 3.5 log* 
∼ 4.5 log* 
Hotze et al, 
2009 
    
Riboflavin λ phage < 4 log Martin et al, 
2005 
    
Proflavine Serratia phage kappa 4 log Brendel, 1970 
 T3 phage 7-11 log Witmer and 
Fraser, 1971 
    
Polyhydroxylated fullerene MS2 phage ∼ 4 log Badireddy et al, 
2007 
 PRD1 phage 
T7 phage 
MS2 phage 
∼ 2.5 log* 
∼ 3.5  log* 
∼ 5 log*  
Hotze et al, 
2009 
* log (N/N0) 
 
Besides this, viral PDI has also been described for phthalocyanine derivatives (Abe and Wagner, 
1995), MB (Yamamoto, 1957; Specht, 1994; Floyd et al, 2004; Marotti et al, 2009), TBO (Yamamoto, 
1957; Wallis and Melnick, 1965; Specht, 1994), neutral red (Wallis and Melnick, 1965), proflavine 
(Wallis and Melnick, 1965), azure B (Specht, 1994) and merocyanine 540 (Sieber et al, 1987; Lytle et al, 
1991; O’Brien et al, 1992). 
 
3. Mechanisms of Photodynamic Inactivation 
The mechanisms of PDI are based on the ability of the PS to absorb energy from light and transfer 
that energy to molecular oxygen. In the dark, the electronic configuration of a PS exists in the so-called 
ground state. The absorption, by the PS, of a photon at an appropriate wavelength initially leads to the 
production of an unstable, electronically-excited state of the PS molecule (the lifetime of this state ranges 
from 10−9 to 10−6 s) (Via and Magno, 2001). The excited PS molecule can then decay to the ground state 
by emission of light (radiative pathway - fluorescence) or by intersystem crossing, affording the excited 
triplet state which has a longer lifetime (10−3 to 10 s) (Via and Magno, 2001). At this point, the PS can 
reach the ground state either by spin inversion followed by phosphorescence emission, or by a non-
radiative process. Due to the longer lifetime of the PS triplet state, this excited state can also react in one 
of two ways (Figure 2): by initiating photochemical reactions that can directly generate reactive oxygen 
species (ROS) (type I pathway), or indirectly by energy transfer to molecular oxygen (type II pathway), 
leading to the formation of singlet oxygen. These events afford toxic species which are responsible for the 
irreparable oxidative damages induced to important biological targets (Schmidt-Erfurth and Hasan, 2000; 
Via and Magno, 2001; DeRosa and Crutchley, 2002; Jori and Brown, 2004). 
 Figure 4. Schematic representation of the photosensitization process (adapted from Wainwright, 
1998). 
 
3.1. Type I and Type II Mechanisms 
Type I mechanism involves hydrogen-atom abstraction or electron-transfer between the excited 
PS and a substrate, yielding free radicals [Equations (1) and (2)]. These radicals can react with oxygen to 
form active oxygen species, such as the superoxide radical anion [Equation (3)]. Superoxide is not 
particularly reactive in biological systems but, when protonated, can lead to the production of hydrogen 
peroxide and oxygen [Equations (4) and (5)] or highly reactive hydroxyl radicals [Equations (6)–(8)] 
(Bonnett, 2000). Type II photooxidation is considerably less complex mechanistically than type I and in 
general there are far fewer products (Girotti, 2001). In this pathway, the excited triplet state PS (3PS*) can 
transfer the excess energy to molecular oxygen (3O2) and relax to its ground state (1PS) creating an 
excited singlet molecular oxygen (1O2) [Equation (9)] (DeRosa and Crutchley, 2002). 1O2 is highly 
electrophilic and can interact with numerous enzymes, leading to the inhibition of protein synthesis and 
molecular alteration of DNA strands, which alters the transcription of the genetic material during its 
replication (mutagenic effect) and, in this way, leading to microbial death [Equation (10)] (Bonnett, 2000; 
Calin and Parasca, 2009). Like nucleic acids and proteins, unsaturated lipids are also prominent targets of 
1O2 and free radical attack. Lipid peroxidation-ensuing reactions can alter surrounding proteins, nucleic 
acids and other molecules, in addition to the lipids themselves (Bonnett, 2000). Therefore, it is likely that 
damage of different kinds caused to the viral envelope is important in the process of microbial 
inactivation (Käsermann and Kempf, 1998).  
 
SubstrateH2 + PS  PSH + SubstrateH (1) 
PS* + Substrate  PS− + Substrate+ or PS* + Substrate  PS+ + Substrate− (2) 
PS− + 3O2  PS + O2− (3) 
O2− + H+  HOO (4) 
2 HOO  H2O2 + O2 (5) 
H2O2 + Fe2+  HO + OH− + Fe3+ (6) 
BiomoleculeH + HO  Biomolecule + H2O (7) 
Biomolecule + 3O2  Biomolecule-OO  products (8) 
PS* + 3O2  PS + 1O2 (9) 
Biomolecules + 1O2  oxidative products (10) 
 
Both type I and type II mechanisms can occur simultaneously or exclusively, and the ratio 
between these processes depends on the PS used and on the concentrations of substrate and oxygen (Via 
and Magno, 2001). The competition between organic substrates and molecular oxygen for the 3PS* 
determines whether the reaction pathway is type I or type II and the predominant mechanism can be 
changed during the course of the PDI process (Min and Boff, 2002). 
  
3.2. Evaluation of the Specific Involvement of Type I and Type II Mechanisms 
An important goal in the investigation of viral PDI is to identify the type of mechanism involved 
(type I or type II) in the presence of a selected PS (Maisch et al, 2005). The simple detection of a reactive 
species does not necessarily explain the mechanism by which a specific PS induces the toxic effect. It is 
generally easier to draw a negative conclusion, i.e., if singlet oxygen is absent, it cannot be the reactive 
species responsible for the photodynamic effect (Ochsner, 1997). The simplest approach for determining 
whether singlet oxygen (type II mechanism) or free radicals (type I mechanism) is involved in the 
photodynamic process is to study the inhibitory effects of various scavengers, i.e., compounds that can 
intercept these ROS at high rates and in a putatively selective manner (Girotti, 2001; Min and Boff, 2002; 
Wondrak et al, 2005). 
 
3.2.1. Type I Mechanism Scavengers 
A first line of defence against ROS is, of course, the protection against their formation. However, 
the interception of the damaging species once formed, to prevent it from further deleterious reactions, is 
also a deactivation strategy of defence. In general, free radical scavengers neutralize the radical species by 
donating one of their own electrons. The scavenging agents themselves are not particularly toxic before 
and after the electron donation (Sies, 1997). 
Three different types of scavenging are possible, which include the transfer of the radical 
character with the formation of a reactive scavenger-derived radical; trapping of free radicals with the 
formation of a stable or inert free radical trap; and molecules which mimic quenching enzyme activities. 
In general, scavenger molecules either prevent free radicals from being formed or remove them before 
they can damage vital molecular components (Sies, 1997). 
Several free radical scavengers have been used to evaluate the specific involvement of type I 
mechanism during mammalian viruses and bacteriophages PDI with different PS (Table 2). 
Table 2. Free radical scavengers used in mammalian viruses and bacteriophages PDI. 
PS Scavenger Microorganism Scavenger 
protection 
Reference 
Mammalian viruses     
 
Aluminum phthalocyanine 
tetrasulfonate  
Reduced glutathione 
Mannitol 
Glycerol 
SOD 
VSV 
VSV 
VSV 
VSV 
little/no effect 
little/no effect 
little/no effect 
little/no effect 
Rywkin et al, 
1992 
     
Polyhydroxylated fullerene  Glutathione (2.0 mM) SFV 
VSV 
no effect 
no effect 
Käsermann and 
Kempf, 1997 
 Hydroquinone (2.0 mM) SFV 
VSV 
no effect 
no effect 
Käsermann and 
Kempf, 1997 
     
Merocyanine 540 Glutathione (10 and 30 
mmol L-1) 
Cysteamine (10 and 30 
mmol L-1) 
SOD (1.5 to 29 U mL-1) 
HSV-1 30-50% 
 
60-70% 
 
no effect 
O’Brien et al, 
1992 
     
Methylene blue Mannitol (100 mM) 
Glycerol (10 mM) 
SOD (300 U mL-1) 
Catalase (30 U mL-1) 
HSV-1 24% 
24% 
24% 
24% 
Müller-
Breitkreutz et 
al, 1995 
     
Bacteriophages     
 
5,10,15-(4-β-D-
glucosylphenyl)-20-
phenylporphyrin  
DMTU (0.1-5.0 mM) T7 phage 44% Gábor et al, 
2001 
     
5,10.15,20-Tetrakis(4-β-D-
glucosylphenyl) porphyrin 
DMTU (0.1-5.0 mM) T7 phage 79% Gábor et al, 
2001 
     
5,10,15-(4-β-D-
galactosylphenyl)-20-
(pentafluorophenyl)-
porphyrin 
DMTU (0.1-5.0 mM) T7 phage 89% Egyeki et al, 
2003 
     
5-(pentafluorophenyl)-
10,15,20-tris(1-
methylpyridinium-4- 
yl)porphyrin 
D-mannitol (100 mM) T4-like phage 
Qβ 
20% 
no effect 
Costa et al, 
submitted 
 L-cysteine (100 mM) T4 phage 9% Costa et al, 
submitted 
 
 
   
5,10,15,20-tetrakis(1-
methylpyridinium-4-
yl)porphyrin 
D-mannitol (100 mM) T4 phage no effect Costa et al, 
submitted 
     
Proflavine L-cysteine (0.025 M) T3 phage 75-80% Witmer and 
Fraser, 1971 
     
Polyhydroxylated fullerene SOD MS2 phage no effect Badireddy et al, 
2007 
 
  
3.2.1.1. Free Radicals in PDI of Mammalian Viruses  
Free radical species had, in general, little or no effect on the photoinactivation of the studied 
mammalian viruses (Table 2). In fact, it can be observed that the rate of inactivation of HSV (O’Brien et 
al, 1992; Rywkin et al, 1992; Müller-Breitkreutz et al, 1995), influenza virus (Lenard and Vanderoef, 
1993), Semliki Forest virus (SFV) and VSV (Käsermann and Kempf, 1997) in the presence of different 
PS and scavengers like glutathione, mannitol, glycerol, superoxide dismutase (SOD), catalase and 
hydroquinone was not significantly affected. Although this data suggest that free radicals are not major 
players in the viral inactivation process, the participation of type I reaction pathways cannot be ruled out, 
as was shown by the considerable level of protection afforded by glutathione and cysteamine when 
merocyanine 540 was used as PS for inactivation of HSV-1 (O’Brien et al, 1992). 
 
3.2.1.2. Free Radicals in PDI of Bacteriophages  
The photoinactivation rate of some bacteriophages can be reduced in the presence of free radical 
scavengers, suggesting a contribution of radical species in the inactivation process (Table 2). In particular, 
it was reported that the inhibition of T7 phage photoinactivation in the presence of glycoconjugated meso-
tetraarylporphyrins varied according to the structure of the PS and the concentration of dimethylthiourea 
(DMTU) (Gábor et al, 2001; Egyeki et al, 2003). In fact, T7 phage PDI by meso-tetrakis(4-β-D-
glucosylphenyl)porphyrin (Gábor et al, 2001) and 5,10,15-(4-β-D-galactosylphenyl)-20-
(pentafluorophenyl)porphyrin (Egyeki et al, 2003) seemed to be mainly mediated by free radical species, 
as revealed by the protection effect of free radical scavenger DMTU, contrary to T7 phage 
photosensitization by 5,10,15-(4-β-D-glucosylphenyl)-20-phenylporphyrin, which revealed a significantly 
smaller contribution from type I mechanism. The highest inhibition was reached at about 1.0 mM of 
DMTU; further increase in scavenger concentration did not decrease the slope of photoinduced 
inactivation of phages. However, in spite of inhibiting the efficacy of the PS, DMTU did not completely 
inhibit T7 phage PDI (Gábor et al, 2001; Egyeki et al, 2003). Similar results were reported for T3 phage 
in the presence of L-cysteine as the scavenger and proflavine as the PS. However, the photoinactivation 
rate of MS2 by a polydroxylated fullerene was not affected by the presence of SOD, suggesting a 
negligible contribution of radical species, such as the superoxide radical anion (Badireddy et al, 2007). 
T4-like phage PDI was also little or not affected by the presence of free radical scavengers L-cysteine and 
D-mannitol in the presence of porphyrin derivatives, leading to the conclusion that free radical species are 
not major participants in phage PDI (Costa et al, submitted). 
 
3.2.2. Type II Mechanism Quenchers 
In general, the action of chemical singlet oxygen quenchers involves the reaction of singlet oxygen 
with the quenching agent, producing an oxidized product. Another possibility is the deactivation of 
singlet oxygen to ground state (3O2) by physical quenching, achieved by either energy or charge transfer, 
without consumption of oxygen or product formation (Bisby et al, 1999; Min and Boff, 2002). Residues of 
histidine, tryptophan and tyrosine in proteins are considered to be major natural quenchers of singlet oxygen 
(Baker and Kanofsky, 1992). 
Several singlet oxygen quenchers have been used to evaluate the specific involvement of type II 
mechanism during viral PDI with different PS (Table 3). 
Table 3. Singlet oxygen quenchers used on mammalian viruses and bacteriophage PDI. 
PS Quencher Microorganism 
Quencher 
protection 
Reference 
Mammalian viruses     
     
Aluminum phthalocyanine 
tetrasulfonate 
Sodium azide VSV 
significant 
effect 
Rywkin et al, 1992 
 Tryptophan VSV 
significant 
effect 
 
Rywkin et al, 1992 
Rose bengal β-carotene Influenza virus significant 
effect 
Lenard and 
Vanderoef, 1993 
 Sodium azide Influenza virus 
significant 
effect 
Lenard and 
Vanderoef, 1993 
     
Hypericin Sodium azide HIV 
significant 
effect 
Degar et al, 1992 
     
Methylene blue 
Imidazole (5.0 and 
10 mM) 
HSV-1 55-75% 
Müller-Breitkreutz 
et al, 1995 
     
Bacteriophages     
 
5,10,15-(4-β-D-galactosylphenyl)-20-
(pentafluorophenyl)porphyrin 
Sodium azide (0.1-5.0 
mM) 
T7 phage 38% Egyeki et al, 2003 
     
5-(pentafluorophenyl)-10,15,20-tris(1-
methylpyridinium-4-yl)porphyrin 
Sodium azide (100 
mM) 
T4 phage 
Qβ 
80% 
39% 
Costa et al, 
submitted 
 L-histidine (50 mM) T4 phage 
 
74% Costa et al, 
submitted 
     
meso-tetrakis(1-methylpyridinium-4-
yl)porphyrin 
Sodium azide (100 
mM) 
T4 phage 90% Costa et al, 
submitted 
 L-histidine (100 mM) T4 phage 
 
78% 
 
Costa et al, 
submitted 
     
5,10,15,20-Tetrakis(4-β-D-
glucosylphenyl)porphyrin 
1,3-
diphenylisobenzofura
n (0.1-5.0 mM) 
T7 phage 42% Gábor et al, 2001 
     
5,10,15-(4-β-D-gluco- sylphenyl)-20-
phenylporphyrin 
1,3-
diphenylisobenzofura
n (0.1-5.0 mM) 
T7 phage 74% Gábor et al, 2001 
     
Polyhydroxylated fullerene β-carotene T7 phage 
PRD1 phage 
69% 
56% 
Hotze et al, 2009 
     
 β-carotene (26 µM) MS2 phage 50-60% Badireddy et al, 
2007 
     
Rose bengal Sodium azide (3.5-35 
mM) 
M13 phage 31% Abe et al, 1997 
 
 
3.2.2.1. Singlet Oxygen in PDI of Mammalian Viruses  
Singlet oxygen seems to be the most important mediator of the virucidal activity (Table 3) on 
mammalian viruses. The rate of viral photoinactivation is significantly inhibited by oxygen removal or by 
addition of singlet oxygen quenchers, such as β-carotene, imidazole, L-histidine or sodium azide (O’Brien 
et al, 1992; Rywkin et al, 1992; Lenard and Vanderoef, 1993; Müller-Breitkreutz et al, 1995; Costa et al, 
submitted). Hypericin may induce photochemical alterations on HIV major capsid protein p24, which are 
inhibited by sodium azide, suggesting that the damage results from singlet oxygen (Degar et al, 1992). 
When merocyanine 540 (O’Brien et al, 1992), phthalocyanine derivatives (Rywkin et al, 1992) or rose 
bengal (Lenard and Vanderoef, 1993) were used as PS, the results suggest that 1O2 is the main cytotoxic 
species involved in VSV photoinactivation, while type I reactants such as hydroxyl radicals are less 
important. 
 
3.2.2.2. Singlet Oxygen in PDI of Bacteriophages  
Considering the PDI of bacteriophages in the presence of singlet oxygen quenchers, the results 
(Table 3) suggest that, in most of the studied cases, singlet oxygen is an important mediator of the toxic 
effect induced by PDI. However, the participation of free radicals cannot be ruled out. For instance, the 
inactivation of M13 bacteriophage by MB was inhibited from 1.72 log to 0.54 log by sodium azide in a 
quencher dose-dependent mode, up to a concentration of 3.5 mM. However, photoinactivation occurred 
even in the presence of sodium azide, suggesting that both type I and type II mechanisms may be 
involved in the M13 photoinactivation process. In the presence of quencher concentrations ranging from 
3.5 to 35 mM, sodium azide protective effect was not observed, as evidenced by increasing rates of M13 
phage photoinactivation, reaching a plateau thereafter (Abe et al, 1997). Also, the effect of singlet oxygen 
quenchers and of hydrogen peroxide indicated singlet oxygen as the main factor responsible for the loss 
of biological activity of bacteriophage M13 by rose bengal (DiMascio et al, 1989). 
The efficiency of 5,10,15-(4-β-D-galactosylphenyl)-20-(pentafluorophenyl)porphyrin to 
photoinactivate T7 phage decreased in 38% in the presence of sodium azide (Egyeki et al, 2003). This 
result, and the ones obtained in the presence of DMTU (Table 2), proved that for this PS, both 
mechanisms play a role in T7 phage photoinactivation, with type I being the predominant one. Similar 
results were obtained by  
Gábor et al (2001) in the presence of glycoconjugated meso-tetraarylporphyrin derivatives as PS and 
using 1,3-diphenylisobenzofuran as the singlet oxygen quencher. When T7 phage was phototreated with 
5,10,15,20-tetrakis(4-β-D-glucosylphenyl)porphyrin, the rate of inactivation decreased 42% in the 
presence of 1,3-diphenylisobenzofuran. When 5,10,15-(4-β-D-glucosylphenyl)-20-phenylporphyrin was 
used, the rate of protection substantially increased (74%). It can then be concluded that the type of PDI 
mechanism depends on the PS structure, with the symmetric derivative exerting its toxic effect mainly via 
the generation of free radicals, whether the asymmetric derivative proceeds mainly by singlet production 
(Gábor et al, 2001). However, in the study of Egyeki et al (2003) using the same asymmetric 5,10,15-(4-
β-D-galactosylphenyl)-20-(pentafluorophenyl)porphyrin as PS, and the same phage, the toxic effect 
occurred mainly via free radical generation. Besides this, the contribution of type I and type II processes 
was PS concentration-dependent and the sum of the photoinactivation rate measured in the presence of 
scavengers was smaller than the one measured without the scavengers. This result may imply a synergism 
between singlet oxygen and hydroxyl radical-mediated damages or it can also be supposed that the 
efficiency of neither scavenger is 100% (Gábor et al, 2001; Egyeki et al, 2003). 
A recent study showed that irradiation of polyhydroxylated fullerene suspensions (40 µM) in the 
presence of β-carotene reduced the photoinactivation rate of PRD1 and T7 phages, demonstrating singlet 
oxygen involvement (Hotze et al, 2009). Also, when the T4-like phage was irradiated in the presence of 
porphyrin derivatives and singlet oxygen quenchers sodium azide and L-histidine, the rate of phage 
inactivation was considerably reduced, suggesting that singlet oxygen may be an important mediator 
of the virucidal activity of these PS (Costa et al, submitted). However, from the data obtained, other 
inactivation mechanisms cannot be excluded (Hotze et al, 2009; Costa et al, submitted). 
Although some data about the importance of type I and II mechanisms in PDI of bacteriophages 
are discrepant, in general, it seems that the type II pathway is more important than the type I mechanism 
in phage PDI. On the other hand, there are only a few studies focusing on the simultaneous effect of 
singlet oxygen and free radicals scavengers under the same protocol of viral PDI (Rywkin et al, 1992; 
Müller-Breitkreutz et al, 1995; Gábor et al, 2001; Egyeki et al, 2003; Badireddy et al, 2007; Costa et al, 
submitted). 
 
4. Molecular Targets of Viral PDI 
The short-lived ROS generated by photodynamic mechanisms are responsible for the damage 
induced to critical molecular targets (Wainwright, 2003). Different viral targets, such as the envelope 
lipids and proteins, capsid and core proteins and the nucleic acid can be attacked by singlet oxygen and/or 
other ROS (hydrogen peroxide, superoxide and hydroxyl radicals) to achieve the loss of infectivity 
(Müller-Breitkreutz et al, 1995). For a better understanding of the photoinactivation process, the 
knowledge of how the molecular targets are affected by PDI assumes a great importance (Garcia et al, 
2009). For this reason, a detailed photophysical and photochemical study of the interactions between the 
toxic species generated by the PS and key biomolecules such as lipids, proteins and nucleic acids is 
essential for the knowledge and prediction of photosensitization process efficiency (Miranda, 2001). 
However, the studies performed show that the primary target of PDI depends on the chemical structure of 
the PS, the targeted virus and the mechanism of photoinactivation (Gábor et al, 2001). 
  
4.1. Nucleic Acids 
Depending upon the viruses, the nucleic acid can be either DNA or RNA (single or double 
stranded). The size of the nucleic acid also varies depending on the viruses. Several studies have shown 
that both DNA and RNA mammalian viruses and phages are efficiently inactivated by PDI. There is now 
considerable information that PS like MB can bind to and penetrate viral membranes, whereupon they 
intercalate with nucleic acids. Upon activation by light, the generated ROS can cause the destruction of 
the nucleic acids, particularly at guanine residues, preventing viral replication (Wainwright, 2000). 
However, there is a difference in target selectivity depending on the mechanism involved: sugar moieties 
are usually attacked by radicals (generated via type I process) and guanine residues are the targets of 
singlet oxygen (generated via type II process) (Wainwright, 1998). 
 
4.1.1. DNA Damage 
From the four DNA bases, guanine is the most susceptible component to suffer a type I 
photosensitization reaction, due to the fact that it exhibits the lowest oxidation potential among DNA 
bases and it is the only base that can be oxidized by singlet oxygen (type II process) (McBride et al, 
1992). 
The treatment of viruses with MB and other heterocyclic dyes resulted in the damage of viral 
DNA (Kadish et al, 1967; Schnipper et al, 1980; Specht, 1994; Schagen et al, 1999) either by base 
modification or base loss, single strand breaks (SSB), or cross-links of DNA with proteins (Schnipper et 
al, 1980; OhUigin et al, 1987; Abe and Wagner, 1995; Bachmann et al, 1995; Zupán et al, 2008). It is 
known that cationic porphyrins can bind to nucleic acids via intercalation into base pairs or self-stacking, 
inducing lesions upon photoinactivation due to the easy oxidation of guanine residues (Mettath et al, 
1999; Kubát et al, 2000; Caminos and Durantini, 2008). 
The binding of cationic porphyrins to DNA is presumably due to the electrostatic interaction 
between the positively-charged substituents in the porphyrin macrocycle and the negatively charged 
phosphate oxygen atoms of DNA (Caminos and Durantini, 2009). However, porphyrin binding to DNA is 
not a prerequisite for an efficient photosensitization, since free porphyrins are more effective in virus 
inactivation than the DNA-bound species (Zupán et al, 2008). This observation, which is in conflict with 
the generally accepted idea that the porphyrin molecule must be in close vicinity with the site of 
photosensitized damage, may be explained by the lower quantum yield of singlet oxygen by the bound 
porphyrin when compared with the free one (Zupán et al, 2008). 
 
4.1.1.1. Damages in the DNA of Mammalian Viruses 
Viral DNA is thought to be a critical target structure for PDI by MB and light (Wallis and 
Melnick, 1965). DNA isolated from adenovirus treated with 1.3 µM MB exhibited a smear in Southern 
blot analysis, indicative of random DNA fragmentation (Schagen et al, 1999). MB plus light treatment of 
HSV-1 gives rise to DNA damage and blocks DNA replication (Müller-Breitkreutz and Mohr, 1997).  
 
4.1.1.2. Damage in the DNA of Bacteriophages 
An internal component of T4 phage has been suggested as an important target because MB needs to 
cross the outer barrier made by its protein capsids in order to produce a significant effect (Kadish et al, 
1967). In fact, some of the irradiated phages could still inject functional genetic material but have lost 
their ability to form plaques, suggesting that their DNA was damaged. Protein synthesis was also severely 
impaired (Kadish et al, 1967). Treatment of M13 phage with MB and aluminum phthalocyanine 
tetrasulfonate (AlPcS4) caused strand breaks and piperidine-labile bonds in DNA, which is correlated 
with the loss of infectivity. This is in agreement with the proposal that lesions of the viral genome might 
be responsible for the lethality induced by sensitization (Abe and Wagner, 1995). DNA strand cleavage 
was found to be MB concentration and light dose dependent. Viral inactivation and DNA damage were 
found to be oxygen-dependent processes. However, DNA damage was not correlated with the loss of 
PM2 phage infectivity, as observed in transfection studies which measured the infectivity of the extracted 
viral DNA, indicating that DNA from MB-treated phage was just as capable of generating progeny virus 
as the untreated controls (Specht, 1994). The observed DNA damage is not correlated with loss of phage 
infectivity and may not be the prime target of viral PDI, because 100% of closed circular DNA was 
recovered from the MB phototreated PM2 phage (Specht, 1994). Concerning the effects of PDI on 
isolated viral DNA, treatment of M13mp2 DNA with increasing concentrations of MB, in the presence of 
light, yielded increasing amounts of 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodguo), a prevalent 
adduct produced by singlet oxygen and perhaps by oxygen free radicals. At 100 µM MB, 1 residue of 8-
oxodguo was produced for every 40 residues of deoxyguanosine in DNA. Thus, treatment of M13mp2 
DNA with MB plus light resulted in putative alterations at deoxyguanosine residues that impede the 
progression of DNA synthesis in vitro (McBride et al, 1992). 
 
4.1.2. RNA Damage 
RNA has been suggested to be a key factor in viral PDI with many PS, but direct evidence of a 
correlation between RNA damage and infectivity loss has not been reported yet, as is the case of VSV 
when treated with phthalocyanine derivatives (Abe and Wagner, 1995). In RNA, as for DNA (Castano et 
al, 2004), guanine is suggested as the major target for oxidation by photosensitizing agents and light. 
  
4.1.2.1. Damage in the RNA of Mammalian Viruses 
VSV genome was damaged by 30 µg mL−1 of a chlorophyll derivative and red light illumination 
which caused a decrease of as much as 85% in RNA polymerase activity, which can be due to damage in 
the viral RNA polymerase complex, and 98% inhibition of viral RNA synthesis in 6 hours (Lim et al, 
2002). According to Moor et al (1997), the RNA and/or the RNA polymerase complex of VSV might be a 
major target for its photoinactivation by AlPcS4 and MB. MB and phthalocyanine derivatives inactivated 
VSV and inhibited fusion of the virus envelope with Vero cells. The degree of inhibition was small 
compared to the extent of virus inactivation, suggesting that non-membrane targets, like the viral RNA, 
might be involved in VSV photoinactivation. However, there is no report of a correlation between RNA 
damage and loss of infectivity (Abe and Wagner, 1995). Photoinactivation of HIV-1 by MB and light lead 
to destruction of its RNA (Bachmann et al, 1995). 
 
4.1.2.2. Damage in the RNA of Bacteriophages 
Following MB plus light exposure, the Qβ RNA genome exhibited sufficient lethal lesions to 
account for phage inactivation (Schneider et al, 1999). However, the protein component of the phage also 
exerted some effect in viral PDI (Schneider et al, 1999). In a comparison of RNA photoinactivation using 
MB and rose bengal as the PS, Schneider et al (1993) suggested a causal relationship between 8-oxodguo 
formation in RNA and R17 and Qβ bacteriophage inactivation. However, no direct relationship between 
photodynamically induced RNA damage and viral inactivation was described (Schneider et al, 1993). 8-
oxoguanosine formation or oxidative damage of Qβ RNA alone does not directly account for the lethal 
event of the virus. Directly treating extracted phage RNA with MB and light caused a loss of activity in 
the infectious RNA assay but there was a much greater loss of activity if the phage RNA was treated with 
MB and light in the phage per se. The results demonstrated that Qβ RNA infectious activity is 
significantly more affected by photoinactivation in its protein-associated virion state as compared with its 
purified isolated polymer state (Schneider et al, 1999; Floyd et al, 2004). Inactivation of purified RNA by 
MB and light, in the absence of proteins, most likely occurs due to oxidative damage to the RNA at the 
site at which MB is bound and might involve oxidized bases such as 8-oxodguo or strand breaks 
(Schneider et al, 1999). 
In spite of the reduced number of reports focusing on the damage induced by PDI in the nucleic 
acids of mammalian viruses and bacteriophages, it can be concluded that both DNA and RNA are 
potential targets of viral PDI. However, there are no studies specifically focusing on the damages induced to 
DNA and RNA of both mammalian viruses and bacteriophages under the same PDI protocol. 
 
4.2. Outer Structures 
Enveloped viruses are inactivated more rapidly than non-enveloped viruses because the 
destruction of the envelope structure is generally accompanied by loss of virus infectivity (Lytle et al, 
1991; North et al, 1992; Smetana et al, 1994; Ben-Hur and Horowitz, 1996; Käsermann and Kempf, 
1998). The damages caused by photodynamic reactions on unsaturated lipids present in their envelopes 
and/or on major envelope proteins, which act as PS binding-sites, modify their structure and avoid cell 
infection and virus replication (Müller-Breitkreutz et al, 1995; Käsermann and Kempf, 1997). However, 
some studies showed that non-enveloped viruses can also be efficiently inactivated by the toxic action of 
PS (Welsh and Adams, 1954; Yamamoto, 1957; Kadish et al, 1967; Lytle et al, 1991; Kastury and Platz, 
1992; Abe and Wagner, 1995; Jockush, 1996; Lee et al, 1997; Schneider et al, 1999; Gábor et al, 2001; 
Egyeki et al, 2003; Costa et al, 2008; Zupán et al, 2008; Costa et al, 2010). 
The higher susceptibility to PDI of enveloped viruses, relatively to non-enveloped viruses, 
indicates that the viral envelope may be a more important target than nucleic acids for photosensitization. 
It also indicates that the unsaturated lipids present in the envelope, as well as the major envelope proteins, 
are important PDI targets. However, as far as it is known, no studies focus on the degradation of viral 
envelope lipids after PDI or even on other viral internal lipids. There are, however, many studies about 
the effects of PDI on viral envelope proteins as well as on other core proteins. 
The statement that enveloped viruses are more easily inactivated than non-enveloped ones is only 
based in indirect studies which compare the inactivation results of enveloped and non-enveloped viruses. 
The enveloped viruses used in PDI protocols (O’Brien et al, 1992; Lenard et al, 1993; Abe and Wagner, 
1995; Moor et al, 1997; Smetana et al, 1998; Lim et al, 2002; Vzorov et al, 2002) were only assayed for 
their protein alterations and no additional experimental work was done concerning their lipids. However, 
the results of PDI obtained by Lytle et al (1991) with the enveloped φ6 phage, although indirectly, are in 
good accordance with what is reported in the literature about the major contribution from lipids for the 
viral photoinactivation process.  
Relative to proteins degradation by PDI, the results of different studies showed that the main 
damage is the formation of protein cross-links, followed by other types of damage, which include loss of 
proteins, alterations in protein molecular conformation, mass and charge, and alterations in protein band 
intensity (Table 4). 
When proteins are irradiated with UV or visible light in the presence of a PS, photooxidation of 
sensitive amino acid residues such as cysteine, histidine, tyrosine, methionine and tryptophan, and 
covalent cross-linking of peptide chains can be observed, leading to the formation of molecular 
aggregates (Girotti, 1976; Verweij and Steveninck, 1982), disrupting their normal folding conformation, 
thus forcing them into other conformations that affect their normal functioning (Macdonald and 
Dougherty, 2001). In fact, the formation of cross-linked/aggregated material appears to be a major 
consequence of photosensitized-mediated protein oxidation (Davies, 2003), and it has been demonstrated 
that the formation of protein cross-links is not a primary photodynamic event, but a secondary reaction 
between the photooxidation products of sensitive amino acid residues and other groups in the protein 
(Verweij and Steveninck, 1982). 
The PS per se can induce alterations in the folding of some enzymes, leading to the exposure of 
some amino acid residues normally shielded in the protein, and to the shielding of others usually exposed 
in the molecule. These protein modifications lead to changes in properties such as solubility, proteolytic 
susceptibility, absorbance, and fluorescence emission of several of their amino acids. These alterations 
are mainly mediated by hydrogen peroxide and hydroxyl radical generation, although singlet oxygen 
mediated reactions could also occur (Afonso et al, 1999). The amino acids located in the surface of the 
protein are photooxidized at a much faster rate than the residues buried in the interior of the molecule. If a 
protein is completely unfolded, susceptible amino acids may also be attacked and photodegraded (Jori et 
al, 1970; Ochsner, 1997). 
 
Table 4. Degradation of viral outer structures after mammalian viruses and bacteriophages PDI. 
Virus Type of damage PS Reference 
Enveloped-mammalian viruses 
HSV-1 Viral envelope (reduced ability to 
adhere to and penetrate host cells) 
Merocyanine 540 O’Brien et al, 
1992 
 Viral envelope (prevention of 
viral adsorption and host 
penetration) 
Phthalocyanine derivatives Malik et al, 1993 
 Glycoprotein D; loss of proteins; 
dimerization; protein cross-links; 
alterations in protein molecular 
mass and charge 
Phthalocyanine derivatives Smetana et al, 
1998 
    
HSV-2 Viral envelope (prevention of 
viral adsorption and host 
penetration) 
Phthalocyanine derivatives Malik et al, 1993 
HSV Protein cross-links Phthalocyanine derivatives Malik et al, 1996 
    
VZV Viral envelope (prevention of 
viral adsorption and host 
penetration) 
Phthalocyanine derivatives Malik et al, 1993 
    
HIV Major capsid protein p24 Hypericin Degar et al, 1992 
HIV-1 Loss of infectivity; loss of fusion 
function; membrane proteins 
cross-links 
Hypericin Lenard et al, 
1993 
 Loss of infectivity; loss of fusion 
function; membrane proteins 
cross-links 
Rose bengal Lenard et al, 
1993 
 p24 and gp120 proteins; proteins 
cross-links  
Methylene blue Bachmann et al, 
1995 
 Inhibition of cell fusion activity of 
Env proteins 
 
Natural and sulfonated 
Tetraarylporphyrins 
Vzorov et al, 
2002 
    
VSV Loss of infectivity; loss of fusion 
function; cross-linking of G and 
M proteins 
Hypericin Lenard et al, 
1993 
 Loss of infectivity; loss of fusion 
function; cross-linking of G and 
M proteins 
Rose bengal Lenard et al, 
1993 
 Inhibition of fusion of the 
envelope to Vero cells; G protein 
Methylene blue Abe and Wagner, 
1995 
 Inhibition of fusion of the 
envelope to Vero cells; G protein 
Aluminum phthalocyanine 
tetrasulfonate 
Abe and Wagner, 
1995 
 G and M proteins; protein cross-
links 
Phthalocyanine derivatives Moor et al, 1997 
 G, M, L and N proteins; protein 
cross-links 
Chlorophyll derivatives Lim et al, 2002 
    
Influenza virus Loss of infectivity; loss of fusion 
function; cross-linking of G and 
M proteins 
Hypericin Lenard et al, 
1993 
 Loss of infectivity; loss of fusion 
function; cross-linking of G and 
M proteins 
Rose bengal Lenard et al, 
1993 
 Loss of infectivity; HA fusion 
protein; protein cross-links  
Rose bengal Lenard and 
Vanderoef, 1993 
    
Sendai virus Loss of infectivity; loss of fusion 
function; cross-linking of G and 
M proteins 
Hypericin Lenard et al, 
1993 
 Loss of infectivity; loss of fusion 
function; cross-linking of G and 
M proteins 
Rose bengal Lenard et al, 
1993 
    
Vaccinia virus Histidine residues in virus 
proteins 
Rose bengal Turner and 
Kaplan, 1968 
    
Human 
cytomegalovirus 
Viral envelope (reduced ability to 
adhere to and penetrate host cells) 
Merocyanine 540 O’Brien et al, 
1992 
    
Sindbis virus 
 
Viral envelope (reduced ability to 
adhere to and penetrate host cells) 
Merocyanine 540 Sieber et al, 1987 
 Viral capsid protein Hypericin Yip et al, 1996 
    
Friend 
erythroleukemia 
virus 
Viral envelope (reduced ability to 
adhere to and penetrate host cells) 
Merocyanine 540 Sieber et al, 1989 
    
Non-enveloped mammalian viruses 
    
Adenovirus not damaged Phthalocyanine derivatives Malik et al, 1993 
Enterovirus 71 Appearance/disappearance of 
protein bands; increase of the 
protein bands’ intensity 
Methylene blue Wong et al, 2010 
Non-enveloped bacteriophages 
    
T7 phage Protein capsid; loosening of the 
protein-DNA interaction 
Glycoconjugated meso- 
Tetraarylporphyrins 
Gábor et al, 2001 
 Capsid and core proteins; 
loosening of protein-DNA 
interaction 
Glycoconjugated meso- 
Tetraarylporphyrins 
Egyeki et al, 
2003 
 Capsid proteins; protein cross-
links 
meso-Tetrakis(1-
methylpyridinium-4-
yl)porphyrin 
Zupán et al, 2008 
 Capsid proteins; protein cross-
links 
Polyhydroxylated fullerene Hotze et al, 2009 
    
M13 phage Coat protein Methylene blue Abe and Wagner, 
1995 
 Coat protein Aluminum phthalocyanine 
tetrasulfunate 
Abe and Wagner, 
1995 
    
PRD1 phage Capsid proteins; protein cross-
links; phospholipids (less 
affected) 
Polyhydroxylated fullerene Hotze et al, 2009 
    
Qβ phage Coat and maturation (A) proteins; 
formation of protein carbonyls; 
RNA-protein cross-links 
Methylene blue Schneider et al, 
1998 
 RNA-protein cross-links Methylene blue Floyd et al, 2004 
    
MS2 phage A protein Polyhydroxylated fullerene Hotze et al, 2009 
 
4.2.1. Damage on Mammalian Viral Outer Structures 
It has been shown that enveloped viruses can be inactivated due to protein damage (Lenard et al, 
1993; Malik et al, 1993; Moor et al, 1997; Smetana et al, 1998). However, while the same treatment is 
reported to be ineffective against some non-enveloped viruses (Malik et al, 1993; Smetana et al, 1998), 
the results from Wong et al (2010) showed that even a non-enveloped virus can be efficiently inactivated 
due to the damage induced by PDI to its viral proteins (Table 4). 
The proteins in the viral envelope of HSV-1 were considered to be major targets of merocyanine 
540 photosensitization (O’Brien et al, 1992). Some phtahlocyanine derivatives have been shown to 
induce cross-links in HSV protein that might be responsible for the observed loss of infectivity (Malik et 
al, 1996). Protein analysis by SDS-PAGE, after treatment with phthalocyanine derivatives, revealed 
irreversible changes in the HSV-1 envelope proteins, which were reflected by the loss of many proteins, 
the appearance of cross-linked material on the top of the gel and by alterations in the molecular mass and 
molecular charge of the proteins. These alterations contribute, in all likelihood to HSV-1 inactivation 
(Smetana et al, 1998).  
In VSV treated with 3.75–30 µL mL−1 of chlorophyll derivatives and light, the M protein band 
was not detected, which was accompanied by a decrease in the intensity of the G protein band (Lim et al, 
2002). Large complexes of proteins were also detected on the top of the gel, indicating that viral PDI 
cross-linked the proteins (Lim et al, 2002). Using a fusion assay and protein analysis, it was shown that 
MB and AlPcS4 caused a decrease in the intensity of the G-protein (which is known to play a crucial role 
in binding VSV to the host cell) band and a slight decrease in the intensity of M protein (matrix protein) 
band and protein cross-links. However, the observed damage in viral proteins could not account for VSV 
PDI (Moor et al, 1997). VSV was inactivated by MB and phthalocyanine derivatives, which inhibited the 
fusion of the virus envelope to Vero cells. However, the degree of this inhibition was small compared to 
the extent of virus inactivation (43% inhibition vs. 4.7 log or 99.998% inactivation, for MB) (Abe and 
Wagner, 1995). Abe and Wagner (1995) also found few changes in the relative abundance of VSV G 
protein after MB and AlPcS4 phototreatment, and they also observed additional protein bands on SDS-
PAGE analysis (Abe and Wagner, 1995). It was found, by Western blot analysis, that HIV-1 p24 and 
gp120 proteins were altered in size, possibly due to cross-linking, after MB phototreatment (Bachmann et 
al, 1995). However, using the same PS, AlpcS4 and MB, no changes in protein patterns after SDS-PAGE 
of the viral proteins were observed, under conditions that caused complete VSV inactivation (Melki et al, 
1994). 
The results from Vzorov et al (2002) indicated that the porphyrins inhibited the cell fusion activity 
of HIV Env proteins (a biological function that is important for viral entry as well as induction of viral 
cytopathic effects) when expressed from recombinant vectors. These results showed that the viral Env 
protein is an important target of these compounds (Vzorov et al, 2002). 
PDI of influenza virus by rose bengal altered the HA fusion protein and led to protein cross-links 
(Lenard and Vanderoef, 1993). 
Photoinactivation of vaccinia virus with rose bengal significantly altered the concentration and 
oxidized histidine in vaccinia virus protein, suggesting that inactivation was attributed to alterations in 
viral proteins, as opposed to nucleic acids (Turner and Kaplan, 1968). 
Treatment of influenza and Sindbis viruses by hypericin (Lenard et al, 1993), lead to an extensive 
cross-linking of the envelope proteins, which may have impaired the capacity of the viruses to adhere to 
and penetrate the host cells. 
The protein profile of the non-enveloped enterovirus 71 was considerably altered after a low dose 
PDI and a MB concentration ≥ 0.5 µM, as revealed by a smearing and the disappearance of several 
protein bands (Wong et al, 2010). However, enterovirus 71 PDI was also due to damages in the viral 
genome (Wong et al, 2010).  
 
4.2.2. Damages on Bacteriophage Outer Structures 
In spite of the limited available data for enveloped bacteriophages, substantially higher 
photoinactivation rates compared with other non-enveloped phages were described (Lytle et al, 1991). 
The photoinactivation by merocyanine 540 of four bacteriophages, two non-enveloped phages without 
lipids (phi X174 and T7), a non-enveloped phage with lipids (PRD1), and an enveloped phage with an 
external lipoprotein envelope (phi 6) was studied by Lytle et al (1991). The survival curves of the 
different viruses clearly demonstrated different levels of sensitivity to photoinactivation by this PS, with 
phi 6 being the most sensitive, followed by T7 (21-fold less sensitive). While both PRD1 and phi 6 have 
lipid components, only phi 6 was photoinactivated by the PS. Thus, the internal lipid components of 
PRD1 were not sufficient to allow photoinactivation by merocyanine 540. A higher inactivation rate with 
a fullerene derivative was also observed by Hotze et al (2009) for a phage without lipids (T7 phage) than 
for PRD1 phage. The dissimilarities in phage composition resulted from differential resistance to singlet 
oxygen by the outer structures, since PRD1 has a double capsid with an internal lipid membrane, whereas 
T7 has a single proteinaceous capsid lacking lipids, and both phages contain double stranded DNA with 
similar GC content (48% for T7 and 51% for PRD1) (Hotze et al, 2009). Phage proteins were 
significantly affected by photosensitization (30–92%) when compared to the relatively smaller effect on 
nucleic acids in both PRD1 and T7, and lipids in PRD1 phage (≤ 13%), as assessed by FTIR spectra 
analysis (Hotze et al, 2009). The higher T7 phage inactivation is consistent with greater damage to its 
proteinaceous capsid. Besides this, SDS-PAGE analysis further evidenced that oxidative cross-linking of 
capsid proteins induced by exogenous singlet oxygen is the likely cause of phage inactivation (Hotze et 
al, 2009). The high propensity for MS2 phage inactivation by this PS (compared to PRD1 and T7 phages) 
possibly arises from damage to its A protein, which is necessary for infecting its host Escherichia coli 
since it contains highly reactive amino acids such as methionine, cysteine, histidine, and tyrosine and not 
to damages to the nucleic acid (Hotze et al, 2009). Glycosylated substituted porphyrins led to structural 
changes at the protein capsid and/or loosening of the protein-DNA interaction, which can be responsible 
for T7 phage inactivation (Gábor et al, 2001). Besides of the alteration of the DNA structure, the 
phototreatment pointed to significant alterations in the protein structure and/or in the DNA-protein 
interaction, which may be the cause of photodynamic inactivation (Egyeki et al, 2003; Zupán et al, 2008). 
The alterations in the DNA secondary structure might also be the result of photochemical damage in 
phage capsid proteins and consequent disruption of the phage particle. Photomodification of core proteins 
can also lead to phage inactivation, even if the primary structure of the DNA part is preserved, since these 
proteins play an important role in the early events of infection and DNA penetration (Egyeki et al, 2003). 
The damage of T7 nucleoprotein is a complex process and clearly both phage DNA and protein capsid are 
affected by photoreactions (Zupán et al, 2008). Irradiation of Qβ bacteriophage in the presence of 
increasing concentrations of MB resulted in exponentially increasing amounts of viral RNA-protein 
cross-linkage products, and this is probably the most important event in viral inactivation (Floyd et al, 
2004). The RNA genome of Qβ bacteriophage contained sufficiently lethal lesions following MB plus 
light exposure to account for the resulting phage inactivation. Nevertheless, the data also indicate that the 
protein component of the phage somehow contributes to the inactivation of the phage (Schneider et al, 
1999). The protein component of Qβ phage is involved in the process of photoinactivation because the 
formation of protein carbonyls and RNA-protein cross-links were efficiently formed by MB plus light 
exposure (Schneider et al, 1998). The close correlation of cross-link formation with phage inactivation 
and the expectation that even one such cross-link in a phage genome would be lethal makes the RNA-
protein cross-link lesion a strong candidate for the primary inactivating lesion of Qβ phage exposed to 
MB and light (Schneider et al, 1999).  
Little alteration of M13 phage proteins on SDS-PAGE after MB and AlPcS4 photoinactivation 
was observed by Abe and Wagner (1995). The results of Zupán et al (2004), suggested that the 
tetracationic porphyrin meso-tetrakis(1-methylpyridinium-4-yl)porphyrin did not interact with capsid 
proteins and did not disturb protein-DNA interaction, even if it has a strong stabilization effect on the 
intraphage DNA. 
 
5. Resistance to PDI and Recovery of Viability 
The development of increasing numbers of antiviral agents over the past decades, in the same way 
as with antibiotics, has provided the clinician with therapeutic options previously unavailable. With the 
increasing utilization of antiviral drugs, however, has come an enhanced appreciation of the development 
of antiviral resistance (Malik et al, 1982; Kimberlin and Whitley, 1996; Pillay, 1998; Yoshikawa, 2002; 
Jori and Brown, 2004; Maisch et al, 2004). Drug resistance is costly to the health service, to the patient 
who fails to gain maximum therapeutic benefit, and for the community in which resistant viruses may be 
spread (Pillay and Zambon, 1998).  
There is now an urgent need for the development of novel, convenient and inexpensive measures 
for combating antimicrobial-untreatable infections and limiting the development of additional 
antimicrobial resistant microorganisms. Photodynamic technology may provide one approach to meet this 
need, both in terms of therapy and in terms of sterilization, by a mechanism that is markedly different 
from that typical of most antimicrobials (Reddi et al, 2002; Jori and Brown, 2004; Jori and Coppellotti, 
2007). 
As mentioned before, photosensitization involves the generation of singlet oxygen and free radical 
species, which cause molecular damage. Whether microorganisms could develop resistance to these 
active oxygen species is still questionable (Minnock et al, 2000) and, consequently, the development of 
microbial resistance to photosensitization is still under debate. Until now, the development of microbial 
resistance to PDI is not known and is thought very improbable to be developed. In general, the 
development of resistance to PDI by microbial strains should be considered as an unlikely event since this 
process is typically multi-target, with ROS causing damage to many microbial components, which is at a 
variance with the mechanism of action of most antimicrobial drugs (Maisch et al, 2004; Demidova and 
Hamblin, 2005; Jori et al, 2006). In contrast to most common antimicrobials, the number of molecular 
alterations required to ensure survival would be too great and the microorganism would require multi-site 
mutations to become highly resistant, an event with significantly lower probability than single-site 
mutations, which is often sufficient for conferring resistance to small-molecule inhibitors (Wainwright, 
2009; Cheng et al, 2010). This particular property of microbial PDI is important regarding the repeated 
treatment of chronic and/or recurrent infections (Maisch et al, 2004). 
Microbial PDI, when compared to standard treatments which may require application for several 
weeks to achieve an effective killing of the microorganism, shortly after initiation of light exposure, 
exhibits serious and irreversible damage of microorganisms (Costa et al, 2008; Costa et al, 2011). This 
damage does not allow the creation or operation of any kind of anti-drug or mutagenic mechanism. 
Microbial PDI is therefore very effective and, up until now, no photosensitization-resistant mutants have 
been found (Costa et al, 2011). 
 
5.1. Resistance of Mammalian Viruses and Recovery of Viability after Photosensitization 
Data from North et al (1994) show that HIV azidothymidine (AZT)-resistant strains were as 
susceptible as the AZT-sensitive ones to photosensitization with a benzoporphyrin derivative. This 
finding comes as no surprise since the mechanisms of action of AZT (inhibition of reverse transcription) 
and light-activated benzoporphyrin derivative are different. Thus, mutations in the virus that occur at the 
reverse transcriptase level will not affect photodynamic destruction (North et al, 1994). 
Studies focusing on the possible development of viral resistance are extremely scarce and little is known about the 
recovery of viral viability after consecutive photodynamic treatments. 
 
5.2. Bacteriophage Resistance and Viability Recovery after Photosensitization 
Concerning bacteriophages, there is only one study focusing on the possible development of viral 
resistance after photosensitization (Costa et al, 2011). After 10 consecutive cycles of photodynamic 
treatment,   
the T4-like phage, in the presence of the tricationic porphyrin 5-(pentafluorophenyl)-10,15,20-tris(1-
methylpyridinium-4-yl)porphyrin (Tri-Py+-Me-PF) at 5.0 µM under white light irradiation, exhibited no 
changes in the rate of photoinactivation during the course of the experiments, meaning that no resistance 
was observed. If phage resistance would occur, important reductions on phage photoinactivation 
efficiency would be detected between experiments. Besides that, T4-like phage did not recover its 
viability after exposure to Tri-Py+-Me-PF during 120 min of irradiation (Costa et al, 2011). In a 
preliminary study by Perdrau and Todd (1933), all attempts at reactivating the inactivated Staphylococcus 
phage by MB were unsuccessful.  
 
6. Factors Affecting Viral PDI 
6.1. Effect of the Number of Charges, Symmetry, Size of Meso Substituent Groups and Photosensitizer 
Concentration 
It has been shown that the location and binding site of the PS, which is highly dependent on the 
structure and intramolecular charge distribution, is an important factor in microbial PDI (Merchat et al, 
1996; Minnock et al, 2000). 
In terms of molecular structure, molecular charge is important in determining antimicrobial 
activity. Positively charged PS are generally more efficient and can act at lower concentrations than 
neutral and anionic PS molecules (Demidova and Hamblin, 2005). The positive charges on the PS 
molecule appear to promote a tight electrostatic interaction between the positively charged PS and the 
negatively charged sites at the viral capsids and envelopes, orientating the PS toward sites which are 
critical for the stability and metabolism of a particular microorganism (Merchat et al, 1996; Dowd et al, 
1998; Casteel et al, 2004). This kind of association increases the efficiency of the photoinactivation 
process. 
Cationic PS photodamage can be induced in nucleic acid or viral outer structures by PS binding or 
by PS localized in its vicinity (Zupán et al, 2004). For instance, it is more likely that positively charged 
PS will be effective in causing nucleic acid damage than will neutral or anionic congeners, which mainly 
act against the outer side of the microorganism (Wainwright, 2004). 
The symmetry and the size of the chain of meso substituent groups also affect the photodynamic 
effect. PS with opposite charged groups are more symmetrical than PS with adjacent charged groups. The 
adjacent positive charges in the PS macrocycle should result in a molecular distortion due to electrostatic 
repulsion (Kessel et al, 2003). The toxicity of a PS can be modulated by the introduction of selected 
substituents on the macrocycle periphery. In this way, the physicochemical properties of a synthetic PS 
can be manipulated in order to enhance its interactions with the structural features of the viruses, such as 
viral capsids, and to minimize the interactions with plasma membranes or mammalian cell membranes 
(Casteel et al, 2004).  
The amphiphilic nature of a PS is another important feature affecting PDI efficiency and can be 
modulated by the introduction of adequate functionalities in the macrocycle periphery, such as different 
numbers of positive charges, an asymmetrical charge distribution, or introduction of aromatic 
hydrocarbon side chains (Banfi et al, 2006; Almeida et al, 2011).  
PS concentration is also an important parameter that must be taken into account since viral PDI 
was shown to be strongly influenced by PS concentration. Increasing the PS concentration reduces the 
time needed to achieve complete viral inactivation, thus increasing the efficiency of a particular PDI 
protocol (Costa et al, 2008). 
 
6.1.1. Mammalian Viruses PDI 
Complete inactivation of VSV (4.2 log) can be obtained by treating it with 1.0 µM of the anionic 
phthalocyanine derivative AlPcS4 and 5 min illumination with red light. For the neutral phthalocyanine 
derivative (Pc4), complete inactivation (4 log) was achieved using a much lower amount of PS (4.5 nM) 
in combination with 10 min illumination (Moor et al, 1997). The inactivation of VSV in PBS showed a 
linear relationship with illumination time (Moor et al, 1997). Inactivation of the fusion activity of VSV, 
influenza and Sendai viruses was reached with nanomolar concentrations of hypericin and rose bengal 
and was absolutely dependent upon light and increased with increasing time of illumination (Lenard et al, 
1993). HAV in PBS or plasma was completely inactivated within 10 min (>3.7 log) by the cationic 
symmetric porphyrin meso-tetrakis(1-methylpyridinium-4-yl)porphyrin. In contrast, inactivation of HAV 
to 3.6 log with the anionic symmetric porphyrin meso-tetrakis(4-sulfonatephenyl)porphyrin required 90 
min (Casteel et al, 2004). The rate and extent of inactivation appeared to vary with the nature of the meso 
substituent groups (Casteel et al, 2004). HIV and VSV lost infectivity upon illumination with hypericin 
and rose bengal in a concentration-dependent manner (Lenard et l, 1993). 
 
6.1.2. Bacteriophage PDI 
MS2 phage inactivation has been observed with neutral porphyrin derivatives. However, this 
required higher irradiation periods (30 min) than for the cationic ones (1 min) (Casteel et al, 2004). 
Neutral glycosylated substituted porphyrins can also significantly photoinactivate the T7 phage (Gábor et 
al, 2001; Egyeki et al, 2003). The T4-like phage PDI was achieved by exposing the phage in the presence 
of six cationic porphyrins at different concentrations (0.5, 1.0 and 5.0 µM) to white light for 270 min. The 
results showed that phage photoinactivation varied according with the PS concentration, with higher 
concentrations being the most efficient ones (Costa et al, 2008). The T4-like phage PDI also varied with 
the number of porphyrin charges, with tri- and tetracationic porphyrin derivatives being more effective in 
viral inactivation that the dicationic ones, which inactivated the phage below the limit of detection. Tetra- 
and tricationic porphyrin derivatives (meso-tetrakis(1-methylpyridinium-4-yl)porphyrin and 5-
(pentafluorophenyl)-10,15,20-tris(1-methylpyridinium-4-yl)porphyrin, respectively) lead to complete T4-
like phage inactivation (∼7 log) after 270 min of irradiation with 40 W m−2 (Costa et al, 2008). This 
tetracationic porphyrin showed similar results in another study (7 log of reduction) for lambda phage 
inactivation, when irradiated with light of 658 nm (Kastury and Platz, 1992). Increasing porphyrin 
concentration at a fixed light dose leads to increased viral inactivation (Kastury and Platz, 1992). A 
concentration-dependent effect was also detected with a porphyrin derivative (Egyeki et al, 2003), but 
over 2.0 µM of PS the process was saturated. A further increase in porphyrin concentration did not lead to 
a higher inactivation rate of T7 phage. Aggregation and/or photobleaching of PS are likely explanations 
(Egyeki et al, 2003). Cationic meso-tetrakis(1-alkylpyridinium-4-yl)porphyrin derivatives with different 
alkyl substituent groups were tested for MS2 phage inactivation but, with the exception of 5,10,15,20-
tetrakis(4-sulfonatophenyl)porphyrin, showed toxicity even in the absence of light (Casteel et al, 2004).  
In a study conducted by Gábor et al (2001), the porphyrin derivative with symmetrical 
glycosylated groups was found to be twice as effective as the asymmetrical one on the inactivation 
process of T7 phage. According to Costa and colleagues (2008), the rate of T4-like phage inactivation 
was also dependent on the lipophilic character of the meso-substituent groups. The presence of a 
lipophilic aryl group in one of the meso positions of the porphyrin core appears to have an important role 
in phage inactivation, affecting the rate and efficiency of T4-like phage (Costa et al, 2008). Casteel et al 
(2004) have also observed differences in the photoinactivation rate of MS2 phage when they used PS with 
different alkyl substituent groups and concluded that the rate and extent of inactivation appeared to vary 
with the nature of the meso substituent groups. 
 
6.2. Effect of Different Light Sources and Fluence Rate on Antimicrobial PDT  
PDT requires a source of light to activate the PS by exposing it to visible or near-visible light at a 
specific wavelength (Konopka and Goslinski, 2007). The light source for PDT must also exhibit suitable 
spectral characteristics coinciding preferentially with the maximum absorption wavelength range of the 
PS, applied in order to generate enough ROS to produce an efficient toxic effect (Robertson et al, 2009). 
In parallel with the advances in chemistry (related with the discovery and synthesis of new and 
more efficient PS) there has also been much activity in developing new light sources, better suited for the 
photosensitization process. Briefly, these include user-friendly lasers frequently based on solid state laser 
diodes, as well as inexpensive light emitting diodes (LED) and filtered broad-band lamps (Brancaleon and 
Moseley, 2002).  
PS activation has been achieved via a variety of light sources, such as arc plasma discharge lamps, 
metal halogen lamps, slide projector illumination assemblies, and a variety of lasers. For treatment of 
larger areas, non-coherent light sources, such as tungsten filament, quartz halogen, xenon arc, metal 
halide, and phosphor-coated sodium lamps, are in use. Recently, non-laser light sources, such as LED, 
have also been applied in PDT. These light sources are much less expensive and small, lightweight and 
highly flexible, its lifetime can reach up to one hundred thousands hours, and can be manufactured to 
wavelengths that activate commercially available PS (Veenhuizen and Stewart, 1995; Allison et al, 2004; 
Juzeniene et al, 2004; Kübler, 2005; Konopka and Goslinski, 2007). 
At first glance, the available literature on fluence rate effects for PDT seems contradictory. Some 
studies indicate less damage at low fluence rate, others indicate more killing at lower, compared to higher, 
fluence rates for the same total fluence and some indicate no influence of fluence rate at all (Juzeniene et 
al, 2004; Kübler, 2005; Konopka and Goslinski, 2007). A reduction in the fluence rate lowers the rate of 
oxygen consumption, thereby extending the radius over which singlet oxygen may be formed and 
consequently increasing the phototoxic effect (Lukšiene, 2005). Qin et al (2008) showed that an increase 
in the fluence rate increases microbial damage, although, it seems to have an upper limit of photons to 
observe this effect. Since each PS molecule can only absorb one photon at a time, when the number of 
light photons bypasses the number of PS molecules, the PS will no longer be able to absorb the photons 
“in excess” and the rate of PDI will not increase. In fact, if the number of photons is higher than this limit, 
the antimicrobial effect will decrease because the dye in suspension will not absorb all the excess light 
(Qin et al, 2008). Schindl et al (2001) referred that the biological effect of light depends on the fluence, 
irrespective of the time over which this dose is delivered. Maclean et al (2008) also indicate that the 
inactivating light may be applied at high irradiance over a short time or at lower irradiance over a longer 
time. A numerical model, assuming that the rate of photodynamic damage occurring at time t is 
proportional to the fluence rate at that time and the local concentrations of PS and oxygen can be 
established. However, according to this model, relatively low fluence rates can be nearly as effective as 
high fluence rate sources if applied over the same period of time (Langmack et al, 2001). 
There is also a direct correlation between the phototoxic effect and the PS concentration and light 
fluence. With a lowering of the PS concentration, more light has to be applied to achieve identical effects, 
and vice versa. Lower doses of PS require higher activating light fluences, and higher fluence requires a 
longer duration of light application (Schmidt-Erfurth and Hasan, 2000).  
 
6.2.1. Effect of Light on Mammalian Viruses PDI 
The effects of dengue virus inactivation were increased with the increase of MB concentration, the 
enhancement of power density of the light source and the extension of illumination time, as well as the 
decrease of illumination distance. This enabled the narrow bandwidth light system to kill or inactivate the 
enveloped virus at much greater distance in much shorter time (Huang et al, 2004). VSV in the presence 
of MB was rapidly inactivated by red (provided by LED incident light at 272 W cm−2) or green-yellow 
light (provided by low-pressure sodium lamps at a fluence rate of 165 W cm−2) but slower by white light 
(provided by a bank of fluorescent tubes at a fluence rate of 42 W cm−2) (Mohr et al, 1997), showing that 
higher power densities produce a high rate of viral inactivation than low fluence rates. Wagner et al 
(1993) also showed that red light of 9 W m−2, given at a total dose of 1.8 × 104 and 3.2 × 104 J m-2, 
inactivated MB-treated VSV by 6 and ≥ 7 log, respectively. VSV inactivation was linearly dependent on 
the fluence rate of red light illumination (Wagner et al, 2002).  
 
6.2.2. Effect of Light on Bacteriophage PDI 
In terms of what is known about phage PDI, only one study focusing on the effect of different 
light sources and power densities (Costa et al, 2010) exists. In this study, cationic porphyrin derivatives 
(meso-tetrakis(1-methylpyridinium-4-yl)porphyrin and 5-(pentafluorophenyl)-10,15,20-tris(1-
methylpyridinium-4-yl)porphyrin), when irradiated with different sources of light (fluorescent PAR 
lamps, sun light and halogen lamp) with fluence rates ranging from 40 W m−2 to 1690 W m−2, efficiently 
photoinactivated non-enveloped phages. All light sources tested lead to reductions of about 7 log for the 
somatic T4-like phage. However, the rate and the extent of inactivation were dependent on the light 
source, namely when low fluence rates were used (40 W m−2) and on the energy dose, being considerably 
more effective when light was delivered at a lower fluence rate. However, depending on the light source 
used, different irradiation periods were required to inactivate T4-like phage to the limits of detection. The 
results also showed that the efficacy of T4-like phage inactivation, using the same fluence rate, was 
dependent on the light source used, in particular when the light is delivered at a low fluence rate. M13 
phage was phototreated with 5.0 µM MB and was inactivated in an irradiation dose-dependent manner 
(Abe et al, 1997). Kastury and Platz (1992) showed that increasing the concentration of a PS at a fixed 
light dose leads to increased viral inactivation as does an increase in the total light exposure at a fixed PS 
concentration. The inactivation rate of T1 bacteriophage increased with increasing fluence rate, indicating 
that the distance of the sample from the light source is a variable which must be controlled (Welsh and 
Adams, 1954). At higher PS concentrations, the inactivation rate reaches a maximum and then decreases, 
because the filtering effect of the dye decreases the effective fluence rate (Welsh and Adams, 1954). In a 
simple model purposed by Lee et al (1997), the phage survival ratio can also be considered as a 
decreasing exponential fraction of the light fluence (assuming that the fluence is uniform throughout the 
system). 
7. Conclusion 
The efficiency of different types of PS in viral PDI has been proved for different types of 
mammalian viruses and bacteriophages, whether they are enveloped or non-enveloped, for either DNA or 
RNA viruses. Even though enveloped viruses are more easily inactivated than non-enveloped ones, 
several studies confirm that non-enveloped mammalian viruses and phages can be efficiently inactivated 
by PDI. The type of viral nucleic acid has not been described as an important factor affecting viral 
photoinactivation but, as far as it is known, no studies specifically focus on the photoinactivation 
behaviour of DNA and RNA viruses. However, RNA phage MS2 was highly susceptible to 
photoinactivation when compared with DNA phages under the same conditions of photosensitization. 
The type of mechanisms involved in the process of viral photosensitization was already elucidated 
and singlet oxygen and free radical species were identified as important contributors for an effective viral 
PDI. However, the contribution of singlet oxygen seems to be more pronounced in mammalian viruses 
and bacteriophages PDI. There are, however, few studies simultaneously comparing the contribution of 
both types of mechanisms (type I and type II) involved in viral PDI. The primary targets for the 
photoinactivation of viruses, whether treating mammalian viruses or phages, are the outer structures. 
Although there are several studies about the specific effects of PDI on viral proteins, for different types of 
mammalian viruses and phages, there are no studies concerning the specific effects of PDI on viral lipids. 
However, it has been clearly shown that enveloped viruses are more easily inactivated than their non-
enveloped counterparts, which imply that the lipids present on viral envelopes are important targets of 
viral PDI. 
PS are effective in inactivating the phages to the limits of detection in a way that they do not 
recover viability, avoiding the development of viral resistance. Nothing is known yet for the particular 
case of mammalian viruses but, as the viral targets are the same for mammalian viruses and phages, it is 
also expected that no resistance will be developed in the case of mammalian viruses. Besides that, viral 
PDI is equally effective whether the mammalian virus is sensitive or resistant to conventional antiviral 
agents. Taking into account all these advantages, PDI for viral inactivation can be regarded as a 
promising alternative therapy to conventional antiviral treatments, namely for the disinfection of blood 
and blood products, preventing viral contamination and for the treatment of wound and burn infections. 
Viral PDI has a fast mode of action and has also the additional benefits of being more economical and an 
environmental friendly technology, which might be successfully used also in the environmental field for 
wastewater, drinking water and fish-farming water disinfection. 
Different PS concentrations and different light sources and fluence rates were tested, showing that 
they are important PDI parameters that must inevitably be taken into account when a viral 
photosensitization protocol has to be elaborated. The inactivation of mammalian viruses and phages can 
be attained at micromolar-level PS concentrations and different light sources are equally effective, 
depending on the final dose at which the viruses are exposed to. Besides that, PS can also be modulated 
by the addition of different meso substituent groups and positive charges in order to facilitate their 
interactions with the viruses, making them more efficient for mammalian viruses and phages PDI. 
The similarity of the results obtained for mammalian viruses and bacteriophages show that they 
exhibit a similar behaviour when submitted to viral photoinactivation techniques: (i) the PS used for viral 
PDI were equally effective in the photoinactivation of mammalian viruses and bacteriophages; (ii) the 
mechanism of mammalian viruses and bacteriophage photosensitization involves the production of singlet 
oxygen (type II mechanism) with a slight contribution of free radical species (type I mechanism); (iii) 
singlet oxygen and free radicals were shown to affect viral nucleic acids and also the proteins and lipids 
present in the mammalian viruses and bacteriophages outer surfaces, with the latter being considerably 
more affected by PDI; and (iv) the rate and extent of mammalian viruses and phages PDI is also affected 
by the same factors, like the PS concentration and number of positive charges, the nature and position of 
meso substituent groups, the fluence rate and energy dose. Consequently, it is important to persist in the 
development of more PDI phage studies to clarify some aspects of viral PDI, such as influence of viral 
nucleic acid type (DNA or RNA) in the photoinactivation efficiency and the possibility of viral resistance 
development and viability recovery after photosensitization. It will also be important to study the 
synergistic effect between viral PDI and antiviral classical methodologies using bacteriophages as models of 
mammalian viruses’ photoinactivation. 
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CHAPTER 2 
 
 
Sewage bacteriophage inactivation by cationic porphyrins: influence of 
light parameters 
 
Abstract 
Photodynamic therapy has been used to inactivate microorganisms through the use of targeted 
photosensitizers. Although the photoinactivation of microorganisms has already been studied under 
different conditions, a systematic evaluation of irradiation characteristics is still limited. The goal of this 
study was to test how the light dose, fluence rate and irradiation source affect the viral photoinactivation 
of a T4-like sewage bacteriophage. The experiments were carried out using white PAR light delivered by 
fluorescent PAR lamps (40 W m-2), sun light (600 W m-2) and a halogen lamp (40–1690 W m-2). Phage 
suspensions and two cationic photosensitizers (Tetra-Py+-Me and Tri-Py+-Me-PF) at concentrations of 
0.5, 1.0 and 5.0 µM were used. The results showed that the efficacy of the bacteriophage 
photoinactivation is correlated not only with the sensitizer and its concentration but also with the light 
source, energy dose and fluence rate applied. Both photosensitizers at 5.0 µM were able to inactivate the 
T4-like phage to the limit of detection for each light source and fluence rate. However, depending on the 
light parameters, different irradiation times are required. The efficiency of photoinactivation is dependent 
on the spectral emission distribution of the light sources used. Considering the same light source and a 
fixed light dose applied at different fluence rates, phage inactivation was significantly higher when low 
fluence rates were used. In this way, the light source, fluence rate and total light dose play an important 
role in the effectiveness of the antimicrobial photodynamic therapy and should always be considered 
when establishing an optimal antimicrobial protocol. 
 
 
Introduction 
As human population densities increase, it becomes more and more difficult to provide supplies of 
high-quality potable water from surface and ground water stocks, and the removal of harmful 
microorganisms, such as bacteria, viruses and protozoa, assumes greater significance. Although the 
transmission of microbial diseases has been reduced by the development of good water supplies and 
hygienic procedures for a whole range of human activities, it is still important to find novel, convenient, 
environmentally-friendly and inexpensive methods to avoid microbial contamination. Currently, 
photodynamic therapy is receiving considerable interest as a potential antimicrobial treatment. 
Photosensitizers, namely porphyrin derivatives, are promising chemical disinfectants for the inactivation 
of pathogens as they are effective in the presence of light and oxygen, without the formation of 
potentially toxic products (Jemli et al, 2002; Magaraggia et al, 2006; Carvalho et al, 2009). 
Photodynamic antimicrobial phototherapy (PACT) has been proven to be a powerful method for 
inactivating viruses, such as murine retroviral vectors, human immunodeficiency viruses (HIV-1 and -2) 
(Schagen et al, 1999; Vzorov et al, 2002), hepatitis viruses (A and B) (Wagner et al, 2002; Casteel et al, 
2004), vesicular stomatitis virus (VSV) (Horowitz et al, 1991), herpes simplex viruses (Silva et al, 2005; 
Tomé et al, 2005; Tomé et al, 2007), human papillomavirus (Wainwright, 2004) and influenza A (Lenard 
and Vanderoef, 1993). The effect of PACT on bacterial viruses (bacteriophages or simply phages), 
frequently used as indicators of enteric viruses and public health risk, has already been tested with success 
not only on collection phages (Abe et al, 1997; Lee et al, 1997; Wagner et al, 1998; Egyeki et al, 2003; 
Zupán et al, 2004; Embleton et al, 2005) but also on sewage bacteriophages (Costa et al, 2008; Almeida et 
al, 2009; Carvalho et al, 2009). 
Several studies indicate that the physicochemical properties of the sensitizer, namely the light-
absorption characteristics and the efficiency of singlet oxygen and free radicals production, have an 
impact on the efficacy of photosensitization (Reddi et al, 2002; Lukšiene, 2005; Lukšiene and Zukauskas, 
2009). Photosensitization occurs when the photosensitizer (PS) is able to absorb and transfer the energy 
of the incident light to molecular oxygen leading to the formation of toxic species. However, it is 
recognized that in addition to the PS properties, the characteristics of the incident light must be 
considered and controlled to increase the efficiency of PACT (Prates et al, 2009). In the literature, light 
parameters are usually discussed in terms of light dose (also identified as fluence) (Kasturi and Platz, 
1992; Jemli et al, 2002; Costa et al, 2008; Alves et al, 2009; Prates et al, 2009) but, as the restriction of 
the reciprocity rule to rather narrow limits for most photobiological reactions, the dose–time relationship 
(fluence rate) should also be taken into account (Schindl et al, 2001). 
A very wide selection of light sources is available, ranging from thermal radiators, which are heated until 
they start glowing and thus emit light (for instance, incandescent lamps) to luminescent radiators, which 
utilize the electronic excitation of atoms to emit light (for instance, gas discharge lamps, light emitting 
diodes (LED) and lasers) (Schmidt, 2005; Lukšiene and Zukauskas, 2009). 
Recently we have shown that porphyrins with three or four positive charges are able to inactivate 
environmental non-enveloped viruses, allowing them to be used as a new, cheap and accessible 
technology for wastewater treatment (Costa et al, 2008). In order to establish the best conditions for an 
efficient photoinactivation of somatic bacteriophages, we have studied how phage inactivation, in the 
presence of efficient PS, is affected by: (i) light source, (ii) light dose and (iii) fluence rate. For this 
purpose, we selected the T4-like sewage bacteriophage, used as indicator of the presence of enteric 
viruses, and the photosensitizers 5,10,15,20-tetrakis(1-methylpyridinium-4-yl)porphyrin tetra-iodide 
(Tetra-Py+-Me) and 5-(pentafluorophenyl)-10,15,20-tris(1-methylpyridinium-4-yl)porphyrin tri-iodide 
(Tri-Py+-Me-PF). Tri-Py+-Me-PF is a tricationic porphyrin recently described by our group as a 
promising PS for the inactivation of several types of microorganisms and Tetra-Py+-Me is the most 
extensively studied PS in bacterial and viral photoinactivation processes (Costa et al, 2008; Carvalho et 
al, 2009; Oliveira et al, 2009). 
 
 Material and Methods 
Porphyrin synthesis 
Porphyrins 5,10,15,20-tetrakis(1-methylpyridinium-4-yl)porphyrin tetra-iodide (Tetra-Py+-Me) 
and 5-(pentafluorophenyl)-10,15,20-tris(1-methylpyridinium-4-yl)porphyrin tri-iodide (Tri-Py+-Me-PF) 
(Figure 1) used in this work were prepared in two steps as previously described (Maestrin et al, 2004; 
Tomé et al, 2004). First, the neutral porphyrins were synthesized by Rothemund and crossed Rothemund 
reactions, using pyrrole and the appropriate benzaldehydes (pyridine-4-carbaldehyde and 
pentafluorophenylbenzaldehyde) at reflux in acetic acid and nitrobenzene. Then, the resulting porphyrins 
were purified by column chromatography (silica) and the pyridyl groups were quaternized by reaction 
with methyl iodide. Porphyrins were purified by crystallization from chloroform-methanolpetroleum ether 
and their purities were confirmed by thin layer chromatography and by 1H NMR spectroscopy. The 
spectroscopic data was in accordance with the literature (Maestrin et al, 2004; Tomé et al, 2004). Stock 
solutions (500 µM) of each porphyrin in dimethyl sulfoxide were prepared by dissolving the adequate 
amount of the desired porphyrin in a known volume. The absorption spectral features of the PS were the 
following: [porphyrin] lmax nm (log e); [Tetra-Py+-Me] in DMSO 425 (5.43), 516 (4.29), 549 (3.77), 588 
(3.84), 642 (3.30); [Tri-Py+-Me-PF] in DMSO 422 (5.48), 485 (3.85), 513 (4.30), 545 (3.70), 640 (3.14). 
 
Phage selection and identification 
A wastewater sample from a secondary-treated sewage plant of the city of Aveiro (Portugal) was 
used to select the somatic bacteriophages of Escherichia coli C (ATCC 13706) (Costa et al, 2008). DNA 
extraction and purification of phage suspension was done using standard techniques (Sambrook et al, 
1989). The phage was identified as a T4-like phage that has 82% of homology with the Enterobacteria 
phage RB43 (Costa et al, 2008). The nucleotide sequence of the phage has been deposited in the GenBank 
database under accession n◦ EU026274. 
 
Bacteriophage host viability test 
As bacteria are sensitive to the photosensitizers, the viability of the viral host was evaluated in 
order to prove that the phage inactivation was only due to the photoinactivation by the photosensitizer and 
not due to bacterial host inactivation by the porphyrin derivatives. So, accordingly to the procedure 
described by Costa et al (2008) additional samples were collected in each sampling time after irradiation, 
with white light delivered by the set fluorescent PAR lamps with a fluence rate of 40 W m-2. Then the 
samples were washed by ultra-centrifugation at 28.000 g for 90 min, at room temperature, to remove the 
photosensitizer (washed experiments). The photosensitizer-free pellet of phages was re-suspended in PBS 
buffer, serially diluted and pour plated by the double layer technique, using the agar double layer 
technique (Adams, 1959) and the aforementioned strain of E. coli as host (Costa et al, 2008). The results 
obtained were compared with those resulting from direct spread (non-washed experiments) after 
irradiation. This bacteriophage host viability test was done at the beginning of the work and only for the 
most effective porphyrin (Tri-Py+-Me-PF) at the highest concentration (5.0 µM). In the other experiments 
this step was not done, but the Petri dishes were incubated in dark conditions. 
 
Light sources 
The photodynamic effect of the cationic PS was evaluated by exposing the sewage somatic 
bacteriophage in the presence of PS to a set of fluorescent PAR lamps, halogen lamp and sun. The first 
light source is constituted by 13 fluorescent lamps OSRAM 21 of 18 W each one, PAR radiation (380–
700 nm) with a fluence rate of 40 W m-2. The second light source used is comprised of an illumination 
system (LC-122 LumaCare, London) equipped with a halogen 250 W quartz-type lamp and coupled to an 
interchangeable fibre optic probe (400–800 nm). This illumination system was used to irradiate the 
microcosm’s setup with white light (400–800 nm) at fluence rates from 40 W m-2 to 1690 W m-2. The 
desired fluence rate was obtained by variation of the distance of the fibre tip to the beakers. The 
experiments with solar irradiation were carried out outside the laboratory. Samples were exposed to solar 
PAR light on sunny summer days, with an average fluence rate of 600 W m-2. The microcosm was 
covered with a glass Petri plate to filter the ultraviolet radiation. Only the PAR radiation of the solar 
spectrum was used in order to avoid viral inactivation by UV radiation during solar exposure and thus to 
allow the comparison of the results with those obtained with the two artificial lights. UV radiation would 
inactivate the viruses and, consequently, would increase the rate of phage inactivation during the 
exposition to the photosensitizers. All the fluence rates were measured with a radiometer LI-COR Model 
LI-250. 
 
Experiments with different light sources 
The influence of different light sources of white light on phage inactivation by the two cationic 
porphyrins at different concentrations was evaluated through quantification of the number of 
bacteriophages in laboratory conditions. A phage suspension was diluted in phosphate buffer (PBS) until 
5 x 107 PFU mL-1 and aseptically distributed in 600 mL acid-washed and sterilised glass beakers (20 mL 
per each of five beakers). The photosensitizer from a stock solution (500 µM in DMSO) was added to 
three beakers to achieve final concentrations of 0.5, 1.0 and 5.0 µM and the other two were used as dark 
and light controls. In the light control no porphyrin was added but the beaker was exposed to the same 
irradiation protocol. In the dark control, the photosensitizer at the highest concentration (5.0 µM) was 
added to the beaker and it was covered with aluminium foil. The test beakers and the light and dark 
controls were submitted to a pre-irradiation period in the dark during 10 min under 100 rpm stirring at 
20–25 ºC. After the pre-irradiation period, the five beakers, under stirring (100 rpm) and in a 
thermostatized bath at 20–25 ºC, were exposed in parallel to white light radiation generated by the 
different light sources. Sub-samples of 1.0 mL were taken at regular intervals and analysed, in duplicate, 
for bacteriophage number. Since the irradiation sources had different fluence rates, it was also compared 
the efficacy of sewage T4-like bacteriophage inactivation using the same fluence rate delivered by 
different light sources. These experiments were carried out using the most efficient photosensitizer Tri-
Py+-Me-PF at the highest concentration (5.0 µM) irradiated at 40 and 600 W m-2. The Petri plates were 
kept in the dark immediately after spreading and during the incubation to avoid the inactivation of the 
bacterial host by the photosensitizer. Viral density (PFU mL-1) was determined at each time point as the 
mean of the two duplicates in the most convenient dilution series. Viral survival at each time was 
calculated by dividing the mean number of viruses surviving at each time by the initial number (at time 
zero). Viral reduction was expressed as a log value. For each experimental condition (light source, 
photosensitizer and concentration) two independent experiments were carried out with two replicates 
each. 
 
Experiments at different fluence rates with a fixed total light dose 
To evaluate the influence of the light fluence rate on the bacteriophage inactivation, phage 
suspensions, incubated with the most effective porphyrin (Tri-Py+-Me-PF), were exposed to the same 
energy dose delivered with four different light fluence rates ranging from 150 to 1200 W m-2. An 
illumination system (LC-122 LumaCare, London) equipped with a halogen 250 W quartz-type lamp and 
coupled to an interchangeable fibre optic probe (400–800 nm) was used. The fibre tip was placed at the 
adequate distance from the beaker in order to deliver a fluence rate of 150, 300, 600 and 1200 W m-2. The 
total light dose of 216 J cm-2 corresponded to irradiation periods of 30 min at 1200 W m-2, 60 min at 600 
W m-2, 120 min at 300 W m-2 and 240 min at 150 W m-2. Sub-samples of 1.0 mL were collected at 
established intervals corresponding to 54, 108, 144 and 216 J cm-2 light doses.  
The rate of phage inactivation was evaluated through the quantification of the number of 
bacteriophages, using the above described protocol. Light and dark control experiments were also carried 
out simultaneously. For each irradiation period two independent experiments were carried out with two 
replicates each. 
 
Statistical analysis 
All experiments were done in duplicate. Statistical analysis was performed using SPSSWIN 14.0. 
The significance of difference in phage inactivation between the two photosensitizers’ values was 
assessed using one-way ANOVA. The differences in phage inactivation during the incubation period 
were also evaluated using one-way ANOVA. Only the data with normal distribution (assessed by 
Kolmogorov-Smirnov test) and with homogeneity of variances (assessed by Levene test) were used. A 
value of p < 0.05 was considered significant. 
 
 
Results 
The phototoxic action on T4-like sewage bacteriophage by the two cationic porphyrin derivatives 
(Figure 1) was initially assessed by exposing the test assembly to different photosensitizer concentrations 
(0.5, 1.0 and 5.0 µM) and to white light from different light sources and fluence rates. 
 
  
Figure 1. Structure and UV-Vis spectra (in DMSO) of the two cationic porphyrins used in this study for the photoinactivation 
of T4-like bacteriophage. 
 
Bacteriophage host viability 
The bacteriophage host viability test showed that the pattern of phage inactivation was not 
affected by the presence of photosensitizer during the incubation period (18 h) in the dark. The pattern of 
phage inactivation was similar in washed and in non-washed samples (Costa et al, 2008). This means that 
the photosensitizer does not affect the bacteria during incubation of the Petri plates in the dark and, 
therefore, the washing step by ultra-centrifugation, a time consuming procedure, was not carried out. 
However, in all the experiments, the Petri plates were kept in the dark during the incubation period. 
 
Bacteriophage viability 
Without light (dark control), the photosensitizers at the highest concentration (5.0 µM) did not 
exhibit activity against the phage for the exposure time (270 min). A similar trend was observed for the 
phage in the absence of the PS for all the irradiation periods with white light (light control) (Figures 2 to 
6). It is important to note that the light used in the experiments did not affect viral viability. Inactivation 
was observed only when the phage was incubated with the photosensitizer and irradiated with the 
appropriate light dose. 
 
Influence of light sources on bacteriophage inactivation 
The efficiency of the sewage bacteriophage inactivation for the two cationic porphyrin derivatives, 
irradiated with selected light sources, was different. Although the two cationic porphyrins at 5.0 µM, 
when activated by all the light sources, were able to inactivate the sewage T4-like phage to the limit of 
detection, the phage photoinactivation with a halogen lamp occurred faster than with solar irradiation or 
with fluorescent lamps (Figures 2 to 4).  
In fact, when the illumination system (halogen lamp) was used at a fluence rate of 1690 W m-2, 
the Tri-Py+-Me-PF and Tetra-Py+-Me porphyrins, at a concentration of 5.0 µM, were able to inactivate 
the sewage T4-like phage by more than 7 log (Figure 2) after 25 and 45 min (data not shown), 
respectively. Under these light conditions, for a concentration of 1.0 mM, both photosensitizers produced 
a moderate phage inactivation after 30 min of exposure to light (2.2 and 1.3 log for Tri-Py+-Me-PF and 
Tetra-Py+-Me). For the lowest concentration of photosensitizers (0.5 µM) the inactivation varied between 
reductions of 0.8 to 1.3 log after 30 min of irradiation (Figure 2). With these light conditions (1690 W m-
2) the pattern of phage inactivation was similar for both porphyrins (ANOVA, p > 0.05) for all the 
concentration tested (Figure 2). 
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Figure 2. Variation of the numbers of the sewage bacteriophage after irradiation with the illumination system (halogen lamp) 
at 1690 W m-2 in the presence of Tri-Py+-Me-PF (A) and Tetra-Py+-Me (B), respectively (-- light control, -- dark control, -
- 0.5 µM, -- 1.0 µM, -- 5.0 µM). Error bars represent standard deviations. 
 
 
Under solar light (~ 600 W m-2), T4-like phage was also efficiently photoinactivated (> 99.9999% 
of inactivation) with reductions of 7.2 log for Tri-Py+-Me-PF (5.0 µM) after 90 min and 7.0 log for Tetra-
Py+-Me (5.0 µM) after 180 min of irradiation (data not shown). With 1.0 µM of sensitizer, the 
inactivation ranged from 3.1 to 0.8 log after 90 min of exposure for Tri-Py+-Me-PF and Tetra-Py+-Me, 
respectively. For concentrations of 0.5 µM, the reductions observed were 1.5 and 0.1 log (after 90 min), 
for Tri-Py+-Me-PF and Tetra-Py+-Me, respectively (Figure 3). With this light source, the pattern of phage 
inactivation was similar for Tri-Py+-Me-PF and Tetra-Py+-Me, but only for the highest concentration (5.0 
µM) (ANOVA, p > 0.05). For the other concentrations (0.5 and 1.0 µM) the pattern of phage inactivation 
was different for both porphyrins (ANOVA, p < 0.05) (Figure 3).  
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Figure 3. Variation of the numbers of the sewage bacteriophage after irradiation with solar light (600 W m-2) in the presence 
of Tri-Py+-Me-PF (A) and Tetra-Py+-Me (B), respectively (-- light control, -- dark control, -- 0.5 µM, -- 1.0 µM, -- 
5.0 µM). Error bars represent standard deviations. 
 
Porphyrins irradiated with a set of 13 fluorescent lamps (40 W m-2), at 5.0 µM, also inactivated 
the T4-like phage to the limit of detection with reductions of 7.0 log (after 180 min of irradiation) and 7.2 
log (after 270 min of irradiation) for Tri-Py+-Me-PF and Tetra-Py+-Me, respectively. Again, for the lower 
concentrations (0.5 and 1.0 µM) the inactivation was moderate and ranged from reductions of 3.6 and 1.5 
log for 1.0 µM and reductions of 1.8 to 0.9 log for 0.5 µM, respectively, for Tri-Py+-Me-PF and Tetra-
Py+-Me, after 270 min of exposure to white light (Figure 4). Also, for both porphyrins, with this light 
source the pattern of phage inactivation was similar for the highest concentration (5.0 µM) (ANOVA, p > 
0.05) and different for the other concentrations (0.5 and 1.0 µM) (ANOVA, p < 0.05) (Figure 4).  
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Figure 4. Variation of the numbers of the sewage bacteriophage after irradiation with the set of 13 fluorescent PAR lamps (40 
W m-2) in the presence of Tri-Py+-Me-PF (A) and Tetra-Py+-Me (B), respectively (-- light control, -- dark control, -- 0.5 
µM, -- 1.0 µM, -- 5.0 µM). Error bars represent standard deviations. 
 
The results of the comparison of the efficacy of sewage T4-like bacteriophage inactivation by Tri-
Py+-Me-PF using the same fluence rate delivered by different light sources are presented in Figures 5 and 
6. The results show that the efficacy of phage inactivation at a low fluence rate (40 W m-2) depends on the 
light source (Figure 5). However, at a high fluence rate (600 W m-2) this dependence was not observed 
(Figure 6). At a fluence rate of 40 W m-2, the phage was inactivated to the limit of detection (> 99.9999% 
of inactivation, corresponding to a reduction of 7.2 log) only when irradiated with fluorescent lamps 
(380–700 nm). With a halogen lamp coupled to an interchangeable fibre optic probe (400–800 nm), the 
rate of phage inactivation was considerably lower (reduction of 2.5 log) even after 270 min of irradiation 
B A 
B A 
(Figure 5). However, the difference between the two sources was only significant for T180 and T270 
(ANOVA, p < 0.05). At 600 W m-2, the phage was inactivated to the limit of detection (> 99.9999% of 
inactivation, reduction of 7.2 log) after 90 min of irradiation with both light sources (solar irradiation and 
halogen lamp) (Figure 6). However, the pattern of inactivation for the two light sources was significantly 
different for T0 and T30 (ANOVA, p < 0.05 for T0 and T30 and p > 0.05 for T60, T90 and 120). 
0
2
4
6
8
0 30 60 90 120 150 180 210 240 270
Time of Exposure (min)
Lo
g 
(P
FU
 
m
L-
1 )
0
2
4
6
8
0 30 60 90 120 150 180 210 240 270
Time of Exposure (min)
Lo
g 
(P
FU
 
m
L-
1 )
 
Figure 5. Variation of the numbers of the sewage bacteriophage after irradiation with the set of 13 fluorescent PAR lamps (A) 
and illumination system (halogen lamp) (B) at 40 W m-2 in the presence of porphyrin Tri-Py+-Me-PF (-- light control, -- 
dark control, -- 5.0 µM). Error bars represent standard deviations. 
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Figure 6. Variation of the numbers of the sewage bacteriophage after irradiation with solar light (A) and with the illumination 
system (halogen lamp) (B) at 600 W m-2 in the presence of porphyrin Tri-Py+-Me-PF (-- light control, -- dark control, -- 
5.0 µM). Error bars represent standard deviations. 
 
 
Influence of fluence rate using a specific light source on bacteriophage inactivation 
The previous results lead us to evaluate how the bacteriophage inactivation would be affected by 
different fluence rates delivered by the same light source. This is to ensure that the obtained results were 
due only to the fluence rate, and not to the different emission spectra of the light sources. In this study we 
used the halogen lamp and the most efficient PS (Tri-Py+-Me-PF).  
For a total light dose of 216 J cm-2, the rate of viral photoinactivation was more effective when the 
fluence rates were 150, 300 and 600 W m-2. Under these conditions, the phage was inactivated to the limit 
of detection (> 99.9999% of inactivation) (Figure 7). However, for a fluence rate of 1200 W m-2 the 
bacteriophage was not totally inactivated (reductions of 5.4 log). The differences between the phage 
B A 
B A 
inactivation with a fluence rate of 1200 W m-2 and other fluence rates were significant except for the 
highest light dose (ANOVA, p > 0.05).  
For total light doses of 144 and 108 J cm-2, the rate of phage inactivation was higher when the 
light was delivered at a lower fluence rate (reductions of 5.9 and 4.9 log, with 150 and 300 W m-2 for 144 
J cm-2 and of 4.0 and 3.6 log for 108 J cm-2, respectively) than when the light was delivered at 600 and 
1200 W m-2 (reductions ranging from 1.8 to 3.1 log). The same pattern was obtained when a light dose of 
54 J cm-2 was used (reductions of 2.3 and 1.8 log for 150 W m-2 and 300 W m-2 and of 1.4 and 1.1 log, 
respectively for 600 and 1200 W m-2). 
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Figure 7. Variation of the numbers of the sewage bacteriophage after a total light dose of 54, 108, 144 and 216 J cm-2 
delivered at the fluence rates of 150, 300, 600 and 1200 W m-2. 
 
 
Discussion 
The present study demonstrates that the two cationic porphyrins Tetra-Py+-Me and Tri-Py+-Me-
PF, when irradiated with different sources of light (fluorescent PAR lamps, sun light and halogen lamp) 
with fluence rates ranging from 40 W m-2 to 1690 W m-2, can efficiently photoinactivate sewage non-
enveloped viruses. All light sources tested lead to reductions of > 99.9999% for the somatic T4-like 
phage. However, the rate and the extent of inactivation are dependent on: (1) the structure and 
concentration of the photosensitizer; (2) the light source, namely when low fluence rates are used (40 W 
m-2); and (3) the energy dose, being considerably more effective when light was delivered at a lower 
fluence rate.  
At the highest concentration tested (5.0 µM) reductions of approximately 7 log are obtained with 
both porphyrins irrespective of the light source used. However, depending on the light source used, 
different irradiation periods are required to obtain these reductions. Irradiation with a halogen lamp (1690 
W m-2) for 45 min leads to an efficient phage inactivation (~ 7.2 log of reduction) with both sensitizers. 
Both PS when irradiated with solar light (600 W m-2) or with a set of fluorescent lamps (40 W m-2) for 
short periods gave a small phage inactivation (until 2.2 log after 60 min of irradiation) but are able to 
inactivate the phage to the limit of detection (reductions of about 7 log) after 180–270 min of irradiation. 
It is important to note, however, that at the end of the experiments, for the lowest photosensitizer 
concentrations (0.5 and 1.0 µM), the rate of inactivation was higher with solar light and with fluorescent 
lamps rather than with the halogen lamp. This can be explained by the fact that less PS molecules are 
available in the microcosms for the photoinactivation process and a portion of the light energy is not used 
to generate cytotoxic oxygen species.  
As observed before, the structure and concentration of the photosensitizer influences phage 
photoinactivation (Milanesio et al, 2003; Lazzeri et al, 2004; Tomé et al, 2005; Caminos et al, 2006; 
Costa et al, 2008; Almeida et al, 2009). The two cationic porphyrins, irradiated under the same 
conditions, inactivated the sewage T4-like phage differently. For concentrations of 5.0 µM, the reductions 
observed were almost 7 log (limit of detection) for both Tri-Py+-Me-PF and Tetra-Py+-Me although these 
reductions were reached at different irradiation times. However, at 1.0 and 0.5 µM the rate of inactivation 
was significantly lower (3.6 and 1.8 log, respectively). In fact, it is known that increasing the 
concentration of a sensitizer at a fixed light dose leads to increased viral inactivation as does an increase 
in the total light exposure at a fixed sensitizer concentration (Kasturi and Platz, 1992). Milanesio and co-
workers (2003) also support the basic concept that, after irradiation with visible light, cell survival of 
human cells is dependent upon both intracellular sensitizer concentration and light exposure level. Similar 
results were obtained by other authors with bacteria (Lazzeri et al, 2004; Caminos et al, 2006).  
The results also show that the efficacy of sewage T4-like bacteriophage inactivation using the 
same fluence rate is dependent on the light source used (for Tri-Py+-Me-PF), in particular when the light 
is delivered at low fluence rate. At 40 W m-2 the phage inactivation with fluorescent lamps is much more 
efficient than with halogen lamps under the same experimental conditions (fluence rate, irradiation time 
and PS concentration). However, similar phage inactivation is observed when a halogen lamp at 600 W 
m
-2
 or solar irradiation is used. The difference in phage inactivation when the same fluence rate of 40 W 
m-2 is delivered by the two different light sources can be justified because the fraction of PS that is 
excited is not the same (Ghetti and Checcucci, 1996; Paula et al, 2009). Although the concentration of the 
PS used is the same, the emission spectra of the two lamps are different and, consequently, the energy 
available to excite the photosensitizer is different. The spectral ranges are: 380–700 nm for the 
fluorescent lamps and 400–800 nm for the interchangeable fibre optic probe coupled to the illumination 
system (halogen lamp). Since the absorption wavelengths for the porphyrin derivatives range from 400 to 
650 nm, part of the energy provided by the halogen lamp (650–800 nm) is not used to excite the 
photosensitizer. On the contrary, for the fluorescent lamps most of the energy is emitted at 545 and 611 
nm that coincides with the Q bands of the PS. When the illumination system (halogen lamp) at 600 W m-2 
and solar irradiation are used this aspect is not so critical for the inactivation process due to the similarity 
of both emission spectra (Figure 8). 
 
 Figure 8. Emission spectra of the light sources used in this study. 
 
When the same light dose is delivered by the same light source but at different fluence rates (150, 
300, 600 and 1200 W m-2) the efficacy of sewage T4-like bacteriophage inactivation is inversely 
proportional to the fluence rate used. Our results show (Figure 7) that the photoinactivation is more 
efficient if the same total amount of photons passing through a bacteriophage suspension is delivered 
during a longer illumination period (lower fluence rate). This is due to the fact that, when a high fluence 
rate is used, the PS in the suspension is not able to absorb the photons in excess (Qin et al, 2008; Prates et 
al, 2009). Similar results were reported by the study of Gábor and collaborators (2001) were they 
described a higher rate of Escherichia coli and Enterococcus hirae inactivation when a similar total light 
dose is received over a longer time period. Recently, Prates et al (2009) described dissimilar levels of 
inactivation on yeast cells when the same light dose is given in different fluence rates. At the same light 
dose, the low fluence rate was more effective than the higher fluence rate (Prates et al, 2009).  
In conclusion, our results show that cationic porphyrins irradiated with three different light 
sources are able to efficiently photoinactivate environmental non-enveloped viruses. These compounds 
can be envisaged as a new, cheap and accessible technology for wastewater treatment. All light sources 
used here were effective in the excitation of the selected PS. Different levels of photoinactivation were 
achieved when the same light dose was received at different periods of irradiation. At higher doses (216 J 
cm-2) the efficiency of the photoinactivation process was not significantly affected by the fluence rate, 
however, at lower light doses, the efficiency was strongly affected by the fluence rate. As the light 
parameters such as light source, fluence rate and total light dose play an important role in the 
effectiveness of antimicrobial photodynamic therapy, they should always be considered when establishing 
an optimal antimicrobial protocol. 
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CHAPTER 3 
 
 
Susceptibility of non-enveloped DNA- and RNA-type viruses to 
photodynamic inactivation 
 
Abstract 
The comparative susceptibility of “DNA- and RNA-type” viruses to photodynamic inactivation has not 
yet been clearly addressed. In this study the effect of the tricationic porphyrin Tri-Py+-Me-PF on the 
inactivation of four DNA and three RNA non-enveloped phages was compared. The results obtained 
show that the photodynamic efficiency varied with the phage type, being the “RNA-type” phages much 
more easily photoinactivated than the “DNA-type” ones. 
 
 
Introduction 
The use of antivirals has largely increased in the last years and resistance to antiviral drugs is now 
well documented for several pathogenic viruses (Kimberlin and Whitley, 1996; Pillay and Zambon, 1998; 
Smee et al, 2002). Moreover, as viruses are genetically flexible, they may mutate quickly and, 
consequently, the emergence of antiviral drug resistance can become a great problem, possibly even 
higher than that observed for bacteria in relation to antibiotics. Consequently, the emergence of antiviral 
drug resistance requires alternative methods, unlikely to cause resistance. Microbial photodynamic 
inactivation (PDI), which uses a combination of a photosensitizer (PS), light and molecular oxygen to 
induce damages of important biological targets (Jori et al, 2011), has been described as a promising 
alternative for viral inactivation, namely for bacteriophages that are frequently used as surrogates of 
mammalian viruses.  
After bacteriophage PDI the virus is rendered unable to penetrate a prospective host cell or it is 
unable to replicate after entry because its genome has been rendered defective, or the virus replication 
cycle is inhibited at some other step (Jockush et al, 1996; Lee et al, 1997). 
Although several studies clearly indicate that enveloped viruses, including the non-usual 
enveloped bacteriophages, are more susceptible to PDI than their non-enveloped counterparts (Lenard et 
al, 1993; Wainwright, 2003), the comparative susceptibility of “DNA- and RNA-type” viruses to PDI has 
not been clearly addressed yet. Studies employing non-enveloped phages like T7 (DNA phage), PM2 
(DNA phage with internal lipids) and MS2 (RNA phage), indicated that both DNA and RNA phages can 
be photoinactivated (Specht, 1994). An increase in T7 phage photoinactivation was observed with an 
increase in methylene blue concentration from 1.0 to 10 µM, while the photoinactivation rate of MS2 did 
not vary under the same experimental conditions. It was suggested that the critical targets for MS2 phage 
were saturated at 1.0 µM of phenothiazines (Specht, 1994). Hotze et al (2009) also showed that PRD1 and 
T7 (“DNA-type” phages) are significantly more resistant to singlet oxygen inactivation than MS2 phage. 
The high propensity for MS2 phage photoinactivation was attributed to the damage of its A protein, 
necessary for infecting its host Escherichia coli since it contains highly reactive amino acids such as Met, 
Cys, His, and Tyr (Hotze et al, 2009). 
The objective of this study was to compare the susceptibility to photodynamic inactivation of a 
series of “DNA- and RNA-type” bacteriophages (the designation “DNA- and RNA-type” is used in 
respect to the nature of the nucleic acid and capsid proteins). For that, a tricationic porphyrin, 5,10,15-
tris(1-methylpyridinium-4-yl)-20-(pentafluorophenyl)porphyrin tri- iodide (Tri-Py+-Me-PF), a very 
promising PS already tested with success against several types of microorganisms (Almeida et al, 2011), 
was used. 
 
 
Methods 
Porphyrin synthesis 
The 5,10,15-tris(1-methylpyridinium-4-yl)-20-(pentafluorophenyl)porphyrin tri- iodide (Tri-Py+-Me-PF) 
used as PS (Figure 1) was prepared in accordance with the methodology referred by Carvalho et al 
(2010). PS purity was confirmed by 1H NMR spectroscopy. The PS was dissolved in dimethyl sulfoxide 
(500 µM stock solution) and sonicated for 30 min before use. 
 
 
Figure 1. Structure of the PS used for bacteriophage photoinactivation. 
 
Bacteriophages  
Wastewater from a sewage secondary-treatment plant (Aveiro, Portugal) was used to select the 
somatic bacteriophages of Escherichia coli C (ATCC 13706) (Costa et al, 2008). Phages of Aeromonas 
salmonicida (AS) and Vibrio anguillarum (VA) were isolated from the aquaculture system Corte das 
Freiras (Ria de Aveiro, Portugal) (Pereira et al, 2011). Pseudomonas aeruginosa phage (PA) was 
obtained from a sewage water sample collected at the wastewater treatment plant of the University of 
Coimbra Hospitals (Vieira, 2011). MS2 and Qβ phages were purchased from DSMZ collection 
(Braunschweig, Germany). LAIST_PG002 phage was isolated from a sewage secondary-treatment plant 
(Lisboa, Portugal) (unpublished data). 
T4-like, AS, PA and VA phages are non-enveloped double stranded (ds) DNA viruses with a 
simple capsid without lipids (Mesyanzhinov et al, 2004; Pereira et al, 2011; Vieira, 2011). MS2, Qβ and 
LAIST_PG002 phages are non-enveloped single stranded (ss) RNA viruses also with a simple capsid 
without lipids (Lee et al, 1997; Schneider et al, 1998; Cho et al, 2005). 
 
Bacteriophage quantification 
Bacteriophage quantification was done by the double agar layer technique (Adams, 1959), using 
E. coli C (ATCC 13706), A. salmonicida, P. aeruginosa and V. anguillarum as host strains, respectively 
for T4-like, AS, PA and VA phages and Salmonella typhimurium WG49 (Havelaar and Hogeboom, 1984) 
for MS2, Qβ and LAIST_PG002 phages. From each sample, duplicates of 1.0 mL of non-diluted or of 
serially diluted samples and 0.3 mL of bacterial host were added to a tube with 5.0 mL of soft TSA 
growth medium. The contents of the tube were mixed by manual rotation and then immediately poured 
onto a TSA monolayer on a Petri plate. After 5 (MS2 phage) and 18 hours (Qβ, LAIST_PG002, T4-like, 
AS, PA and VA phages) of dark incubation at 37 ºC, the number of phage plaques was counted on the 
most convenient series of dilutions and the number of plaque forming units per millilitre (PFU mL−1) was 
determined. 
 
Experimental setup 
Phage photoinactivation by Tri-Py+-Me-PF at 5.0 and 0.5 µM, respectively for “DNA- and RNA-
type” phages, was achieved by exposing the bacteriophages in PBS (≈ 107 PFU mL-1) to white light (13 
fluorescent lamps OSRAM 21 of 18 W each, 380-700 nm) of 40 W m-2 (measured with a light meter LI-
COR Model LI-250) during 270 min, with agitation (100 rpm) at 25 ºC. Dark and light controls were also 
included in the experiment and were carried out simultaneously. In the light control (LC), the phage 
suspension without PS was exposed to the same irradiation protocol. In the dark control (DC), the beaker 
containing the phage suspension and the PS at the studied concentration (0.5 or 5.0 µM) was covered with 
aluminium foil to protect it from light exposure. Sub-samples of 1.0 mL of test and control samples were 
aseptically taken at time 0, 60, 90, 180 and 270 min (for “DNA-type” phages) and at time 0, 15, 30, 60, 
90, 180 and 270 min (for “RNA-type” phages). The kinetics of phage inactivation was evaluated through 
the quantification of the number of phages according to Costa et al (2008). Three independent 
experiments were carried out with two replicates each. 
 
Statistical analysis 
SPSSWIN 14.0 was used for data analysis. The significance of difference in phage inactivation 
among different DNA and RNA phages was assessed using one-way ANOVA. Only the data with normal 
distribution (assessed by Kolmogorov-Smirnov test) and with homogeneity of variances (assessed by 
Levene test) were used.  
 
 
Results 
The results of LC and DC showed that white light or PS under dark did not significantly affect the 
phages viability (Figures 2 and 3), indicating that the reduction on phage survival was due to the PDI 
treatment. 
The efficiency of bacteriophage photoinactivation by Tri-Py+-Me-PF irradiated with 40 W m-2 
during 270 min, was markedly different between DNA (T4-like, AS, PA and VA) and RNA (MS2, Qβ 
and LAIST_PG002) phages (Figures 2 and 3). All phages were efficiently photoinactivated (6-7 log), but 
the inactivation occurred earlier for “RNA-type” phages and at a PS concentration ten times lower than 
that required to efficiently photoinactivate the “DNA-type” ones (0.5 µM versus 5.0 µM and 60-90 min 
versus 180-270 min). 
Although “DNA-type” phages exhibited different rates of photoinactivation (Figure 2), the 
differences were not statistically significant (ANOVA, p > 0.05). T4-like phage was the only DNA phage 
photoinactivated to the limits of detection (∼ 7 log) after 180 min of irradiation at 5.0 µM PS. Reductions 
ranging from 5.7 to 6.1 log, after 270 min of irradiation, were attained for AS, PA and VA phages. 
“RNA-type” phages were all inactivated to the detection limit (6.2 to 7.2 log), after 60-90 min of 
irradiation, in the presence of 0.5 µM PS (Figure 3), and their rates of inactivation were not statistically 
different (ANOVA, p > 0.05).  
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Figure 2. Variation of the number of the “DNA-type” phages after irradiation with white light (40 W m-2) in the presence of 
5.0 µM Tri-Py+-Me-PF (–– T4-like, ––PA, –•– AS, –– VA, –×– T4-like LC, –□– T4-like DC, ––PA LC, –∆–PA DC, –
– AS LC, –– AS DC, –+– VA LC, –◊– VA DC). Each value represents mean ± standard deviation of three independent 
experiments, with two replicates each. 
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Figure 3. Variation of the number of the “RNA-type” phages after irradiation with white light (40 W m-2) in the presence of 
0.5 µM Tri-Py+-Me-PF (–– MS2, –– LAIST_PG002, –♦– Qβ, –– MS2 LC, –∆–MS2 DC,  –×–  LAIST_PG002 LC, –□– 
LAIST_PG002 DC, –+– Qβ LC, –◊–  Qβ DC). Each value represents mean ± standard deviation of three independent 
experiments, with two replicates each. 
 
 
Discussion 
The present study demonstrates that both “DNA- and RNA-type” bacteriophages can be 
efficiently photoinactivated by Tri-Py+-Me-PF when irradiated with white light (40 W m-2), and that 
“RNA-type” phages are more susceptible to PDI than the “DNA-type” ones. The rate and efficiency of 
the inactivation process seem to be dependent on the type of phages. “RNA-type” phages were 
inactivated to the detection limit, after 60-90 min of irradiation with white light at 0.5 µM of Tri-Py+-Me-
PF, while the “DNA-type” phages, although also efficiently inactivated by Tri-Py+-Me-PF, required a 
concentration of PS ten times higher (5.0 µM) and a longer irradiation period (180 min for T4-like phage 
and 270 min for AS, PA and VA phages). 
All “DNA- and RNA-type” phages tested in this study are non-enveloped, with a simple capsid 
without lipids. As the capsid of the studied “DNA-type” phages is composed by a higher diversity of 
proteins (Fokine et al, 2004; Mesyanzhinov et al, 2004), when compared with the capsid of “RNA-type” 
phages (Cho et al, 2005), the major difference between the two phage groups may not only reside on the 
type of nucleic acids, but also on the composition of their capsids, which can also explain the different 
pattern of PDI. 
It has been shown that the main targets of PDI are the external microbial structures that, in the 
case of viruses, are the protein capsids and lipid envelopes (if present) (Hotze et al, 2009). The damages 
of the external viral structures can involve leakage of particle contents and/or inactivation of enzymes 
(Sieber et al, 1992; Zupán et al, 2008). Nucleic acid has been also identified as a PDI target (Abe and 
Wagner, 1995; Hotze et al, 2009). However, although nucleic acid damage occurs, it is not suggested as 
the main cause of viral PDI (Hotze et al, 2009). A demonstration of this is the bacterium Deinococcus 
radiodurans, which is known to have a very efficient DNA repair mechanism, but it is easily killed by 
PDI (Schafer et al, 1998). However, in contrast to DNA, short-lived RNA molecules are rapidly degraded 
in living microorganisms by enzymes (RNase), which are very stable even in harsh environments (Sela et 
al, 1957; Sheridan et al, 1998). Consequently, in the case of viruses, for which the nucleic acid can be ss 
or dsDNA or RNA, and contrarily to bacteria and fungi, the type of nucleic acid can be an important and 
a determinant factor of the efficiency of viral PDI. Moreover, as for bacteria, the damages in the viral 
DNA can yet be repaired by the action of DNA repairing systems of the host cells (Imray and MacPhee, 
1973), but it is impossible for the host cells to repair the damaged nucleic acid of RNA viruses. Therefore, 
“DNA-type” viruses tend to be more genetically stable than “RNA-type” viruses. 
The studies so far conducted with “DNA- and RNA-type” phages (Specht, 1994; Hotze et al, 
2009) showed that “RNA-type” phages were more easily inactivated than “DNA-type” ones under the 
same PDI protocol. However, in these studies, although several “DNA-type” phages were used, only one 
ssRNA phage (MS2) was tested, which precludes a clear picture of the effect of the nucleic acid type in 
viral PDI and generalizations are difficult to be made. In this study, three “RNA-type” phages were used, 
including the well-studied MS2 phage, and all of them were significantly more easily inactivated that any 
of the four “DNA-type” phages tested. 
Associated with the higher stability of DNA strands, and the possibility of DNA repair by the host 
repair system, the more complex capsids of “DNA-type” phages could also contribute to the less effective 
PDI relatively to “RNA-type” phages, which have not RNA host repair mechanisms and have less 
complex capsids. In fact, it has been shown that the main targets of viral PDI are the capsid proteins 
(Hotze et al, 2009). 
In conclusion, this work emphasizes that the efficiency of phages PDI is different for “DNA- and 
RNA-type” phages. However, more and detailed experimental work focusing on the main targets 
involved in the PDI of both “DNA-type and RNA-type” bacteriophages, including also dsRNA phages, is 
under progress. 
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CHAPTER 4 
 
 
Involvement of type I and type II mechanisms on the photoinactivation of 
non-enveloped DNA and RNA bacteriophages 
 
Abstract  
Microbial photodynamic inactivation (PDI), involving the use of a photosensitizer (PS), light and 
molecular oxygen, with the subsequent production of reactive oxygen species (ROS), has been considered 
a promising and effective technology for viral inactivation. Although singlet oxygen is generally accepted 
as the main damaging species in PDI, ROS like free radicals may also be involved in the process, 
inducing damages to proteins, lipids, nucleic acids and other molecular structures. In this study, the 
relative importance of each mechanism (type I and type II) on the photoinactivation of non-enveloped 
DNA (T4-like phage) and RNA (Qβ phage) viruses was evaluated. For this purpose, two cationic 
porphyrins (Tri-Py+-Me-PF and Tetra-Py+-Me) and four different ROS scavengers were used. The 
scavenging effect of sodium azide and L-histidine (singlet oxygen quenchers) and of D-mannitol and L-
cysteine (free radical scavengers) was assessed by exposure of both phages (T4-like and Qβ) to each 
cationic porphyrin (5.0 µM for T4-like phage and 0.5 µM for Qβ phage) and white light (40 W m-2) in the 
presence of different concentrations of the scavengers (5, 10, 50 and 100 mM). Sodium azide and L-
histidine gave the best protection, reducing the phototoxic effect of Tri-Py+-Me-PF on T4-like phage 
respectively by 80 and 72% and in the presence of Tetra-Py+-Me by 90 and 78%. Free radical scavengers 
D-mannitol and L-cysteine did not significantly reduce the rate of T4-like phage photoinactivation (≤ 
20% protection), for both PS). The sodium azide protection on Qβ phage photoinactivation, in the 
presence of Tri-Py+-Me-PF, was lower (39%) when compared with T4-like phage. D-mannitol did not 
exert on Qβ phage any protective effect after 90 min of irradiation. The effect of the simultaneous 
presence of singlet oxygen and free radicals scavengers at 100 mM confirmed that singlet oxygen (type II 
mechanism) is clearly the main ROS involved in T4-like and Qβ phages photoinactivation by these two 
cationic PS. As RNA-type phages are more easily photoinactivated when compared with DNA-type ones, 
the protection conferred by the scavengers during the PDI process is lower and this should be taken into 
account when the main mechanism involved in PDI of different viruses is to be studied. 
 
 
Introduction 
Microbial photodynamic inactivation (PDI) is based on the ability of a photosensitizer (PS) to 
absorb energy from light and, from their excited state, lead to the production of reactive oxygen species 
(ROS), such as singlet oxygen and free radicals (Jori et al, 2011). In the first excited short-lived state, 
achieved by absorption of visible light, the PS can loose its energy by fluorescence emission (radiative 
deactivation process), by internal conversion (radiationless deactivation process) or by transfer of an 
electron from an excited singlet to a long-lived triplet excited state (intersystem crossing process). 
Because of its longer lifetime, the triplet state of PS (3PS*) has a good chance of interacting with other 
molecules. It can react with substrates by an electron and/or hydrogen atom transfer to give free radical 
forms (equations 1 and 2). The excited PS (3PS*) can return to the ground state by reaction with oxygen, 
generating oxygen superoxide radical and other oxygenated products (type I mechanism) (equations 3-5). 
This type of mechanism is dependent on the substrate and PS concentrations, and is favoured when the PS 
is bound or strictly associated with readily oxidizable molecules (Bonnett, 2000; Ogilby, 2010; Jori et al, 
2011). Type II mechanism involves an energy transfer process from the triplet state of PS to ground-state 
oxygen (3O2) giving a ground-state photosensitizer (1PS) and a highly reactive singlet state of oxygen 
(singlet oxygen), which in turn attacks photosensitive targets in its surroundings (equation 6) (Via and 
Magno, 2001; Jori et al, 2011).  
 
 
(eq. 1) SubstrateH2 + 3PS*  PSH + SubstrateH 
(eq. 2) 3PS* + Substrate  PS− + Substrate+ or 3PS*+ Substrate  PS+ + 
Substrate− 
(eq. 3) PS− + 3O2  PS + O2− 
(eq. 4) O2−+ H+  HOO  
(eq. 5) 2 HOO H2O2 + O2 
(eq. 6) 3PS* + 3O2  1PS + 1O2 
 
The reactive oxygen species (ROS) formed via type I or II mechanisms are extremely reactive and 
strongly interact with a variety of biomolecules, like nucleic acids, lipids and proteins (Wainwright, 2004; 
Sagristá et al, 2009). Due to their high reactivity and short half-life, only molecules and structures near to 
the area of singlet oxygen and free radical species production by the PS are directly affected and 
subsequently destroyed (Ogilby, 2010).  
Both type I and type II mechanisms may occur in parallel or exclusively, and the ratio between 
these processes depends on the PS used and on the concentrations of substrate and oxygen (Via and 
Magno, 2001). The competition between organic substrates and molecular oxygen for the triplet excited 
state of the PS determines whether the reaction pathway is type I or type II and the predominant 
mechanism can be changed during the course of the PDI process, as the oxygen in the system becomes 
depleted (Min and Boff, 2002).  
An important goal in the investigation of photosensitization processes in PDI is the elucidation of 
the mechanism of action of a selected PS to determine whether it proceeds via a type I or a type II 
mechanism. The simple detection of ROS, such as singlet oxygen, does not necessarily explain the 
mechanism by which a specific PS induces the phototoxic effect (Ochsner, 1997; Maisch et al, 2005). It is 
generally easier to draw a negative conclusion, i.e., if singlet oxygen is absent, it cannot be the reactive 
species of interest. The simplest approach for determining whether singlet oxygen or free radicals are 
involved in the photodynamic process is to study the inhibitory effect of various scavengers, which can 
intercept the ROS at high rates and in a putatively selective manner (Ochsner, 1997; Girotti, 2001).  
From the experimental work done until now, considerable evidence exists that singlet oxygen is 
the main mediator of biological damage in viral PDI, but pathways yielding other ROS are also possible 
and their participation cannot be excluded (Müller-Breitkreutz et al, 1995; Abe et al, 1997; Wainwright, 
2004; Badireddy et al, 2007; Hotze et al, 2009; Sagristá et al, 2009). Although these works report which 
mechanisms are involved in the viral PDI process, studies using different types of phages (DNA and 
RNA phages), which are normally used as surrogates of mammalian viruses, and different types of 
scavengers and PS are still scarce and the results are sometimes contradictory, when the same PS and 
scavengers are used. Considering the PDI in the presence of singlet oxygen quenchers, the 
photoinactivation of M13 bacteriophage (DNA) by methylene blue (MB) was inhibited from 1.72 log to 
0.54 log, by sodium azide, however, the photoinactivation occurred even in the presence of the quencher, 
suggesting that both type I and type II mechanisms may be involved in M13 photoinactivation by MB 
(Abe et al, 1997). Also, singlet oxygen was considered as the main responsible for the loss of biological 
activity of bacteriophage M13 by rose bengal (DiMascio et al, 1989). The phototoxic effect of 5,10,15-
tris(4-β-D-galactosylphenyl)-20-(pentafluorophenyl)porphyrin on T7 phage was reduced by 38% in the 
presence of sodium azide (Egyeki et al, 2003). Photoinactivation of T7 phage with 5,10,15,20-tetrakis(4-
β-D-glucosylphenyl)porphyrin was reduced by 42% in the presence of 1,3-diphenylisobenzofuran 
(DPBF), also used as singlet oxygen quencher. However, when 5,10,15-tris(4-β-D-glucosylphenyl)-20-
phenylporphyrin was used as PS, the rate of protection substantially increased (74%) in the presence of 
DPBF, showing that the symmetric derivative seemed to exert its phototoxic effect mainly via free 
radicals generation, whereas the asymmetric gluco-derivative proceeded mainly by singlet oxygen 
production (Gábor et al, 2001). MS2 (RNA), PRD1 and T7 (DNA) phages photoinactivation by 
polyhydroxylated fullerene was shown to be significantly inhibited by the presence of β-carotene, a 
singlet oxygen quencher (Badireddy et al, 2007; Hotze et al, 2009). However, the results from Hotze et al 
(2009) do not exclude, during the PDI process in the presence of the singlet oxygen quencher, the 
occurrence of partial singlet oxygen quenching or that the observed photoinactivation was due to other 
mechanism than singlet oxygen production.  
In what concerns to the effect of free radicals scavengers on phage PDI, it was shown that T7 
phage photoinactivation by 5,10,15,20-tetrakis(4-β-D-glucosylphenyl)-porphyrin (Gábor et al, 2001) and 
5,10,15-tris(4-β-D-galactosylphenyl)-20-(pentafluorophenyl)porphyrin (Egyeki et al, 2003) seemed to be 
mainly mediated by free radical species (62% and 89% protection in the presence of dimethylthiourea, 
respectively). Contrarily, superoxide dismutase (SOD) did not protect T7 phage from polyhydroxylated 
fullerene photosensitization, suggesting a negligible superoxide generation by this PS (Badireddy et al, 
2007).  
The aim of this study was to identify the main mechanism involved in T4-like (DNA) and Qβ 
(RNA) phages photoinactivation by two cationic porphyrin derivatives, 5,10,15,20-tetrakis(1-
methylpyridinium-4-yl)porphyrin tetra-iodide (Tetra-Py+-Me) and 5-(pentafluorophenyl)-10,15,20-tris(1-
methylpyridinium-4-yl)porphyrin tri-iodide (Tri-Py+-Me-PF), which already proved to be effective for 
phage photoinactivation (Costa et al, 2008; Costa et al, submitted). In this context, two singlet oxygen 
quenchers (sodium azide and L-histidine) and two free radical scavengers (D-mannitol and L-cysteine) 
were used. 
 
 
Material and Methods 
The toxic effect of Tri-Py+-Me-PF and Tetra-Py+-Me on T4-like (5.0 µM) and Qβ (0.5 µM) 
bacteriophages was evaluated by exposing the phage suspensions to white light (40 W m-2) during 270 
and 90 min, respectively, in the presence of different concentrations (5, 10, 50 and 100 mM) of the singlet 
oxygen quenchers (sodium azide and L-histidine) and of free radical scavengers (D-mannitol and L-
cysteine). Aliquots of the phage suspensions were aseptically collected at 0, 60, 180 and 270 min (for T4-
like phage) and at 0, 10, 20, 30, 40, 60 and 90 min (for Qβ phage) after light exposition. The 
simultaneous presence of singlet oxygen and free radicals scavengers at 100 mM was also evaluated for 
T4-like and Qβ phages PDI by Tri-Py+-Me-PF at 5.0 and 0.5 µM, respectively.  
 
Photosensitizers 
The porphyrin derivatives (Tri-Py+-Me-PF and Tetra-Py+-Me) used as PS (Fig. 1) were prepared in 
accordance with the methodology referred by Carvalho et al (2010). PS purity was confirmed by thin 
layer chromatography and by 1H NMR spectroscopy. Stock solutions of the PS in dimethyl sulfoxide at 
500 µM were prepared and sonicated at room temperature for 30 min before use. 
 
Scavengers 
Stock solutions of sodium azide, L-histidine, D-mannitol and L-cysteine were prepared in ultra pure water 
for a final concentration of 500 mM and kept at 4ºC until use. 
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Figure 1. Structure of the PS used for T4-like and Qβ bacteriophages photodynamic inactivation. 
 
Bacteriophages 
T4-like phage was isolated from a sewage secondary-treatment plant of the city of Aveiro 
(Portugal) using Escherichia coli C ATCC 13706 (American Type Culture Collection, Rockville, MD, 
USA) as host strain (Costa et al, 2008). Qβ phage was purchased from DSMZ collection (Braunschweig, 
Germany). Phage suspensions with 109 particles per mL were used. 
 
Bacteriophage quantification 
The quantification of phages was determined, in duplicate, by the agar double layer technique 
(Adams, 1959), using E. coli C (ATCC 13706) and Salmonella typhimurium (WG49) (Havelaar and 
Hogeboom, 1984) as host strains, respectively, for T4-like and Qβ phages. For each phage, 1.0 mL of 
non-diluted or of serially diluted samples and 0.3 mL of bacterial host were added to a tube with 5.0 mL 
of soft TSA growth medium. After manually mixed, tube contents were immediately poured onto a 
confluent TSA monolayer on a Petri plate. After 18 h of dark incubation at 37 ºC, the number of lysis 
plaques was counted at the most convenient series of dilutions and the number of plaque forming units 
per millilitre (PFU mL-1) was determined.  
 
Experimental setup 
Phage inactivation was achieved by exposing the phage suspensions to white light of 40 W m-2 (PAR 
radiation, 13 fluorescent lamps OSRAM 21 of 18 W each, 380-700 nm), in the presence of each PS and 
the selected scavengers, under stirring (100 rpm) at 25 ºC, during 270 (T4-like phage) and 90 min (Qβ 
phage). Dark and light controls were also included and were carried out simultaneously. Two light 
controls were prepared and exposed to the same irradiation protocol: one including the phage suspension 
without the PS and scavenger (LC), and the other one including the phage suspension and the scavenger 
under study (LCS). Three beakers containing the phage suspensions were prepared as dark controls. In 
one beaker was added the PS and the selected scavenger (DC), in another beaker was added the PS 
(DCPS), and at the third one was added the scavenger (DCS); all beakers were covered with an 
aluminium foil. A beaker with the phage suspension and the PS without any scavenger was also included 
in the experiment (0 mM). Sub-samples of 1.0 mL from each test and control beakers were aseptically 
taken at established time intervals (0, 60, 180, and 270 min for T4-like phage, and 0, 10, 20, 30, 40, 60 
and 90 min for Qβ phage). The protective effect afforded by singlet oxygen and free radicals scavengers 
was evaluated through quantification of the number of phages by the double layer technique, as described 
above. Three independent experiments were carried out with two replicates each. The protection of the 
scavengers was followed until the detection limit of the method was reached. 
 
Effect of singlet oxygen and free radicals scavengers 
The relative contribution of singlet oxygen (type II mechanism) and free radical species (type I 
mechanism) for bacteriophage PDI was evaluated by the presence of specific singlet oxygen (sodium 
azide and L-histidine) and free radical (D-mannitol and L-cysteine) scavengers. For T4-like phage, in the 
presence of Tri-Py+-Me-PF, all four scavengers were tested at different concentrations (5, 10, 50 and 100 
mM). In the presence of Tetra-Py+-Me, sodium azide, L-histidine and D-mannitol were equally tested at 
the concentrations of 5, 10, 50 and 100 mM. T4-like phage PDI with Tri-Py+-Me-PF at 5.0 µM was also 
evaluated in the simultaneous presence of singlet oxygen and free radicals scavengers at 100 mM: sodium 
azide and D-mannitol, sodium azide and L-cysteine, L-histidine and D-mannitol, and L-histidine and L-
cysteine. For Qβ phage, singlet oxygen quencher sodium azide and free radicals scavenger D-mannitol 
were used, at the concentration of 100 mM (the concentration that exerted a significant effect for T4-like 
phage), in the presence of 0.5 µM of Tri-Py+-Me-PF. The photodynamic inactivation of Qβ phage by 0.5 
µM Tri-Py+-Me-PF was also evaluated in the simultaneous presence of sodium azide and D-mannitol at 
the concentration of 100 mM. In all experiments, the scavengers and PS were added to the phage 
suspensions 30 min before irradiation and the suspensions were maintained in the dark during that time. 
The rate of protection afforded by singlet oxygen quenchers and free radicals scavengers in the presence 
of Tri-Py+-Me-PF and/or Tetra-Py+-Me was determined taking into account the irradiation time where 
T4-like and Qβ phages reached their maximum rate of photoinactivation. 
 
Statistical analysis 
SPSSWIN 15.0 was used for data analysis. The significance of difference in phages inactivation in the 
presence of different singlet oxygen and free radicals scavengers was assessed using one-way ANOVA. 
Only the data with normal distribution (assessed by Kolmogorov-Smirnov test) and with homogeneity of 
variances (assessed by Levene test) were used. 
 
 
Results 
Without light, the tested PS (DC, DCPS) did not exhibit any toxicity against any of the phages 
during the total time of the experiment. A similar trend was obtained with the phages in the absence of PS 
(with and without the scavengers) during the time course of the experiments (LC, LCS) (Figures 2 to 7). 
The white light used in the experiments (380 – 700 nm) did not affect viral viability and the phototoxicity 
was due to the photodynamic effect of the PS. 
In the absence of scavengers (0 mM), both cationic porphyrins were able to photoinactivate to the 
limit of detection (about 7 log of reduction) the T4-like and Qβ phages. T4-like phage was inactivated to 
the limit of detection (7.2 log of reduction) by Tri-Py+-Me-PF and Tetra-Py+-Me at the concentration of 
5.0 µM after 180 and 270 min of irradiation, respectively (Figures 2 to 5). The efficiency of T4-like 
phage inactivation by Tri-Py+-Me-PF and Tetra-Py+-Me varied according to the type and concentration of 
the scavenger used. When sodium azide was used, in the presence of Tetra-Py+-Me (Figure 2B), the rate 
of phage photoinactivation was considerably lower (0.7 to 1.9 log) for all the tested concentrations of 
sodium azide (5, 10, 50 and 100 mM), when compared with the control without quencher (0 mM) 
(ANOVA, p < 0.05). However, in the presence of Tri-Py+-Me-PF there was only a significant protection 
effect (ANOVA, p < 0.05) when the highest concentration of sodium azide (100 mM) was used (1.4 log 
of reduction after 180 min of irradiation), compared to the samples in the absence of scavenger (0 mM) 
after the same time of light exposure (Figure 2A). 
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Figure 2. Variation of the numbers of T4-like phage after 60, 180 and 270 min of irradiation, in the presence of 5.0 µM Tri-
Py+-Me-PF (A) and Tetra-Py+-Me (B), and different concentrations of sodium azide (–◊– LC, –– LCS, –×– DCS, –– 
DCPS, –– DC, –– 0 mM sodium azide, –– 5 mM sodium azide, –– 10 mM sodium azide, –– 50 mM sodium azide, –
– 100 mM sodium azide). Each value represents mean ± standard deviation of three independent experiments, with two 
replicates each. Error bars represent standard deviations. 
 
In the presence of L-histidine, the rate of phage inactivation was also considerably reduced for all 
the tested concentrations, when compared with the control without scavenger (0 mM) (ANOVA, p < 
0.05). The highest photoinactivation inhibition was observed at 50 mM for Tri-Py+-Me-PF (but the 
inhibition was not statistically different from that obtained at 100 mM of L-histidine, ANOVA, p > 0.05) 
and at 100 mM of quencher concentration for Tetra-Py+-Me, reaching ∼ 2 log of phages reduction for 
both PS after 180 and 270 min of white light irradiation, respectively for Tri-Py+-Me-PF and Tetra-Py+-
Me (Figure 3). T4-like phage photoinactivation in the presence of singlet oxygen quenchers (sodium 
azide or L-histidine) was not statistically different for both PS (ANOVA, p > 0.05). 
The two PS were less effective to photoinactivate T4-like phages in the presence of singlet oxygen 
quenchers than in the presence of free radicals scavengers. In the presence of D-mannitol at 100 mM and 
B A 
Tri-Py+-Me-PF, a smaller reduction in the photoinactivation rate was observed (5.7 log of phage 
inactivation), relatively to the sample without scavenger (7.2 log), after 180 min of irradiation (ANOVA, 
p < 0.05) (Figure 4). In the presence of Tetra-Py+-Me, D-mannitol (100 mM) did not reveal any protective 
effect, exhibiting a phage reduction of 5.8 log, after 270 min of irradiation. Although the best protective 
effect of D-mannitol might be achieved at 5.0 mM (4.1 log), the differences between different D-mannitol 
concentrations were found to be not statistically significant (ANOVA, p > 0.05) (Figure 4). Similar 
results were obtained when L-cysteine was used as free radical scavenger in the presence of Tri-Py+-Me-
PF. In fact, slight protection of T4-like phage inactivation was observed with the highest concentrations 
tested (50 and 100 mM) relatively to the control sample without scavenger (5.6 and 6.3 log of phage 
inactivation, respectively, against 7.1 log observed for 0 mM) (ANOVA, p < 0.05) (Figure 5). The 
differences between free radical scavengers (D-mannitol and L-cysteine) for Tri-Py+-Me-PF were not 
statistically significant (ANOVA, p > 0.05). 
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Figure 3. Variation of the numbers of T4-like phage after 30, 60, 180 and 270 min of irradiation, in the presence of 5.0 µM 
Tri-Py+-Me-PF (A) and Tetra-Py+-Me (B), and different concentrations of L-histidine (–◊– LC, –– LCS, –×– DCS, –– 
DCPS, –– DC, –– 0 mM L-histidine, –– 5 mM L-histidine, –– 10 mM L-histidine, –– 50 mM L-histidine, –– 100 mM 
L-histidine). Each value represents mean ± standard deviation of three independent experiments, with two replicates each. 
Error bars represent standard deviations. 
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Figure 4. Variation of the numbers of T4-like phage after 30, 60, 180 and 270 min of irradiation, in the presence of 5.0 µM 
Tri-Py+-Me-PF (A) and Tetra-Py+-Me (B), and different concentrations of D-mannitol (–◊– LC, –– LCS, –×– DCS, –– 
DCPS, –– DC,  –– 0 mM D-mannitol, –– 5 mM D-mannitol, –– 10 mM D-mannitol,  –– 50 mM D-mannitol, –– 100 
mM D-mannitol). Each value represents mean ± standard deviation of three independent experiments, with two replicates each. 
Error bars represent standard deviations. 
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Figure 5. Variation of the numbers of T4-like phage after 30, 60, 180 and 270 min of irradiation, in the presence of 5.0 µM 
Tri-Py+-Me-PF and different concentrations of L-cysteine (–◊– LC, –– LCS, –×– DCS, –– DCPS, –– DC, –– 0 mM L-
cysteine, –– 5 mM L-cysteine, –– 10 mM L-cysteine, –– 50 mM L-cysteine, –– 100 mM L-cysteine). Each value 
represents mean ± standard deviation of three independent experiments, with two replicates each. Error bars represent standard 
deviations. 
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Figure 6. Percentage of protection of T4-like phage photoinactivation after 0, 60 and 180 min of irradiation, in the presence of 
5.0 µM Tri-Py+-Me-PF and 100 mM of singlet oxygen quenchers or 100 mM of free radicals scavengers. Each value represents 
mean ± standard deviation of three independent experiments, with two replicates each. 
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Figure 7. Percentage of protection of T4-like phage photoinactivation after 0, 60, and 180 min of irradiation, in the presence of 
5.0 µM Tri-Py+-Me-PF and 100 mM of singlet oxygen and free radicals scavengers. Each value represents mean ± standard 
deviation of three independent experiments, with two replicates each. 
   
 
T4-like phage photoinactivation was also evaluated in the presence of two different scavengers at 
100 mM (a singlet oxygen quencher plus a free radicals scavenger) (Figure 7). The highest protection of 
phage photoinactivation by the PS was observed for L-cysteine plus sodium azide (0.4 log of reduction, 
93% of protection), and the lowest protective effect was observed for D-mannitol and sodium azide (1.3 
log of reduction, 82% of protection). However, the differences between all tested combinations were not 
statistically significant (ANOVA, p > 0.05). The results also show that the rate of phage photoinactivation 
is almost the same, whether singlet oxygen and free radicals scavengers are tested in separate assays, or 
combined within the same sample (Figures 6 and 7). 
 
In the absence of scavengers, Qβ phage was inactivated to the limit of detection by Tri-Py+-Me-PF 
at the concentration of 0.5 µM (reductions of 7.2 log), after 90 min under white light irradiation (Figure 
8). In the presence of sodium azide (100 mM), the rate of phage inactivation was considerably reduced 
(4.4 log of reduction, 39% of protection) when compared with the control without scavenger (0 mM) 
(ANOVA, p < 0.05) (Figure 8). D-mannitol (100 mM) did not exert any protective effect on Qβ phage 
inactivation after 90 min of irradiation (reductions of 7.2 log) (Figure 8). When sodium azide and D-
mannitol (100 mM) were combined, in the same sample, the rate of phage inactivation after 90 min of 
irradiation was identical to that observed when the scavengers were tested in individual assays (Figure 8) 
(ANOVA, p > 0.05). 
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Figure 8. Variation of the numbers of Qβ phage after 10, 20, 30, 40, 60 and 90 min of irradiation, in the presence of 0.5 µM 
Tri-Py+-Me-PF, singlet oxygen scavenger sodium azide and free radicals scavenger D-mannitol (–◊– LC, –– LC sodium 
azide, –×– LC D-mannitol, –– DC PS,  –– DC sodium azide, –-– DC D-mannitol,  –□– DC sodium azide + PS, –+– DC D-
mannitol + PS, –– 0 mM, , –– 100 mM sodium azide, –– 100 mM D-mannitol, –– 100 mM sodium azide + D-mannitol). 
Each value represents mean ± standard deviation of three independent experiments, with two replicates each. Error bars 
represent standard deviations. 
 
 
Discussion 
It is well established that the efficiency of microbial PDI is related to the ability of a PS to 
generate singlet oxygen (type II mechanism) and/or free radical species (type I mechanism) in the course 
of the photodynamic process. For this reason it is important to evaluate the type of ROS produced during 
PDI in order to determine the suitable conditions in which microbial photosensitization should operate 
and to design improved PS molecules. The simplest approach for determining whether singlet oxygen or 
free radicals are involved in a photodynamic reaction is to study the inhibitory effect of various 
scavengers or traps (Ochsner, 1997; Girotti, 2001). 
The present study clearly demonstrates that (1) type II (production of singlet oxygen) is the main 
mechanism of T4-like and Qβ phages photoinactivation by Tri-Py+-Me-PF and Tetra-Py+-Me; (2) the 
protective effect of the scavengers varied with the concentration of the scavengers, as already shown in 
other studies (Abe et al, 1997; Gábor et al, 2001; Egyeki et al, 2003); and (3) the scavengers protective 
effect was higher in T4-like (DNA) than in Qβ (RNA) phages PDI, which was not yet emphasized in 
other studies. 
According to the results obtained, type II (production of singlet oxygen) was clearly the main 
mechanism of T4-like phage photoinactivation by 5.0 µM Tri-Py+-Me-PF and Tetra-Py+-Me and of Qβ 
phage PDI in the presence of 0.5 µM Tri-Py+-Me-PF. The PDI of T4-like phage was largely reduced by 
100 mM of singlet oxygen quenchers sodium azide (80 and 90% of protection in the presence of Tri-Py+-
Me-PF and Tetra-Py+-Me, respectively) and L-histidine (72 and 78% of protection of T4-like phage 
photosensitization by Tri-Py+-Me-PF and Tetra-Py+-Me, respectively). Qβ phage PDI was reduced by 
sodium azide (39% of protection). These results are in accordance with what was stated in previous 
papers about the main role of type II mechanism in viral PDI (O’Brien et al, 1992; Rywkin et al, 1992; 
Lenard and Vanderoef, 1993; Müller-Breitkreutz et al, 1995; Dewilde et al, 1996; Wainwright, 2003; 
Badireddy et al, 2007; Mroz et al, 2007). 
Although sodium azide seemed to be the most protective singlet oxygen quencher, the differences 
between both quenchers were not statistically significant (ANOVA, p > 0.05). In the presence of Tri-Py+-
Me-PF, the lowest quencher concentrations (5, 10 and 50 mM) conferred a protection less than 43% for 
sodium azide and a protection of 52-76% for L-histidine. In the presence of Tetra-Py+-Me, the protection 
conferred by the same concentrations of sodium azide was considerably higher; however, the protection 
conferred by L-histidine was lower, with values ranging from 72 to 85% and 50 to 68%, respectively. 
These results are also in accordance with other studies (Abe et al, 1997; Gábor et al, 2001; Egyeki et al, 
2003) that showed an increased degree of protection with the increase of the quencher concentration.  
Free radicals scavengers were far less protective for T4-like phage, when compared with singlet 
oxygen quenchers. T4-like phage was reduced by 5.7 and 5.8 log in the presence of both PS and 100 mM 
D-mannitol (≤ 20% protection), after 180 min for Tri-Py+-Me-PF and 270 min for Tetra-Py+-Me. D-
mannitol (100 mM) was slightly more protective than L-cysteine after 180 min, exhibiting a rate of T4-
phage inactivation of 6.2 log (9% protection) with Tri-Py+-Me-PF. The differences between both 
scavengers were, however, not statistically significant (ANOVA, p > 0.05). 
Qβ phage PDI proceeded in a similar way, when sodium azide and D-mannitol were tested in the 
presence of Tri-Py+-Me-PF. Singlet oxygen quencher sodium azide was also far more protective when 
compared with free radical scavenger D-mannitol. Qβ phage PDI by 0.5 µM Tri-Py+-Me-PF in the 
presence of sodium azide at 100 mM after 90 min of irradiation with white light was of 4.4 log (39% 
protection) and of 7.2 log in the presence of 100 mM D-mannitol (0% protection). However, the 
protection conferred by the two scavengers for Qβ phage (RNA phage) was lower than that observed for 
T4-like phage (DNA phage). This can be attributed to the fact that non-enveloped RNA phages are more 
easily photoinactivated when compared with the DNA ones (Costa et al, submitted) and, consequently, 
the non-scavenged ROS produced during the PDI process can still be enough to achieve a substantial 
phage inactivation. 
For both phages, the rate of phage inactivation was of the same order of magnitude whether the 
effect of singlet oxygen quenchers and free radicals scavengers was tested separately in independent 
assays or combined in the same sample, which means that there is not a synergistic effect of both types of 
scavengers, as observed in other studies (Gábor et al, 2001; Egyeki et al, 2003).  
Photosensitization by type II mechanism was also observed when Tetra-Py+-Me and Tri-Py+-Me-
PF were used for the photodynamic inactivation of bacteria. E. coli photosensitization was significantly 
reduced by the presence of sodium azide (84% and 87% of bacterial protection, respectively), but less 
reduced in the presence of free radical scavenger D-mannitol (8% and 3% protection, respectively for 
Tetra-Py+-Me and Tri-Py+-Me-PF) (Tavares et al, 2011). 
However, in spite of the major contribution from singlet oxygen, the participation of free radical 
species cannot be ruled out. Some studies also indicate a contribution of free radicals in phage PDI, 
showing that type I mechanism may be equally or even more effective than type II mechanism (Gábor et 
al, 2001; Egyeki et al, 2003). For this reason, it is important to take into account not only the PS excited 
states, but also the whole family of oxy-radicals, such as superoxide anion and hydroxyl, alkoxy and 
peroxy radicals, as intermediate reactive species (Sabbahi et al, 2008). 
In conclusion, the results obtained in this study show that the inactivation of T4-like and Qβ 
phages by PAR white light (40 W m-2) in the presence of Tri-Py+-Me-PF and Tetra-Py+-Me, at 5.0 (T4-
like phage) and 0.5 µM (Qβ phage), occurs predominantly by a type II mechanism (singlet oxygen), 
independently of the phage type. However, as RNA-type phages are more easily photoinactivated when 
compared with DNA-type ones, the protection conferred by the scavengers during the PDI process is 
lower and this should be taken into account when the main mechanism involved in PDI of different 
viruses is to be studied by the use of scavengers.  
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CHAPTER 5 
 
 
A fast screening method (IR spectroscopy) to evaluate viral protein 
damage induced by photosensitization 
 
Abstract  
Microbial photodynamic inactivation (PDI) results in the production of reactive oxygen species (ROS), 
like free radicals and singlet oxygen. Toxic effects of ROS include severe damage to molecular structures 
such as proteins, lipids and nucleic acids. Viral structures like the envelope lipids and proteins, the capsid 
proteins and the nucleic acids, are targets for the PDI of viruses. In this study, the effect of viral PDI on 
phage proteins was studied by two different methodologies, the traditional sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE) and the rapid-screening infrared (IR) spectroscopy. A 
non-enveloped DNA bacteriophage (T4-like phage) was exposed to white light (40 W m-2) during 270 
min, in the presence of 5.0 µM Tri-Py+-Me-PF. The damages induced after PDI on phage proteins were 
evaluated by SDS-PAGE and by IR spectroscopy. Changes on T4-like phage protein profile were clearly 
revealed by both methods, when compared with the dark (IR spectroscopy) and light (SDS-PAGE) 
controls. After SDS-PAGE analysis, T4-like phage protein profile was found to be considerably altered 
by PDI after 90 and 270 min of irradiation. After 270 min of irradiation, seven protein bands presumably 
corresponding to capsid and tail tube proteins exhibited a weakened intensity, and two other protein bands 
showed an increased intensity, effects that are related to phage PDI. IR spectroscopy also revealed 
alterations induced by PDI on phage proteins. After irradiation, the phototreated T4-like phage samples, 
when compared with the dark controls, revealed a time-dependent alteration on the protein profile, 
exhibiting an increase at 1595 cm-1 and a decrease in the 1629 cm-1 peak which is indicative of 
considerable protein alterations induced by PDI. Both methods reveal significant alterations on T4-like 
phage proteins after PDI in the presence of Tri-Py+-Me-PF. Data from IR spectra analysis is in good 
accordance with the ones obtained by SDS-PAGE; since IR spectroscopy is a simple and cost effective 
method, it can be considered a promising and innovative approach for analysis of viral protein damage 
induced by photosensitization. Besides, one single IR spectrum can put in evidence damages induced to 
all viral molecular structures, thus overcoming the delays and complex protocols associated with 
conventional methods. 
 
 
Introduction 
Photodynamic inactivation (PDI) procedures involving the generation of short-lived reactive 
oxygen species (ROS) after the irradiation of photosensitizers (PS), in the presence of molecular oxygen, 
have been shown as a very promising method for viral inactivation (Wainwright, 2003). The ROS 
produced by light-activated PS are shown to react with several biomolecules, which happens by two 
mechanisms: (i) type I mechanism involves electron/hydrogen transfer directly from the excited PS, 
producing ions, or electron/hydrogen removal from a substrate molecule to form free radical species. 
These radicals rapidly react with oxygen, resulting in the production of highly reactive species like 
superoxide and hydroxyl radicals; (ii) type II mechanism involves the production of the electronically 
excited and highly reactive state of oxygen known as singlet oxygen, which is considered to be the major 
toxic species in PDI (Jori and Coppellotti, 2007; Konopka and Goslinski, 2007). Due to the high 
reactivity and short half-life of singlet oxygen and hydroxyl radicals, only molecules and structures that 
are proximal to the area of their production (areas of PS localization) are directly affected by PDI and 
subsequently destroyed (Castano et al, 2004). ROS are shown to attack lipids, proteins, carbohydrates and 
nucleic acids inducing oxidation, cleavage, cross-linking and other modifications, which eventually lead 
to damages in important biological molecules (Niki, 1991). Different viral structures, such as the 
envelope, the capsid or the nucleic acid, can be targets for PDI leading to loss of infectivity (Müller-
Breitkreutz et al, 1995) by inhibiting the adhesion of the virus to the host cell and its penetration (O’Brien 
et al, 1992; Lenard and Vanderoef, 1993), or by inducing damages to viral nucleic acids (Specht, 1994). 
Due to the short half-life and high reactivity of ROS, especially of singlet oxygen, the main targets of PDI 
are the microbial external structures (Ben-Hur et al, 1992; Lenard et al, 1993; Malik et al, 1993; 
Schneider et al, 1998; Smetana et al, 1998; Gábor et al, 2001; Egyeki et al, 2003; Floyd et al, 2004; Hotze 
et al, 2009). It has been shown that enveloped viruses are significantly more sensitive to 
photosensitization than their non-enveloped counterparts, as the former are inactivated due to oxidation of 
their external envelope lipids and proteins (Käsermann and Kempf, 1997), that are not present in the non-
enveloped viruses. For non-enveloped viruses, capsid proteins are the main targets of PDI (Schneider et 
al, 1998; Gábor et al, 2001; Egyeki et al, 2003; Floyd et al, 2004; Zupán et al, 2008; Hotze et al, 2009).  
Core proteins (Müller-Breitkreutz et al, 1995; Egyeki et al, 2003) are also important targets of PDI.   
PDI induced protein damage occurs by backbone fragmentation, photooxidation of essential 
amino acid residues, such as cysteine, histidine, tyrosine, methionine and tryptophan, and by the 
formation of cross-links among different proteins or among proteins and DNA or RNA, thereby 
disrupting the proteins folding conformation and leading to the formation of molecular aggregates 
(Verweij and Steveninck, 1982; Afonso et al, 1999; MacDonald and Dougherty, 2001; Davies, 2003). Of 
the naturally occurring amino acids only those that possess aromatic or sulphur-containing side chains are 
readily oxidized by PDI, leading to protein denaturation and loss of functionality (Min and Boff, 2002; 
Jori and Coppellotti, 2007). The protein analysis by SDS-PAGE and Western blot of herpes simplex virus 
type 1 (HSV-1) treated with phthalocyanine derivatives revealed irreversible changes in the proteins of 
the viral envelope, which were thought to be responsible for HSV-1 inactivation. Some phthalocyanine 
derivatives have also been shown to induce protein cross-links in HSV that might be responsible for the 
observed loss of infectivity (Malik et al, 1996). Treatment of viruses with the PS merocyanine 540, 
hypericin or rose bengal lead to extensive cross-linking of envelope proteins, which may impair the 
capacity of viruses, such as human immunodeficiency virus (HIV), vesicular stomatitis virus (VSV), 
HSV, human cytomegalovirus, sindbis virus and friend erythroleukemia virus, to adhere to and to 
penetrate the host cells (Sieber et al, 1992; Lenard et al, 1993).  
Damages in the capsid protein and/or loosening of the protein-DNA interaction were shown to be 
responsible for T7 phage PDI when treated with a glycoconjugated meso-tetraarylporphyrin derivative 
(Gábor et al, 2001). Nucleic acids of PRD1 and T7 phages were relatively less affected than their proteins 
after photosensitization in the presence of polyhydroxylated fullerene (Hotze et al, 2009). Cross-linking 
of phage capsid proteins was shown to be a main cause of phage PDI (Hotze et al, 2009). 
Photoinactivation of MS2 in the presence of this PS is possibly due to the damages in its A protein which 
is necessary for infecting its host Escherichia coli, since it contains highly reactive amino acids (Hotze et 
al, 2009). Irradiation of Qβ phage in the presence of increasing concentrations of methylene blue (MB) 
resulted in exponentially increasing amounts of viral RNA-protein cross-links, suggesting this lesion as 
the most important event in viral PDI. Oxidative damage of the RNA alone did not directly account for 
Qβ phage inactivation (Floyd et al, 2004). RNA-protein cross-links were also shown to be the most likely 
inactivating lesion after treating Qβ phage with MB (Schneider et al, 1998). 
The studies focusing on the evaluation of proteins as targets of viral PDI are based on 
conventional laborious methods, such as SDS-PAGE and Western blot (Melki et al, 1994; Abe and 
Wagner, 1995; Bachmann et al, 1995; Smetana et al, 1998; Hotze et al, 2009). New fast and cost-effective 
methodologies are needed to determine the main targets of PDI. Since the late 1940s, IR spectroscopy has 
become an accepted tool for the characterization of biomolecules (Margarita and Quinteiro, 2000). IR 
spectroscopy is a form of vibrational spectroscopy and the IR spectra reflect both molecular structure and 
molecular environment (Duygu et al, 2009). An advantage of IR spectroscopy is that this method can be 
applied to powdered, dehydrated or aqueous samples and a single spectrum reflects all microbial 
constituents, such as proteins, lipids, carbohydrates and DNA (Sacksteder and Barry, 2001). IR 
spectroscopy not only provides a competitive and rapid identification but, since it allows the study of the 
microorganism in its intact state, it appears to be a very promising tool also for the study of microbial 
metabolism, antimicrobials susceptibility and other interactions with drugs (Orsini et al, 2000; Duygu et 
al, 2009). 
As far as it is known, there is only one study focusing on the use of IR spectroscopy to evaluate 
the damages induced by PDI on phage proteins (Hotze et al, 2009). The aim of the present study is to 
assess if IR spectroscopy is a suitable rapid-screening methodology to evaluate the major damages 
induced to T4-like phage proteins after PDI. SDS-PAGE was used as a standard methodology. In this 
context, phage PDI was performed in the presence of 5-(pentafluorophenyl)-10,15,20-tris(1-
methylpyridinium-4-yl)porphyrin tri-iodide (Tri-Py+-Me-PF), which already proved to be very effective 
for viral inactivation (Costa et al, 2008; Costa et al, 2010). 
 
 
Material and Methods 
Porphyrin synthesis  
The porphyrin (Tri-Py+-Me-PF) used as PS (Figure 1) was prepared in accordance with the methodology 
referred by Carvalho et al (2010). PS purity was confirmed by thin layer chromatography and by 1H NMR 
spectroscopy. The PS was dissolved in dimethyl sulfoxide (500 µM stock solution) and sonicated for 30 
min before use. 
 
 
Figure 1. Structure of the cationic porphyrin derivative used in this study to photoinactivate the T4-like bacteriophage. 
 
Phage selection and identification 
T4-like phage was isolated from a wastewater-treatment plant of the city of Aveiro (Portugal) 
using Escherichia coli C ATCC 13706 (American Type Culture Collection, Rockville, MD, USA) as host 
strain (Costa el al, 2008).  Phage suspensions with 109 particles per mL were used. 
 
Bacteriophage quantification 
T4-like phage quantification was determined by the agar double layer technique (Adams, 1959), 
using E. coli C (ATCC 13706) as host strain. Duplicates of 1.0 mL of non-diluted or of serially diluted 
samples and 0.3 mL of bacterial host were added to a tube with 5.0 mL of soft TSA growth medium. 
After manually mixed, tube contents were immediately poured onto a confluent TSA monolayer on a 
Petri plate. The number of phage plaques was counted after 18 h of dark incubation at 37 ºC in the most 
convenient series of dilutions and the number of plaque forming units per millilitre (PFU mL-1) was 
determined. 
 
Experimental setup 
Phage inactivation was achieved by exposing the phage suspensions, in the presence of 5.0 µM 
Tri-Py+-Me-PF, to white light of 40 W m-2 (13 fluorescent lamps OSRAM 21 of 18 W each, 380-700 
nm), under stirring (100 rpm) at 25ºC, during 270 min. Dark and light controls were also included and 
were carried out simultaneously. Light control (LC) included the phage suspension without the PS and 
was exposed to the same irradiation conditions. Dark control (DC) included the phage suspension in the 
presence of the PS and was covered with an aluminium foil. 
Aliquots of test and control samples were aseptically taken at selected times (0, 30, 60, 90, 180 
and 270 min) in order to evaluate the efficiency of Tri-Py+-Me-PF for phage inactivation, and for protein 
analysis. The toxic effect of the ROS produced by Tri-Py+-Me-PF on T4-like phage proteins was 
evaluated by SDS-PAGE analysis and by IR spectroscopy, by comparison of the porphyrin-treated 
samples with the controls. The inhibitory effect of the singlet oxygen quencher sodium azide at 100 mM 
on phage PDI was also evaluated by SDS-PAGE analysis. Three independent experiments were carried 
out. 
 
Protein quantification 
Protein concentration was determined by the Micro BCA protein assay kit (Pierce, Rockford, 
USA) according to the manufacturer instructions. 
 
Protein analysis by SDS-PAGE 
Phage suspensions (4.0 mL) were centrifuged at 100.000 g for 1 h at 4 ºC. The pellet was 
recovered and washed with sodium chloride 0.9% (w/v). After a new centrifugation at 100.000 g for 1 h 
at 4 ºC the pellet was washed with 50 mM Tris-HCl (pH 7) and centrifuged for 1 h at 100.000 g at 4 ºC. 
The pellet was re-suspended in a denaturing solution containing 8 M urea, 100 mM Tris, 100 mM bicine, 
2% 2-mercaptoetanol (v/v) and 2% SDS (w/v), sonicated for 5 cycles (5 s each) and kept at -20 ºC until 
analysis. 
Viral proteins were separated (5.0 µg protein/lane) by SDS–PAGE according to Laemmli (1970). 
The separation was performed in the Mini-PROTEAN 3 (Bio-Rad) with lab casted SDS polyacrylamide 
gels (15%). Gels ran for 2 h, at 120 V at 4 ºC. Proteins were visualized by silver staining (O’Connell and 
Stults, 1997). Each gel image was acquired using the GS-800 calibrated imaging densitometer (Bio-Rad). 
Apparent molecular weights and band intensities were determined using the Quantity One v4.1 software 
(Bio-Rad). The apparent molecular weight of the proteins was determined using a molecular weight 
calibration kit as marker, consisting of a mixture of proteins with 250, 150, 100, 75, 50, 37, 25, 20, 15 and 
10 kDa (Precision Plus Protein Standards All Blue, from Bio-Rad). Band optical density (OD) was 
determined as OD per mm2, subtracted for background and corrected for OD differences between gels, as 
described earlier (Lemos et al, 2010). All samples were analysed in triplicate. 
 
Infrared spectroscopy and principal component analysis 
Infrared spectra were obtained with a mid-infrared spectrometer (Perkin-Elmer Spectrum BX) 
equipped with a Golden Gate single reflection diamond ATR system. Spectra acquisition of the samples 
was carried out in the mid-infrared region (between 4000 and 600 cm-1) with a spectral resolution of 8 
cm-1 and co-adding 32 scans. Phage suspensions (4.0 mL) were centrifuged at 100.000 g during 1 h at 4 
ºC. The pellet was recovered, and with the help of a spatula directly placed onto the diamond element, air-
dried under aseptic conditions at the sampling accessory and immediately used for spectra acquisition.  A 
total of 9 spectra (3 from each experiment that was conducted in triplicate) were obtained and the spectral 
region between 1800 and 1300 cm-1 was chosen because it was the one that showed differences between 
treatments.  
 
 Results 
Without light (DC), Tri-Py+-Me-PF did not exhibit activity against T4-like phage, during 270 min. 
A similar trend was obtained with the phage in the absence of the porphyrin during the 270 min of 
irradiation with white light (LC) (Figure 2). T4-like phage was inactivated to the detection limits (7 log of 
reduction) by 5.0 µM Tri-Py+-Me-PF after 270 min of irradiation. In the presence of singlet oxygen 
quencher sodium azide (100 mM), the rate of T4-like phage PDI was considerably reduced (1.4 log of 
reduction) when compared with the phage sample reduction without the presence of the quencher (Figure 
2). 
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Figure 2. Variation of the numbers of infectious T4-like phage after 30, 60, 90, 180 and 270 min of irradiation, in the presence 
of 5.0 µM Tri-Py+-Me-PF and 100 mM sodium azide (–◊– LC,  –∗– DC, –– 5.0 µM Tri-Py+-Me-PF, –– 100 mM sodium 
azide). Each value represents mean ± standard deviation of three independent experiments, with two replicates each. Error bars 
represent standard deviations. 
 
SDS-PAGE analysis 
Similar results were obtained with the phage protein profile, when the test and control samples 
were analysed by SDS-PAGE. After 90 and 270 min of irradiation, light and dark controls revealed a 
protein profile identical to that observed at the beginning of the experiment (Figures 3 A and B). 
 
 
 
Figure 3. SDS-PAGE analysis of T4-like phage proteins after 90 min of PDI by 5.0 µM Tri-Py+-Me-PF (A). Lane 1: T4-like 
phage before irradiation (0 min of irradiation); lane 2: light control; lane 3: dark control; lane 4: T4-like phage PDI treated 
B A 
sample; and after 270 min of PDI by 5.0 µM Tri-Py+-Me-PF (B). Lane 1:  light control; lane 2: dark control; lane 3: T4-like 
phage PDI treated sample; lane 4: T4-like phage PDI treated sample in the presence of 100 mM sodium azide. Green arrows 
indicate bands with increased protein intensity; red arrows indicate bands with weakened protein band intensity; blue arrows 
show the protective effect of sodium azide. 
 
Differences in the protein profiles of T4-like phage were distinguishable by SDS-PAGE after 
phage PDI, when compared with the control samples. The observed differences reflected a change on 
protein bands intensity after PDI. After 90 min of irradiation, in the presence of 5.0 µM Tri-Py+-Me-PF, 
the results from SDS-PAGE analysis revealed substantial alterations on phage proteins. Protein bands 
presumably corresponding to the long tail fiber protein (109 kDa), intron-homing endonuclease (28.2 
kDa), head-proximal tip of tail tube (19.7 kDa), and to valyl-tRNA ligase modifier (13.1 kDa) (Miller, 
2003; Kurzepa et al, 2009) revealed a weakened intensity, whereas bands presumably corresponding to 
the proximal tail sheath stabilizer (31.6 kDa), site-specific DNA endonuclease (24.6 kDa), assembly 
catalyst of distal tail fiber (22.3 kDa), and the baseplate distal hub subunit (20.1 kDa) (Miller, 2003) 
increased their intensity after PDI, when compared with the light control (Figure 4A). At the end of the 
experiment (270 min of irradiation), T4-like phage protein profiles exhibited a similar pattern of 
alterations, with a decrease of the concentration of seven proteins and the increase of two proteins:  phage 
proteins like the long tail fiber protein (109 kDa), vertex head subunit (46 kDa), RNA ligase and catalyst 
of tail fiber attachment (43.5 kDa), intron-homing endonuclease (28.2 kDa), site-specific DNA 
endonuclease (24.6 kDa), head-proximal tip of tail tube (19.7 kDa), and valyl-tRNA ligase modifier (13.1 
kDa) (Miller, 2003; Kurzepa et al, 2009) revealed a weakened intensity after phage photosensitization. 
Two protein bands presumably corresponding to the proximal tail sheath stabilizer (31.6 kDa) (Miller, 
2003) and one uncharacterized protein of 99.1 kDa exhibited an increase in their intensity, when 
compared with the control without PS (LC) (Figure 4B).  
 
 
Figure 4. Induced alterations on T4-like phage proteins, as assessed by SDS-PAGE analysis, after 90 (A) and 270 min (B) of 
irradiation in the presence of 5.0 µM Tri-Py+-Me-PF. Black bars represent the light control (LC); grey bars represent the photo-
treated phage samples. Each value represents mean ± standard deviation of three independent experiments.  
 
 
B A 
When the phage samples were treated with singlet oxygen quencher sodium azide, significant alterations 
were observed on T4-like phage proteins profile, when compared with the porphyrin-treated samples after 
270 min of irradiation (Figure 3B). 
 
IR spectroscopy 
The data from IR spectroscopy, after 30, 60, 90 and 270 min of irradiation in the presence of 5.0 
µM Tri-Py+-Me-PF, revealed several and important alterations on T4-like phage protein profile, when 
compared with the DC and the PS-treated sample at time 0. Immediately after addition of the PS and 
without irradiation, a clear change was detected and the maximum of the amide I band was shifted to 
1629 cm-1. After 30, 60, 90 and 270 min of white light irradiation, T4-like phage profile revealed changes 
with the peak maximum shifting to 1595 cm-1 and time-dependent alterations, with the phototreated 
samples at time 270 min being considerably more affected by PDI than the samples after 30 min of 
irradiation. After 270 min, a clear increase of the peak corresponding to 1595 cm-1 and a decrease of the 
peak corresponding to 1629 cm-1 were obtained when compared with the dark control (DC) and the 
phototreated sample at time 0, revealing significant alterations on peak on the zone of T4-like phage 
proteins. DC, which was also added of DMSO, at times 0, 60 and 90 min revealed no changes in T4-like 
phage proteins during the course of the experiment (Figure 5). 
Chemical modifications and increasing and decreasing peak areas upon Tri-Py+-Me-PF 
photosensitization of T4-like phage after 270 min are summarized in Figure 6.  
 
 
Figure 5. IR spectra of T4-like phage in the dark (DC) after 0, 60 and 90 min in the presence of 5.0 µM Tri-Py+-Me-PF. 
 
 
 Figure 6. IR spectra of T4-like phage after white light irradiation (40 W m-2) after 0, 30, 60, 90 and 270 min in the presence of 
5.0 µM Tri-Py+-Me-PF. 
 
 
Discussion 
It is well established that the ROS generated by PDI are extremely toxic and induce alterations on 
viral molecular structures, such as protein capsids, lipid envelopes and nucleic acids (Käsermann and 
Kempf, 1997; Almeida et al, 2011). In fact, it has been shown that both enveloped and non-enveloped 
viruses can be efficiently inactivated due to the damages induced by PDI on viral proteins (Lenard et al, 
1993; Malik et al, 1993; Moor et al, 1997; Smetana et al, 1998; Hotze et al, 2009; Wong et al, 2010). For 
this reason, it is important to persist in the development of novel, convenient and fast-preparation 
methods to evaluate the damages induced by photosensitization on viral molecular structures. 
The results from this work are in good accordance with what has been stated in the literature, 
about the effect of PDI on viral proteins (Moor et al, 1997; Lim et al, 2002; Hotze et al, 2009), and 
demonstrate that T4-like phage proteins were significantly damaged by photosensitization in the presence 
of 5.0 µM Tri-Py+-Me-PF for 270 min. These results also show that IR spectroscopy can be a promising 
and fast screening method for the detection of protein damages after PDI, which can be used as a first 
approach before the traditional methodology of SDS-PAGE analysis. 
Since a similar number of bands in SDS-PAGE analysis was observed in all samples, protein 
degradation does not appear to be a major consequence of ROS attack. SDS-PAGE analysis revealed 
significant alterations on the density of several protein bands after 90 and 270 min of white light 
irradiation in the presence of 5.0 µM Tri-Py+-Me-PF. Protein bands putatively corresponding to the long 
tail fiber protein (109 kDa), vertex head subunit (46 kDa), head-proximal tip of tail tube (19.7 kDa), and 
four T4-like phage enzymes (Miller, 2003; Kurzepa et al, 2009) revealed a weakened intensity after phage 
photosensitization. On the other hand, two protein bands, one with the same molecular weight of the 
proximal tail sheath stabilizer (31.6 kDa) (Miller, 2003) and other uncharacterized protein of 99.1 kDa 
exhibited an increase in their intensity, when compared with the control without porphyrin, after 270 min 
of irradiation with white light. 
1595 cm
-1
 
When T4-like phage was photosensitized in the presence of 100 mM of sodium azide (a well 
known singlet oxygen quencher) the toxic effect of Tri-Py+-Me-PF was considerably reduced (Figure 2). 
The protein band presumably corresponding to the long tail fiber protein (109 kDa) (Kurzepa et al, 2009), 
which exhibited an accentuated weakening of its intensity in the phototreated sample without quencher, 
showed an intensity identical to the control samples after 270 min or irradiation when sodium azide was 
added to the treated sample (Figure 3B), confirming that sodium azide protected the T4-like phage from 
the light induced Tri-Py+-Me-PF toxic effects.  
Studies from other authors also support the same conclusions of the results obtained with this 
work. Illumination of VSV in the presence of phthalocyanine derivatives caused a decrease in the 
intensity of the glycoprotein (G protein) band and a slight decrease in the intensity of the matrix protein 
(M protein) band. Formation of protein cross-links were also detected, after SDS-PAGE analysis (Moor et 
al, 1997). Contrarily, the formation of protein cross-links was not observed after T4-like 
photosensitization. In another study (Abe and Wagner, 1995), only minor changes on the relative 
abundance of VSV G protein and M13 phage coat protein were observed after photosensitization with 
MB and phthalocyanine derivatives after SDS-PAGE. Also, no additional bands were detected (Abe and 
Wagner, 1995). Protein damage in T7 phage treated with polyhydroxylated fullerene was revealed by 
changes in proteins structure, weakening of some protein bands intensity and by the formation of protein 
cross-links (Hotze et al, 2009).  
The results from IR spectroscopy are in agreement with SDS-PAGE data, confirming the 
existence of significant protein alterations on the photo-treated T4-like phage. Immediately after the 
addition of the PS, in the dark or before irradiation, a change in the peak of amide I with a maximum at 
1629 cm-1 was detected. It is consistent with the attributed effect of dimethyl sulfoxide on proteins, which 
was used to dissolve the porphyrin derivative (Tri-Py+-Me-PF) in this study. It is well-known that the 
addition of organic solvents, like dimethyl sulfoxide, to aqueous solutions of proteins greatly affects the 
conformation of these biomacromolecules (Voets et al, 2010; Fraga et al, 2012). Although at a very small 
percentage (0.05%), when the dimethyl sulfoxide-dissolved porphyrin was added to the phage sample it 
could have affected the proteins, inducing aggregation and increase of β-sheets (Voets et al, 2010), which 
may explain the peak at 1629 cm-1 obtained at time 0 and in the dark controls. However, after 30, 60, 90 
and 270 min of irradiation in the presence of Tri-Py+-Me-PF, IR spectra revealed some important peak 
alterations in the zone corresponding to the region of amides (the same area affected by the DMSO) 
leading to the conclusion that this particular area of the spectrum is extremely sensitive to the toxic action 
of the ROS generated by PDI. Modification in amide I can be attributed to oxidative modifications after 
PDI in protein secondary structures (like β-structures and α-helices), especially since they are told to be 
important structural constituents of T4-like phage capsid, baseplate and tail tube (Leiman et al, 2003; 
Mesyanzhinov et al, 2004), which is in good accordance with the data obtained by SDS-PAGE that 
suggests that some structural phage proteins were changed during the photoinactivation process. 
The increase of the protein peak of 1595 cm-1 and the decrease on the amide I peak of 1629 cm-1 
after PDI may be correlated with the observed alterations of phage protein profile as observed by SDS-
PAGE analysis, revealing significant protein alterations that might be related with T4-like phage 
photoinactivation. 
Although not as specific as SDS-PAGE, which gives us a detailed vision of all the proteins that 
were affected by photosensitization, IR spectroscopy can be efficiently used as an advantageous rapid-
screening method, when the effects of photosensitization on the structure of phage proteins are to be 
studied. In a less time-consuming and in a cost-effective manner, IR analysis can reveal the alterations on 
all viral molecular structures. 
Furthermore, IR spectroscopy has the additional advantage of revealing alterations induced on all 
viral molecular targets, including the proteins, the nucleic acids and the envelope lipids (whether present) 
in one single IR spectrum. Thus, when evaluating the relative importance of different molecular targets, 
IR spectroscopy is suited to reveal the damages induced to all viral constituents, conferring the advantage 
of combining in the same spectrum the results otherwise revealed by three different laborious 
conventional methodologies, turning this methodology less time-consuming and cost-effective.  
In conclusion, since IR spectroscopy was successfully used to assess the protein damages induced 
by 5.0 µM Tri-Py+-Me-PF when irradiated with white light (40 W m-2) during 90 and 270 min, and 
correlated well with the results from SDS-PAGE analysis, it can be used in the future as a promising fast-
screening and cost-effective methodology to evaluate the damages induced by viral PDI. After the initial 
screening, however, to get a further insight into the target damages induced by PDI, conventional 
methodologies like the SDS-PAGE for proteins may also need to be performed. 
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CHAPTER 6 
 
 
Evaluation of resistance development and viability recovery by a non-
enveloped virus after repeated cycles of PDI 
 
Abstract 
Nowadays, the emergence of drug resistant microorganisms is a public health concern. The microbial 
photodynamic inactivation (PDI) has an efficient action against a wide range of microorganisms and can 
be viewed as an alternative approach for treating microbial infections. The aim of this study was to 
determine if a model target virus (T4-like bacteriophage), in the presence of the tricationic porphyrin 
5,10,15-tris(1-methylpyridinium-4-yl)-20-(pentafluorophenyl)porphyrin tri-iodide (Tri-Py+-Me-PF), can 
develop resistance to PDI and recover its viability after photodynamic treatments. To assess the 
development of resistance to PDI after repeated treatments, a suspension of T4-like bacteriophage was 
irradiated with white light (40 W m-2) for 120 min in the presence of 5.0 µM of Tri-Py+-Me-PF (99.99% 
of inactivation) and new phage suspensions were produced from the surviving phages, after each cycle of 
light exposure. The procedure was repeated ten times. To evaluate the recovery of viral viability after 
photoinactivation, a suspension of T4-like bacteriophage was irradiated with white light for 120 min in 
the presence of 5.0 µM of Tri-Py+-Me-PF on five consecutive days. In each day, an aliquot of the 
irradiated suspension was plated and the number of lysis plaques was counted after 24, 48, 72, 96 and 120 
h of dark incubation at 37 ºC. The profile of bacteriophage photoinactivation did not change after ten 
consecutive cycles and no recovery of viability was detected after five accumulated cycles of 
photodynamic treatment. The results suggest that PDI represents a valuable and promising alternative 
therapy to treat viral infections, overcoming the problem of microbial resistance.   
 
 
Introduction 
The introduction of antimicrobial drugs in clinic, in the 1930s, coupled with the use of safe and 
effective vaccines, suggested that infectious diseases could be controlled and, eventually, eradicated. 
Although antimicrobials have saved countless lives and transformed the practice of medicine, the initial 
widespread optimism has proven to be premature and infections still remain the leading cause of mortality 
worldwide. Pathogenic microorganisms are widely spread in nature, there are numerous infection sources, 
and the unfit and prolonged antibiotic and antiviral treatments have led to greater microbial resistance to 
these substances.  
Antimicrobial-resistant pathogens pose an enormous threat to the treatment of a wide range of 
serious infections. Nosocomial and community-acquired agents have developed resistance to a wide range 
 
of antimicrobials and have proven to be highly successful in their ability to develop resistance 
mechanisms, often transferable, against virtually all commonly used antimicrobial drugs (Kimberlin and 
Whitley, 1996; Pillay, 1998; Taylor et al, 2002; Hamblin and Hasan, 2004; Maisch, 2007; Wainwright, 
2009). 
Although there are now many different antimicrobial drugs on the market, the vast majority of 
antimicrobials are antibacterials and, consequently, resistance to antimicrobial drugs is now well 
documented in bacteria (Nishijima et al, 1993; Cookson, 1998; Kömerik et al, 2000; Fridkin, 2001; 
Sievert et al, 2002; Konopka and Goslinski, 2007; Maisch, 2007). Human and animal viruses can also 
develop resistance to antiviral drugs. This may not seem an issue of major concern due to the lack of 
antivirals available, but it should be kept in mind that the use of antiviral drugs is increasing and that 
viruses, being genetically flexible, may mutate quickly and, consequently, the emergence of antiviral drug 
resistance will come as no surprise and will be an everlasting issue. Moreover, the growing availability of 
antiviral drugs and the larger access to combination therapy can lead to the transmission of resistant 
viruses. Transmission of viruses with major resistance mutations may indeed result in partial virological 
response or even therapy failure (Tamalet et al, 2000; Duwe et al, 2001). 
The emergence of antiviral drug resistance requires the research of new alternative methods 
unlikely to cause resistance. Photodynamic inactivation of microorganisms represents a potential 
alternative to meet that need. The main advantages of PDI are the non-target specificity and the potential 
absence of resistance mechanisms due to the mode of action and type of biochemical targets (multi-target 
process) (Jori et al, 2006; Winckler, 2007). Both oxidative mechanisms responsible for the 
photoinactivation of microorganisms, i.e., type I and type II pathways (Wainwright, 1998; Calin and 
Parasca, 2009), lead to highly toxic reactive oxygen species (ROS), such as singlet oxygen (1O2) and free 
radicals (superoxide and hydroxyl radicals), that are able to irreversibly alter microorganisms’ vital 
constituents, resulting in oxidative lethal damage (DeRosa and Crutchley, 2002; Ergaieg et al, 2008).  
The main targets of the viral photodynamic activity are the external structures, such as capsid 
proteins and envelope lipids, and nucleic acids (Vzorov et al, 2002; Egyeki et al, 2003; Wainwright and 
Crossley, 2004; Zupán et al, 2004). The damages to the external microbial structures are sufficient to 
photoinactivate the target microorganism through leakage of microbial contents or inactivation of 
enzymes (Li et al, 1997; Mettath et al, 1999). As the main targets of PDI are the external microbial 
structures, the photosensitizer (PS) does not need to penetrate in the microorganism, having little 
possibility to create or operate any kind of anti-drug mechanisms (Winckler, 2007). 
Until now, the majority of research in this field was done essentially with bacterial strains. 
Photosensitization-resistant mutants have not been found for bacteria (Lauro et al, 2002; Oliveira et al, 
2009; Pedigo et al, 2009). Actinobacillus actinomycetemcomitans, Peptostreptococcus micros, Vibrio 
fischeri and Escherichia coli did not develop resistance to PDI after at least ten cycles of subtotal 
photodynamic inactivation (Lauro et al, 2002; Pedigo et al, 2009; Tavares et al, 2010). Besides that, both 
V. fischeri and E. coli were unable to recover their metabolic activity (Tavares et al, 2010). Moreover, all 
studies that have examined the inactivation of antibiotic resistant bacteria by PDI have found them to be 
as susceptible as their native counterparts (Wainwright, 1998; Embleton et al, 2004; Maisch et al, 2005; 
Trannoy et al, 2006; Maisch, 2007; Grinholc et al, 2008). In spite of all the work with antibiotic resistant 
bacteria, however, there are few studies of PDI using antiviral resistant strains of viruses. The PS 
benzoporphyrin derivative was investigated regarding its ability to destroy azidothymidine (AZT)-
resistant strains of HIV-1. The results showed that AZT-resistant strains appear to be as susceptible to 
photodynamic inactivation as AZT-sensitive strains of HIV (North et al, 1994). Although the recovery of 
viral viability of hepatitis C virus after PDI has already been tested (Cheng et al, 2010), studies 
concerning the development of resistance after repeated exposure to photodynamic treatment have not 
been performed yet.  
The aim of this study is to determine if a model target virus (T4-like bacteriophage), in the 
presence of the tricationic porphyrin 5,10,15-tris(1-methylpyridinium-4-yl)-20-(pentafluorophenyl) 
porphyrin tri-iodide (Tri-Py+-Me-PF), a very promising PS, can develop resistance to PDI after repeated 
photodynamic cycles and recover its viability after photodynamic treatments. The T4-like phage was 
chosen because this phage is used as a model system for understanding general features of viral 
multiplication (Madigan and Martinko, 2006) besides having some important characteristics that make it 
useful as an indicator of enteric viruses, namely the same lifetime, similar structure, size and morphology. 
 
 
Material and Methods 
Photosensitizer 
The tricationic porphyrin Tri-Py+-Me-PF (Figure. 1) used in this work was prepared in accordance 
to the literature (Carvalho et al, 2010). The tricationic porphyrin Tri-Py+-Me-PF was selected as PS 
because this porphyrin, already described by our group, has shown promising results on the 
photoinactivation of several types of microorganisms (Costa et al, 2008; Oliveira et al, 2009; Carvalho et 
al, 2010; Tavares et al, 2010). 
 
 
Figure 1. Structure of the PS used for bacteriophage photoinactivation. 
 
Phage selection and quantification 
A sample of wastewater from a secondary-treated sewage plant near the city of Aveiro (Portugal) 
was used to select the somatic bacteriophages of E. coli C (ATCC 13706) (Costa et al, 2008). The 
quantification of bacteriophages was conducted, in duplicate, by the agar double layer technique (Adams, 
1959) using the aforementioned strain of E. coli (Costa et al, 2008). 
 
Photoinactivation assay 
Phage photoinactivation by Tri-Py+-Me-PF, at the concentration of 5.0 µM, was achieved by 
exposing the T4-like phage in laboratory conditions to white light (13 fluorescent lamps OSRAM 21 of 
18W each, 380–700 nm) with a fluence rate of 40 W m-2 (measured with a light meter LI-COR Model LI-
250) during defined time intervals, with agitation (100 rpm). Dark and light controls were also included in 
the experiment and were carried out simultaneously. In the light control (LC), the phage suspension 
without PS was exposed to the same irradiation protocol. In the dark control (DC), the beaker containing 
the phage suspension and the PS at the studied concentration (5.0 µM) was covered with aluminium foil 
to protect it from light exposure. Sub-samples of 1.0 mL of test and control samples were aseptically 
taken at times 0, 60, 90, 180, and 270 min. The rate of phage inactivation was evaluated through the 
quantification of the number of phages as previously referred (Costa et al, 2008). Two independent 
experiments were carried out with two replicates each. 
 
PDI resistance assay 
To check for the development of resistance to PDI, new phage suspensions were produced after 
each cycle of exposure to photodynamic treatment. In order to obtain a modest phage inactivation, the 
phage suspension in the presence of Tri-Py+-Me-PF (5.0 µM) was exposed to white light in cycles of 120 
min (28.8 J cm-2) in the same conditions of the aforementioned photoinactivation assay. This will allow to 
test if the phages affected by the PS, though not in such a drastic way as occurs when they are irradiated 
for a long period (270 min), are able to develop resistance to PDI. After each cycle of 120 min, sub-
samples of 1.0 mL were aseptically taken and plated by the double agar layer technique. Three phage 
plates were picked up with an inoculation loop and added to 1.0 mL of an E. coli exponential phase 
culture in TSB medium. After 4–5 h of incubation at 37 ºC, the suspension was centrifuged at 10.000g 
during 10 min. The pellet was discharged and the supernatant was collected into a new tube, and kept as a 
new phage stock. An aliquot of 50 µL of the new phage stock was diluted 1:100 in PBS and submitted to 
a new cycle of photodynamic treatment, using the previously described irradiation protocol. Phage 
enumeration was also performed as previously described. Dark and light controls were included in all 
inactivation cycles. This procedure was repeated for ten consecutive cycles. The experiment was 
performed three times and the results were presented as the average means. 
 
PDI viability recovery assay 
Phage photoinactivation in the presence of 5.0 µM Tri-Py+-Me-PF was achieved by exposing the 
phage to white light (40 W m-2) irradiation in the conditions described above, for 120 min, in order to 
obtain only a modest phage inactivation. This procedure allows us to check if the phages affected by the 
PS, though not in such a drastic way as occurs when they are irradiated during 270 min, are able to 
recover their viability. Dark and light controls were also prepared as described above and included in all 
inactivation cycles. Five sub-samples of 1.0 mL of the irradiated phage suspension in the presence of PS, 
LC and DC samples were aseptically taken at time 120 min and plated by the double agar layer technique. 
All Petri plates were incubated at 37 ºC, in the dark, and the number of lysis plaques was counted in each 
of the five Petri plates, after 24, 48, 72, 96 and 120 h, in order to detect the delayed development of lysis 
plaques. The remaining phage suspensions, after the first cycle of irradiation, were kept at room 
temperature in dark conditions for 24 h. After this period, phage suspensions were submitted to a new 
cycle of irradiation (120 min, 40 W m-2) and sub-samples taken and plated following the same procedure. 
This methodology was repeated five times intercalated by 24 h of dark incubation at room temperature. 
 
Statistical analysis 
SPSSWIN 15.0 was used for data analysis. The significance of differences in phage inactivation 
was assessed using one-way ANOVA. Only the data with normal distribution (assessed by Kolmogorov-
Smirnov test) and with homogeneity of variances (assessed by Levene test) was used. A value of p < 0.05 
was considered significant. All experiments were done at least in duplicate. 
 
 
Results 
Bacteriophage response to photoinactivation 
After 270 min of white light irradiation, in the presence of 5.0 µM Tri-Py+-Me-PF, the phage was 
almost completely inactivated (∼ 7 log) (Figure 2). Consequently, in the PDI resistance studies and 
recovery assays, a shorter irradiation time (120 min) was used, in order to obtain a modest phage 
inactivation (∼ 3 log). It was possible, with such procedure, to obtain a sizeable number of lysis plaques, 
which were used to study the possible development of resistance and phage recovery.  
The results of light and dark controls show that phage viability was neither affected by irradiation 
itself nor by the direct effect of the PS in the dark (Figure 2). This indicates that the reductions obtained 
on phage survival after irradiation of the treated samples are only due to the photosensitizing effect of the 
porphyrin. 
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Figure 2. Variation of the number of bacteriophages after irradiation with white light (40 W m-2) in the presence of Tri-Py+-
Me-PF at 5.0  µM. (open square: LC, asterisk: DC, filled square: 5.0 µM). The values are expressed as the mean of two 
independent experiments; error bars represent the standard deviation (small bars are overlapped by the symbols). 
 
 
PDI resistance study 
The rate of phage inactivation in ten consecutive treatments with Tri-Py+-Me-PF at 5.0 µM was 
almost the same (Figure 3). The number of surviving phages was approximately the same in all cycles of 
irradiation (∼ 5 log of surviving phages). That means no appreciable development of resistance in 
partially inactivated phages was observed. In fact, the efficiency of photoinactivation underwent no 
significant change in ten subsequent irradiation cycles (ANOVA, p > 0.05). In each phototreatment, the 
differences between replicates were not significant either (ANOVA, p > 0.05). 
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Figure 3. Photodynamic inactivation efficiency during ten consecutive T4-like phage generations, in the presence of 5.0 µM 
Tri-Py+-Me-PF after 120 min of irradiation with white light (40 W m-2). The values are expressed as the mean of three 
independent experiments (three different phage plates); N0 represents the number of initial phages determined by phage plaque 
counts before the irradiation and N represents the number of surviving phages determined by phage plaque counts after 
irradiation of each experiment; error bars represent the standard deviation. 
  
PDI viability recovery study 
After the first cycle of partial photodynamic inactivation, the phage numbers were reduced to ∼ 4 
log and the number of lysis plaques did not vary significantly (ANOVA, p > 0.05) for each sample during 
the following 120 h (5 days) of incubation at 37 ºC in the dark (Figure 4). After the second cycle of 
irradiation, the phage numbers were reduced to ∼ 2 log and, as for the first cycle, the number of phage 
plaques did not increase after 120 h of incubation (ANOVA, p > 0.05) (Figure 4). After the third cycle of 
irradiation, the phages were inactivated to the detection limit and the formation of new lysis plaques was 
not observed during the following 120 h. The number of lysis plaques was similar in both controls during 
the 120 h of incubation at 37 ºC, in the five cycles of irradiation (ANOVA, p > 0.05). 
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Figure 4. Variation of the number of T4-like bacteriophages after irradiation with white light (40 W m-2) during 120 min in 
presence of Tri-Py+-Me-PF at 5.0 µM, after 24, 48, 72, 96 and 120 h, for five cycles of treatment. For each cycle five Petri 
plates were used for both controls and for the sample. Error bars represent the standard deviation. 
 
 
Discussion 
In this study, it was demonstrated that: (1) the tricationic porphyrin Tri-Py+-Me-PF has antiviral 
activity and effectively inactivates T4-like phage (reduction of ∼ 7 logs) after irradiation with white light. 
The inactivated phages do not recover their viability after 120 h of dark incubation; (2) viruses that 
survived to short treatments, in the presence of 5.0 µM Tri-Py+-Me-PF, do not develop resistance after ten 
repeating cycles of PDI.  
In general, the development of resistance to photosensitization by microorganisms should be 
considered as an unlikely event, because this is typically a multi-target process, which marks the 
difference between PDI and the mechanism of action of most antimicrobial drugs (Maisch et al, 2004). 
Moreover, it is questionable if microorganisms can develop resistance to ROS, which mediate 
photodynamic inactivation. Up to now, there are only a few reports concerning a potential specific 
resistance mechanism against ROS. Although antioxidant enzymes, such as superoxide dismutase, 
catalase and peroxidase, give protection against some ROS, they do not protect against singlet oxygen 
(Wainwright and Crossley, 2004) that, according to the literature, is the main ROS through which the PS 
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exert their photodynamic action (Nitzan et al, 1989; Müller-Breitkreutz et al, 1995; Hadjur et al, 1998; 
Maisch et al, 2005; Maclean et al, 2008). Moreover, these enzymes are also inactivated by singlet oxygen 
(Kim et al, 2001). The results of this study corroborate the literature (Lauro et al, 2002; Tavares et al, 
2010) in what concerns to the absence of resistance mechanisms in bacteria exposed to photodynamic 
inactivation events. This finding is of particular interest mostly because the effect of consecutive 
phototreatments on the possible gain of viral resistance had not yet been addressed.  
The results of the resistance assay show that, after ten consecutive phototreatments, the T4-like 
phage did not exhibit any evident signs of resistance to PDI. The porphyrin Tri-Py+-Me-PF can 
potentially lead to simultaneous binding to several components/ subunits of the viral capsid and to the 
nucleic acid (DNA), avoiding the development of resistance to photosensitization. The virus would 
require multi-site mutations to become resistant, an event with significantly lower probability than single-
site mutation which is often sufficient for conferring resistance to small molecule inhibitors. 
When the phage was subjected to ten consecutive PDI cycles, the fraction of non-inactivated 
viruses did not show strong variation between cycles. After the first exposure to white light, the phage 
plaques produced after irradiation of the viral suspension were used to produce new phage stocks in the 
presence of host bacterial cells. After ten consecutive sessions of 120 min with 5.0 µM Tri-Py+-Me-PF, 
any reduction in the efficacy of the photosensitization of T4-like phage was observed. If phage resistance 
to PDI would occur, significant reductions on phage photoinactivation efficiency would be detected 
between experiments. This would be interpreted as an indication of enhanced resistance of the phages of 
later generations in relation to the ones in the initial stocks. However, this was not observed, thus 
invalidating the hypothesis of the acquisition of resistance to PDI by bacteriophages. Although there were 
some variations between treatments and even between the three replicas of each treatment, these 
differences were not significant (ANOVA, p > 0.05) and were possibly due to different concentrations of 
the distinct suspensions of phages produced before each cycle of photoinactivation. 
The multi-target property of PDI can also explain the irreversible effects on the bacteriophage 
viability by the tricationic porphyrin Tri-Py+-Me-PF after 120 min of irradiation. T4-like bacteriophage 
was irradiated for 120 min in order to obtain only a modest phage inactivation. This allowed us to test if 
the phages were affected by the PS, though not in such a drastic way, as happened when irradiated for 
long period of time (270 min), during which all phages are inactivated and are able to recover their 
viability. During 120 h of incubation after phototreatment, the phages, by being in the presence of their 
host, have all the necessary conditions to recover from the photodynamic treatment. If new phage plaques 
would appear in the Petri plates during the 5 days of dark incubation it would mean that the 
bacteriophages, previously not able to produce plaques, after the ‘‘lethargy period’’ become competent to 
recover from the PDI treatment. However, the phages were not able to recover their viability in the 120 h 
post-phototreatment period. This indicates that when the phages are efficiently inactivated they cannot 
recover from the photodynamic effect. Using a period of irradiation of 120 min, the phages were 
inactivated to the limits of detection only after three consecutive cycles and did not recover within 120 h. 
This result indicates that, although one cycle of 120 min of photodynamic treatment with Tri-Py+-Me-PF 
is not enough to inactivate all the phages in the suspension, the phages inactivated after this time do not 
recover their viability. This is in accordance with what was found for hepatitis C virus, which did not 
recover its viability after exposure to 5,10,15,20-tetraki(3,5-dicarboxy-4,4’-biphenyl)porphyrin (Cheng et 
al, 2010). 
In conclusion, the results of this study show that Tri-Py+-Me-PF has potential use as an efficient 
alternative to conventional antimicrobial drugs to treat viral infections. With this PS, viral resistance and 
the potential recovery of viral viability after photodynamic treatment are not a problem. 
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CHAPTER 7 
 
DISCUSSION 
 
Several factors including the PS concentration, the number of charges and the nature and location 
of the meso-substituent groups on the PS macrocycle (Costa et al, 2008), can affect the microbial 
photoinactivation. Among other factors, phage PDI is also influenced by the light source and the light 
dose and fluence rate used to excite the PS, as demonstrated by the results of the present study. The rate 
and extent of T4-like phage PDI increased with the increase of the light fluence rate and, for the same PS 
concentration, a higher light fluence rate considerably reduces the time needed to achieve the same 
amount of inactivation (∼ 7 log). When the same light dose was delivered by the same light source at 
different fluence rates, the rate of T4-like phage PDI was higher for lower fluence rates, that is, longer 
irradiation times. 
The two cationic porphyrin derivatives, at relatively low concentrations (0.5 and 5.0 µM), when 
irradiated with white light (40 Wm-2) can efficiently photoinactivate DNA- and RNA-type non-enveloped 
viruses (reductions of 6-7 log). Bacteriophage photosensitization proceeds mainly via the mechanism 
involving the production of singlet oxygen (type II mechanism), as was revealed by the presence of 
singlet oxygen quenchers. Free radical scavengers also indicate the participation of radical species (type I 
mechanism), although at a minor scale. For that reason, their participation on phage PDI cannot be ruled 
out. Singlet oxygen and free radicals are known to induce damages to several viral molecular structures 
which include the viral proteins, lipids and nuclei acids (Käsermann and Kempf, 1997). In this study, the 
ROS produced after irradiation of a cationic porphyrin induced significant alterations on T4-like phage 
proteins, as revealed by SDS-PAGE analysis and IR spectroscopy. Since viral PDI is a multi-target 
process, the possibility of resistance development is very improbable and, in fact, T4-like phage did not 
develop any kind of resistance to viral PDI, even after consecutive cycles of photosensitization. Besides 
this, once inactivated by photodynamic procedures, T4-like phage did not recover its viability.  
In order to elaborate an efficient protocol for viral PDI, it must inevitable focus on several factors 
influencing the photodynamic effect. The rate and extent of viral photosensitization, among other factors, 
is affected by the type and concentration of PS and also by the light source used to excite the PS, as well 
as by the fluence rate throughout the process. The energy dose is also an important parameter that must be 
taken into account in a viral PDI episode.  
 Tetra-Py+-Me and Tri-Py+-Me-PF, when irradiated with different sources of light, including 
fluorescent PAR lamps (40 W m-2), sun light (600 W m-2) and a halogen lamp (1690 W m-2), can 
efficiently photoinactivate the T4-like phage. However, the rate and the extent of T4-like phage 
inactivation varied with the nature and concentration of the PS, the light source used to irradiate the phage 
suspensions, and with the applied energy dose. 
Depending on the light source used, different irradiation periods are required to obtain the same 
rate of phage inactivation. Tri-Py+-Me-PF and Tetra-Py+-Me, irradiated under the same conditions, 
differently inactivated the T4-like phage. At a PS concentration of 5.0 µM, sources providing higher 
fluence rates required shorter periods of irradiation to achieve a 7 log reduction. However, when the 
lowest PS concentrations were used (0.5 and 1.0 µM), the rate of T4-like phage PDI was lower for the 
halogen lamp, when compared with the other two light sources. Increasing the PS concentration at a fixed 
light dose leads to an increased rate of inactivation, as does an increase in the irradiation period at a fixed 
PS concentration. Besides this, the rate of phage inactivation with Tri-Py+-Me-PF was also dependent on 
the light source used, even when the given fluence rate was the same. At 40 W m-2, phage inactivation 
with fluorescent lamps is much more efficient than with the halogen lamp, under the same experimental 
conditions (fluence rate, irradiation time and PS concentration). Although the PS concentration is the 
same, the emission spectra of these two lamps are different and, consequently, the energy available to 
excite the PS is not the same. Part of the energy provided by the halogen lamp (650-800 nm) is probably 
not used to excite the PS. On the other hand, most of the energy emitted by the set of fluorescent lamps 
(380-700 nm) coincides with peaks of PS light absorption. Contrarily, the fluence rate of 600 W m-2 
produced a similar amount of inactivation whether supplied by the halogen lamp or the sun itself. The 
light source used for PDI must exhibit suitable spectral characteristics that coincide with the maximum 
absorption wavelength range of the PS in order to generate enough ROS to produce an efficient toxic 
effect (Robertson et al, 2009).  
When the same energy dose is delivered by the same light source, but at different fluence rates 
(150, 300, 600 and 1200 W m-2), the efficacy of T4-like phage PDI is inversely proportional to the light 
intensity. Phage PDI is more effective if the energy dose is received during longer irradiation periods (low 
fluence rates). An increase in the fluence rate enhances the killing effect; however, it seems to be an 
upper limit of photons to observe this effect. In fact, if the number of photons is higher than this limit, the 
antimicrobial effect will decrease because the PS in the suspension will not be able to absorb all the 
photons in excess. This may explain what happened when the high light intensity was used (Qin et al, 
2008; Prates et al, 2009). Other authors reached the same conclusion, that low fluence rates caused more 
damage than high fluence rates for the same total light dose (Foster et al, 1993; Veenhuizen and Stewart, 
1995; Robinson et al, 1998). However, another study suggested that the rate of inactivation is a function 
of the energy dose, irrespective of the fluence rate used to provide that dose. The inactivating light may 
be applied at high fluence rate over a short time or at a lower fluence rate over a longer time (Maclean et 
al, 2008).  
According to the results obtained with this study, both DNA- and RNA-type bacteriophages can 
be efficiently photoinactivated by Tri-Py+-Me-PF when irradiated with white light (40 W m-2) during 270 
min; however, RNA-type phages are considerably more susceptible to PDI than the DNA-type ones, 
requiring ten times lower porphyrin concentration (0.5 µM) and only 60-90 min of irradiation, when 
compared with the 180-270 min required to produce the same rate of inactivation (6-7 log)  on DNA-type 
phages. According to the observed differences, it seems reasonable to assume that the inactivation process 
is dependent on the nucleic acid type of phages. It is well known that the capsids of the DNA-type phages 
used in this work are far more complex and composed of a higher number of different proteins (Fokine et 
al, 2004; Mesyanzhinov et al, 2004) than those of RNA-type phages (Cho et al, 2005). The major 
difference between DNA- and RNA-type phages PDI may not only reside on their nucleic acids, but also 
on the nature of their capsid proteins, which are considered to be the main targets of non-enveloped 
viruses PDI (Hotze et al, 2009). The differences in the inactivation kinetics, which were observed 
between DNA- and RNA-type phages, may be attributed to dissimilarities in their structure and 
composition.  Contrarily to DNA, short-lived RNA molecules are rapidly degraded in living 
microorganisms by enzymes (RNase), which are very stable even in harsh environments (Sela et al, 1957; 
Sheridan et al, 1998). Consequently, in the case of viruses, the type of nucleic acid can be an important 
and determinant factor of the efficiency of viral PDI. Moreover, as for bacteria, the damages in the viral 
DNA can yet be repaired by the action of DNA repairing systems of the host cells (Imray and MacPhee, 
1973), but it is impossible for the host cells to repair the damaged RNA of viruses. Therefore, DNA-type 
viruses tend to be more genetically stable than RNA-type viruses. 
As far as it is known, the results of viral PDI with DNA- and RNA-type phages showed that, 
under the same protocol, RNA-type phages are more easily inactivated than DNA-type ones (Specht, 
1994; Hotze et al, 2009). However, is not easy to draw a clear picture of the effect of the viral nucleic 
acid type on phage photosensitization due to the lack of diversity of RNA-type phages used in phage PDI 
(only MS2 phage was tested) in assays were several DNA-type phages are used. PDI effect on phage 
nucleic acids was already tested for non-enveloped DNA-type phages like M13 (Abe and Wagner, 1995). 
After methylene blue (MB) treatment, M13 phage DNA was damaged, which correlated with phage 
photoinactivation, leading to the conclusion that DNA might be an important target of PDI (Abe and 
Wagner et al, 1995). DNA-type phages like PRD1 and T7 were also studied, but their DNA was shown to 
be relatively less affected than the proteins after photosensitization in the presence of fullerene derivatives 
(Hotze et al, 2009). T7 phage PDI in the presence of porphyrin derivatives was shown to be mediated by 
protein oxidation (Gábor et al, 2001; Zupán et al, 2008) and also by damages on the DNA (Zupán et al, 
2008). Oxidative damage of Qβ phage RNA alone by MB did not directly account for Qβ phage 
inactivation (Floyd et al, 2004). Instead, photoinactivation was mainly mediated by protein damages as 
revealed by the formation of viral RNA-proteins cross-links (Schneider et al, 1998; Floyd et al, 2004). 
Although enveloped phages are told to be more sensitive to viral PDI than their non-enveloped 
counterparts (Lytle et al, 1991; Smetana et al, 1994; Käsermann and Kempf, 1998), due to damages on 
their external structures, nothing is known about the effect of viral PDI on their lipids. However, the 
results from Lytle et al (1991) with the enveloped RNA-type φ6 phage, although indirectly, are in good 
accordance with what is said in the literature about the major contribution from lipids for the viral 
photoinactivation process. 
In this study, four DNA- and three RNA-type phages were used, and all RNA-type phages were 
significantly more easily photoinactivated than any of the DNA-type ones.  
It is well established that the efficiency of viral PDI is strongly correlated with the ability of a PS 
to generate singlet oxygen (type II mechanism) and/or free radical species (type I mechanism), after being 
excited by light in the presence of molecular oxygen. In order to define the optimal conditions of a PDI 
protocol and to design improved and more efficient PS, it is important to determine which ROS are 
produced during a photodynamic procedure and the main mechanism by which phage PDI occurs.  
After several experiments with Tri-Py+-Me-PF and Tetra-Py+-Me at 0.5 and 5.0 µM, respectively 
for T4-like and Qβ phages, irradiated by white light of 40 W m-2 during 270 and 90 min, respectively, in 
the presence of singlet oxygen and free radicals scavengers, it was concluded that type II mechanism 
(production of singlet oxygen) is the main process responsible for the inactivation of both phages by these 
PS. Phage PDI was dependent on the PS used and on the concentration of the tested scavengers. T4-like 
and Qβ phages were mainly photoinactivated by type II mechanism, as revealed by the presence of singlet 
oxygen quenchers sodium azide and L-histidine. However, the protective effect of the scavengers was 
lower for Qβ, when compared with T4-like phage. Due to the easier photoinactivation of Qβ phage, it 
may be assumed that the ROS present in the phage suspension during the irradiation period had enough 
time to exert their toxic effect on the phage molecular structures before starting to be scavenged. 
The results obtained with this study corroborate well with what is stated in the literature (O’Brien 
et al, 1992; Rywkin et al, 1992; Lenard and Vanderoef, 1993; Müller-Breitkreutz et al, 1995; Dewilde et 
al, 1996; Wainwright, 2003; Badireddy et al, 2007; Mroz et al, 2007). However, although singlet oxygen 
is shown as the main ROS on viral PDI, the participation of free radical species cannot be ruled out. In 
some cases, type I mechanism may be equally or even more effective than type II mechanism (Abe et al, 
1997; Gábor et al, 2001; Egyeki et al, 2003; Hotze et al, 2009). 
Phage PDI was largely reduced by sodium azide (100 mM). Sodium azide protected T4-like and 
Qβ phages from the toxic effect of the singlet oxygen generated by Tri-Py+-Me-PF, reducing the rate of 
phage PDI by 80% and 39%, respectively. In the presence of Tetra-Py+-Me, T4-like phage was 
considerably more protected by 100 mM of sodium azide (90% of protection). L-histidine (100 mM) was 
slightly less efficient in protecting T4-like phage from the toxic effect of the singlet oxygen generated by 
Tri-Py+-Me-PF (72% of protection) and Tetra-Py+-Me (78% of protection). These results show that both 
PS (Tri-Py+-Me-PF and Tetra-Py+-Me) have similar behaviour on viral PDI. 
Contrarily, free radical species did not seem to be very active participants in this particular study 
due to the reduced degree of protection against Tri-Py+-Me-PF and Tetra-Py+-Me, conferred by D-
mannitol and L-cysteine, when compared with singlet oxygen quenchers. D-mannitol (100 mM) protected 
T4-like phage by 20%, in the presence of Tri-Py+-Me-PF, after 180 min of irradiation. D-mannitol also 
did not protect Qβ phage from photosensitization. L-cysteine at a concentration of 100 mM protected T4-
like phage by 9% from the free radicals generated by Tri-Py+-Me-PF. Besides this, the rate of T4-like and 
Qβ phages PDI was identical whether the effect of singlet oxygen and free radicals scavengers was tested 
separately in independent assays or combined in the same sample, excluding the possibility of a 
synergistic effect between both types of scavengers, as observed in other studies (Gábor et al, 2001; 
Egyeki et al, 2003). 
It can then be concluded that, although T4-like and Qβ phages PDI proceeds at different times and 
rates, the mechanism of photosensitization is not affected by the phage type. In fact, T4-like and Qβ 
phages PDI occurred in a very similar way, when the same PS and scavengers were used, leading us to 
conclude that the main mechanism by which viral photosensitization takes place is the same (type II 
mechanism), whether using a DNA- or a RNA-type phage, depending however on the type of PS which is 
used. 
It is well known that the ROS produced during viral PDI are extremely reactive and induce 
damages on several important biomolecules, such as proteins, lipids and nucleic acids (Käsermann and 
Kempf, 1997), to induce oxidation, cleavage, cross-linking and modification, which eventually cause 
damage (Niki, 1991). As the understanding of a particular PS toxicity implies the knowledge of its 
microbial targets, it is important to evaluate the damages on viral molecular structures, namely on viral 
proteins, which are considered to be one of the main targets of viral PDI.  
According to SDS-PAGE and IR spectroscopy analysis, T4-like phage proteins were considerably 
affected by photosensitization after 270 min of white light irradiation (40 W m-2), in the presence of 5.0 
µM Tri-Py+-Me-PF, showing that they can be important targets of viral PDI. Though not as specific as 
SDS-PAGE, which allows a detailed analysis of all the affected proteins, the similar results obtained by 
SDS-PAGE and IR spectroscopy make the latter a promising and innovative fast screening methodology 
for the detection of protein damages after viral photosensitization, overcoming the delays associated with 
SDS-PAGE analysis, in a less time-consuming and cost-effective way. These results are in accordance 
with what is stated on the literature, which imply the phage proteins as critical targets of viral PDI (Abe 
and Wagner, 1995; Moor et al, 1997; Lim et al, 2002; Egyeki et al, 2003; Hotze et al, 2009). 
SDS-PAGE analysis of T4-like phage proteins after 90 and 270 min of PDI, in the presence of 5.0 
µM Tri-Py+-Me-PF, revealed significant alterations on the density of several protein bands. Protein bands 
presumably corresponding to the long tail fiber protein (109 kDa), vertex head subunit (46 kDa), head-
proximal tip of tail tube (19.7 kDa), and four T4-like phage enzymes (Miller, 2003; Kurzepa et al, 2009) 
revealed a weakening of their intensity after phage photosensitization. Contrarily, other protein bands, 
like those putatively corresponding to the proximal tail sheath stabilizer (31.6 kDa) (Miller, 2003) and 
one uncharacterized protein of 99.1 kDa exhibited an increasing in their intensity, when compared with 
the control without porphyrin, after 270 min of irradiation with white light.  
Since the same number of bands was observed in all lanes and the formation of protein 
agglomerates was not observed, neither protein fragmentation nor the formation of protein cross-links 
seemed to be a major consequence of ROS attack on T4-like phage proteins. The phototreatment of T4-
like phage by Tri-Py+-Me-PF pointed to significant alterations in the proteins structure, which may be the 
cause of phage photodynamic inactivation. 
After 270 min of irradiation in the presence of sodium azide (100 mM), the protein band 
presumably corresponding to the long tail fiber protein (109 kDa), which is important for host 
recognition, was not affected by photosensitization. At the end of the experiment, the protein band 
intensity is identical to that of the control without porphyrin (LC), revealing a significant protective effect 
of singlet oxygen quencher sodium azide, as was already shown. 
In what concerns to the results obtained with the IR spectroscopy, it can also be concluded that 
T4-like phage exhibits significant protein alterations after 30, 60, 90 and 270 min of irradiation in the 
presence of 5.0 µM Tri-Py+-Me-PF. Immediately after the addition of the PS, in the dark or before 
irradiation (time 0), a change in the peak of amide I with a maximum at 1629 cm-1 was detected. It is 
consistent with the attributed effect of dimethyl sulfoxide on proteins (Voets et al, 2010), which is used to 
dissolve the porphyrin derivative (Tri-Py+-Me-PF) in this study. However, after 30, 60, 90 and 270 min of 
irradiation, IR spectra revealed some important peak alterations in the zone corresponding to amides (the 
same area affected by the DMSO) leading to the conclusion that this particular area of the spectrum is 
extremely sensitive to the toxic action of the ROS generated by PDI. Reductions in amide I peak areas 
can be attributed to oxidative modifications in protein secondary structures (like β-structures and α-
helices), specially since they are told to be important structural constituents of T4-like phage capsid, 
baseplate and tail tube (Leiman et al, 2003; Mesyanzhinov et al, 2004). 
Damages in external components, as revealed by SDS PAGE analysis and IR spectroscopy, 
suggest that T4-like phage PDI resulted from the loss of ability to bind to the host receptors and 
subsequent impairment of infectivity, as observed by Hotze et al (2009) after T7 phage PDI in the 
presence of polyhydroxylated fullerene. 
The increase in the peak area corresponding to 1595 cm-1 and the decrease in the region of 1629 
cm-1, as revealed by the results of IR spectroscopy analysis may be correlated with the observed protein 
damages by SDS-PAGE analysis.  
From the similar results obtained with both methods, it can be concluded that, although not 
specific and detailed as SDS-PAGE analysis, which allows the determination of proteins molecular 
weights and reveals the changes on proteins density and charge and the formation of protein cross-links 
(Schneider et al, 1999; Floyd et al, 2004; Hotze et al, 2009), IR spectroscopy can be seen as a promising 
and fast screening method, when the damages on viral proteins after PDI are to be detected. Besides, one 
single IR spectrum reveals the alterations in all viral molecular structures, which include the nucleic 
acids, capsid and internal proteins and lipids (whether present). Consequently, IR spectroscopy represents 
a very promising tool for the evaluation of the molecular damages induced by PDI, since one sample is 
just enough to reveal the most damaged targets and which one is being the most damaged one under the 
same PDI conditions. For this reason, IR spectroscopy is less time-consuming and a cost-effective 
procedure, when compared with the laborious and more expensive SDS-PAGE analysis. 
Since viral PDI is typically a multi-target process, the development of resistance to 
photosensitization is considered to be a very unlikely event (Maisch et al, 2004). However, to make use of 
viral PDI as an efficient alternative to conventional antiviral drugs, all aspects concerning the possibility 
of resistance development and viral viability recovery have to be cleared up.  
The results from this study demonstrated that T4-like phage does not recover its viability after 120 
h of dark incubation at 37 ºC, when treated with 5.0 µM Tri-Py+-Me-PF for 120 min under white light 
irradiation (40 W m-2). When applied to the same PDI protocol, the T4-like phages that survived to a sub-
lethal photosensitization episode, did not develop resistance, even after ten repeating cycles of porphyrin 
phototreatment.  
These findings are of extreme importance since, as far as it is known, this is the first report 
focusing on the issue of viral resistance after several episodes of viral photosensitization. Although there 
are no other studies focusing on the possibility of viral resistance development and/or viability recovery 
after PDI, the results of this study are in accordance with what is known about bacterial PDI (Lauro et al, 
2002; Tavares et al, 2010). These studies also showed that the bacteria exposed to consecutive PDI events 
did not develop any resistance mechanisms. 
As stated above, the ROS produced by Tri-Py+-Me-PF (especially singlet oxygen) can potentially 
attack several viral molecular structures, such as the capsid proteins and the DNA, which avoids the 
development of resistance to photosensitization. The phage would require multi-site mutations to become 
resistant, an event with significantly lower probability than single-site mutation, which is often sufficient 
for conferring resistance to small molecule inhibitors (like antiviral drugs). On the other hand, the PS 
used in PDI are not consumed (a situation that only happens when they are not stable under light, 
undergoing a process called photobleaching) during the process of photosensitization differing from what 
happens with the conventional antimicrobial drugs, which are consumed after the antiviral treatment. The 
PS are only used as catalysts for the production of toxic ROS, which also contributes to avoid the 
development of resistance. Moreover, it has been shown that the PS do not need to penetrate into the 
microorganisms to achieve an efficient inactivation, which is also another factor favouring the lack the 
viral resistance (Zupán et al, 2008). After ten consecutive cycles of PDI, of 120 min each, T4-like phage 
did not suffer any reduction on the rate of inactivation. If phage resistance to photosensitization would 
occur, significant reductions on phage PDI efficiency would be detected between subsequent 
experiments. Although there were some variations between treatments and even between the three 
replicas of each treatment, the differences were not statistically significant (ANOVA, p > 0.05) and were 
possibly due to different concentrations of the distinct suspensions of phages produced before each new 
cycle of photoinactivation. 
The multi-target nature of viral PDI can also explain the irreversible effects on the bacteriophage 
viability by Tri-Py+-Me-PF after 120 min of irradiation. During the 120 h of incubation after 
phototreatment, the phages are incubated in the presence of their bacterial host, which offers them all the 
necessary conditions to recover from the photodynamic treatment. If new phage plaques would appear in 
the Petri plates, during the 5 days of dark incubation, it would mean that the bacteriophages, previously 
not able to infect their host, after the ‘‘lethargy period’’ become competent to recover from PDI. As 
expected, the phages were not able to recover their viability in the 120 h post-phototreatment period. 
When the phages are efficiently inactivated they cannot recover from the photodynamic effect.  
 
In conclusion, it can be shown that (i) for the same PS concentration, higher fluence rates required 
shorter irradiation times to produce the same amount of inactivation. Also, the same light dose is more 
effective if given for longer periods of irradiation. For these reasons, light parameters such as light source, 
fluence rate and total light dose played an important role in the effectiveness of phage PDI, and they 
should always be considered when establishing an optimal antiviral protocol; (ii) bacteriophage PDI in 
the presence of cationic porphyrin derivatives under white light irradiation, although very efficient for 
both DNA- and RNA-type phages, is considerably different for these two phage types, with the latter 
being considerably more susceptible to PDI; (iii) bacteriophage PDI in the presence of Tri-Py+-Me-PF 
and Tetra-Py+-Me proceeds mainly by singlet oxygen generation (type II mechanism). However, the 
participation of free radicals species (type I mechanism) cannot be ruled out; (iv) PDI significantly 
affected the phage proteins, as revealed by the changes in proteins density after SDS-PAGE analysis, and 
by the changes on 1629 and 1595 cm-1 peak areas as revealed by IR spectra analysis; and (v) Tri-Py+-Me-
PF can be efficiently used for phage PDI without the risk of viral resistance development or the 
possibility of the phage to recover its viability, as revealed after consecutive episodes of photodynamic 
treatment.  
 
 
FUTURE WORK 
Although bacteriophage PDI is already successfully in use, the understanding of several aspects of 
the process of photosensitization is still in its infancy. Future work will supply a tool to clear up and get 
further knowledge of the following points: 
• evaluation of the damages induced by photosensitization on phage nucleic acids (DNA 
and RNA); 
• evaluation of the damages induced by photosensitization on the lipids of enveloped 
phages; 
• effectiveness of immobilized photosensitizers for phage photosensitization and evaluation 
of their possible re-utilization; 
• evaluation of the applicability of photosensitization in the inactivation of mixed viral 
populations; 
• evaluation of the efficiency of photosensitization in animal models. 
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